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Multiple regression modeling techniques allow for rapid and accurate prediction of 
migration times and resolution values for micellar electrokinetic chromatography (MEKC) as 
well as the development of quick screening methods using steady-state fluorescence 
spectroscopy.  All studies reported in this dissertation include optimization of calibration models 
and predictions of dependent variables by the use of validation samples.  The root-mean-square 
percent relative error (RMS%RE) is used as a figure of merit for characterizing the performance 
of the calibration models. MEKC separations of achiral and chiral analytes were performed using 
an achiral molecular micelle, poly(sodium N-undecylenic sulfate), and chiral molecular micelles, 
poly(sodium N-undecanoyl-L-leucylvalinate) or poly(sodium N-undecanoyl-L-isoleucylvalinate), 
at various operating temperatures, applied voltages, pH, and molecular micelle concentrations in 
the background electrolyte.  The RMS%RE values of predicted migration time, resolution, and 
resolution per unit time of the chiral as well as the achiral analytes ranged from 8.78 to 37.73% 
for all MEKC studies.  Chiral analysis using steady-state fluorescence spectroscopy was 
employed to investigate the use of chiral molecular micelles as chiral selectors by multivariate 
regression modeling of spectral data. PLS-1 was used to correlate changes in the fluorescence 
emission intensity of several fluorescent analytes in the presence of non-fluorescent molecular 
micelles and fluorescent chiral molecular micelles (FCMMs) in the presence of non-fluorescent 
analytes.  In terms of RMS%RE, the ability of the model to accurately predict the enantiomeric 
composition of future samples was dependent on the chiral analyte, molecular micelle, as well as 





Optical activity was first observed by the French physicist, Jean Baptiste Biot, in 1813 
when he studied the behavior of the vibrational plane of polarized light.1 He discovered that 
certain liquids rotate the plane of polarization in equal magnitude but opposite direction.  
Clockwise rotation, rotation to the right, is considered to be dextrorotary and is designated by a 
(+) sign.  Likewise, counterclockwise rotation, rotation to the left, is levorotary and is designated 
by a (-) sign.  A chiral compound is optically inactive if it is a racemic mixture and there is no 
rotation of the plane of polarized light. 
Optical isomers or enantiomers exist because they are chiral compounds. Chirality was 
discovered by Louis Pasteur in 1848 when he demonstrated the optical inactivity of a racemic 
sample of tartaric acid.  In addition, he separated the enantiomers and observed that the crystals 
rotated polarized light in opposite directions with the same magnitude.2 As a result, Pasteur 
concluded that optically active molecules are due to asymmetric atoms.  In 1874, Jacobus 
Henricus van’t Hoff related the chemical bonds of the carbon atom in optically active 
compounds to a three-dimensional tetrahedron.3 He discovered that enantiomers differ in their 
three-dimensional spatial arrangement.  Two enantiomers have the same physical properties, i.e. 
boiling point, melting point, density, dipole moment, and refractive index, and the same chemical 
properties unless in the presence of other chiral molecules. 
The word chiral originates from a Greek word meaning hand, and one of the most 
universal examples of chirality is the human hands (Figure 1.1).4   Any molecule lacking a plane, 
center, or axis of symmetry, and having a non-superimposable mirror image is a chiral 
 2
molecule.5 Two most common classes of chiral compounds are molecules that have point 
(asymmetric atom) or axial chirality (asymmetric plane) and are illustrated in Figure 1.2.  A 
molecule with point chirality has a carbon atom with four different substituents.  Although most 
chiral molecules have point chirality, a stereogenic carbon is not necessary for a molecule to 
exist in enantiomeric form.  Many compounds have an axis of chirality where there is restricted 
rotation around a bond and a non-superimposable spatial arrangement exists.  The enantiomers of 
these molecules are usually named by use of the R/S configuration system which is based on the 













Figure 1.2 Structures of two types of chiral molecules. 
 
Molecules having point chirality may also use the R/S naming system based on the Cahn-Ingold-









identify the asymmetric carbon, 2) assign the priority to each group (higher atomic number is 
given priority and higher atomic mass is given priority) using the sequence 1 > 2 > 3 > 4, 3) the 
lowest priority group [4] is viewed so that it is positioned away from the viewer, and 4) the 
remaining three groups are counted in the direction from the highest priority.  If the direction is 
clockwise, the enantiomer is designated R or rectus (meaning right in Latin).  Likewise, if the 
direction is counterclockwise, the enantiomer is designated S or sinister (meaning left in Latin).  
An example of this process is illustrated in Figure 1.3.  The substituents are prioritized, and the 
direction of decreasing priority number is counterclockwise.  Thus, the molecule as illustrated in 
Figure 1.3 is the S-enantiomer.  Other naming systems include the D/L and (+)/(-) naming 
conventions and are unrelated to the R/S naming convention.  As previously noted, the (+)/(-) 
system is based on optical activity.  Similar to the R/S system, the D/L naming convention is 









 Chirality is important in many industries including the pharmaceutical industry due to 
differences in pharmacological and physiological properties of enantiomers.  One enantiomer of 
a chiral drug may have therapeutic effects and the other enantiomer may be ineffective or toxic.7-
13 A well known occurrence that demonstrated the importance of enantiomeric activity was the 





















pharmacokinetic characteristics of individual isomers.  Thalidomide was prescribed in racemic 
form as a sedative to pregnant women to treat morning sickness.  As a result, many babies 
suffered from birth defects and some were even stillborn.  This was due to the different 
pharmacological activity of each enantiomer of thalidomide.  The R-enantiomer is the 
therapeutic form of the drug that was responsible for the desired treatment and the S-enantiomer 
is the teratogenic form responsible for the birth defects.14  
In an effort to eliminate potential toxic side effects, many drugs are marketed as a single 
enantiomer.  In addition, the Food and Drug Administration is demanding the accurate 
determination of purity for the production of single enantiomer drugs.15 This is an ongoing 
challenge because 80% of the chiral market is found in the pharmaceutical industry and the 
number of chiral drugs and drug sales continues to increase every year.16,17  Figure 1.4 illustrates 
the increase in chiral drug sales and the increase of the amount of chiral drugs marketed as single 
enantiomers from 1996 to 2002. 
 














% chiral drug sales (out of all
drugs sold)
% of chiral drugs marketed as a
single enantiomer (out of chiral
drugs)
 5
 Chirality also plays an important role in the agricultural, fragrance, and food industries.  
Some chiral pesticides and herbicides may have different insecticidal or herbicidal effects where 
one form can be harmful to our environment or to humans while the other form is responsible for 
controlling pests or weeds.  In the food and fragrance industries, chiral compounds have been 
found to have different tastes and smells.12 Table 1.1 summarizes the different activities of some 
chiral molecules found in the pharmaceutical, agricultural, fragrance, and food industries. 
 
















Compound Enantiomeric Activity Structure 
Thalidomide R – sedative  















   
Penacillamine 
 
R – mutagen  










Limonene R – lemon smell/taste  









Asparagine D – sweet taste 












1.2 Methods of Chiral Analysis 
Chiral discrimination of two enantiomers requires the formation of a diastereomeric 
complex between the enantiomer and a chiral selector. A chiral selector is a chiral auxiliary agent 
capable of interacting enantioselectively with a pair of enantiomers.  Once this complexation 
occurs, the diastereomers can be analyzed using several analytical techniques.  Unlike 
enantiomers, diastereomers are not mirror images and have different physical and chemical 
properties which allow for discrimination between a diastereomeric pair.  Additional studies are 
needed to understand the exact mechanism of chiral recognition, however, the “three-point 
interaction rule” provides some insight into the complex formation.18,19 Figure 1.5 illustrates the 
interaction between a chiral selector and an enantiomer.  This model depicts the mechanism that 
requires the interaction of at least three points on one enantiomer with the chiral selector for 
chiral recognition to occur.  Spatial restraints prevent the other enantiomer from interacting in 





























1.2.1 Capillary Electrophoresis 
 Gas chromatography (GC) and high performance liquid chromatography (HPLC) have 
been some of the most widely used chromatographic techniques for chiral separation.20 As 
previously noted, separation is achieved due to the formation of a diastereomeric complex 
between an enantiomer and a chiral selector.  These diastereomers have a different boiling point, 
volatility, and polarity, which allows for separation using GC and HPLC.  In general, a column 
contains a sample which is dissolved or suspended in a gas or liquid mobile phase that interacts 
with a stationary phase.  The sample components have different solubilities in the mobile and 
stationary phases.  As a result, the components separate while traveling through a column due to 
varying mobilities.  While GC and HPLC are unquestionably effective, there are some major 
drawbacks, including the analysis time and sample consumption using HPLC and the 
requirement that the analytes are volatile for GC.     
 The use of capillary electrophoresis (CE) addresses some of the disadvantages 
encountered with HPLC and GC.  CE is a separation technique capable of the high resolution of 
diverse analytes while consuming small amounts of sample and reagents.  Some of the first CE 
experiments were performed by Hjerten in 1967.21 Years later, Mikkers et al.22 and Jorgenson 
and Lukacs23 demonstrated that CE could achieve high resolution of small pharmaceutical 
analytes and polymers. The electrophoresis occurs in a narrow-bore silica capillary, and the 
separation is based upon the differences in the electrophoretic mobility of solutes dissolved in 
buffer under an applied electric field.  CE instrumentation is simple and consists of a capillary, 
buffer reservoirs, a sample reservoir, a high-voltage power supply, two electrodes (anode and 
cathode), a detector, and a data output and handling device (see Figure 1.6).  The ends of the 
capillary are positioned in the buffer reservoirs which contain the two electrodes used to supply 
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current from the high voltage supply.  The capillary is filled with buffer prior to sample injection. 
The migration of the analytes occurs when the buffer reservoir replaces the sample reservoir and 









   
Figure 1.6 Schematic of CE instrumentation. 
 
There are numerous modes of CE including capillary zone electrophoresis (CZE), 
micellar electrokinetic chromatography (MEKC), capillary isoelectric focusing (CIEF), capillary 
gel electrophoresis (CGE), capillary isotachophoresis (CITP), and capillary 
electrochromatography (CEC).20 Table 1.2 lists a brief description of each mode, which all have 
different mechanisms of separation; however, the same fundamental theory and principles.  This 
family of CE techniques has a wide application range and is capable of separating several 
different classes of analytes including small ions, small achiral and chiral molecules, peptides, 
















Table 1.2  Modes of CE.20 
Mode Brief Description Class of Analytes  
CZE separation performed in buffer, also known 
as free solution CE  
 
 
Small ions, small charged molecules, 
peptides, proteins 
 
MEKC CZE with the addition of surfactants 
serving as pseudostationary phase 
 
 
Small charged/uncharged molecules, 
peptides, oligonucleotides 
 









CITP On-capillary pre-concentration technique Small ions, small charged/uncharged 
molecules, peptides, proteins 
 
 
CEC Separation performed using an immobilized 
stationary phase 
Small ions, small molecules, peptides, 
proteins, oligonucleotides 
   
The driving force for flow in many CE modes, including MEKC, is electroosmotic flow 
(EOF).  In normal mode, the EOF causes the bulk flow of the components (ionic and neutral) 
from anode to cathode as a result of the formation of an electric double layer or Stern layer on 
the inner capillary wall.  Figure 1.7 illustrates the formation of the Stern layer and the 
development of the EOF which occurs in several steps:24 
1. The deprotonation of the capillary wall forms silanol groups (SiO-). 
2. Counterions (cations) are attracted to the SiO- groups in order to maintain a charge 
balance 

























Figure 1.7   Development of the EOF. 
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Step 1. Deprotonation of the capillary wall.
Step 2. Cations are attracted to capillary wall, Stern layer formation
Step 3. Applied voltage causes cations to migrate toward cathode
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The overall movement of all charged and neutral species to the cathode occurs because the 
cations are solvated.  In CEC the magnitude of the EOF is calculated by: 
                                                             νEOF = (ε ζ / η) E                                                              1.1 
                                                              µEOF =  (ε ζ / η)                                                               1.2 
where ν is the velocity of the EOF, µ is the mobility of the EOF, ε is the dielectric constant, ζ is 
the zeta potential, η is the solvent viscocity, and E is the applied electric field.  It is interesting to 
observe that the mobility of the EOF is independent of the applied electric field.  The zeta 
potential occurs in the diffuse layer inside of the capillary and is determined by the extent of the 
charge on the capillary wall, which is pH dependent.20,24  Therefore, higher buffer pH values will 
increase the number of SiO- groups and increase the EOF.  Likewise, lower buffer pH values will 
decrease the number of SiO- groups and decrease the EOF. 
The separation of ions is based upon the solute velocity while neutral species migrate 
with the EOF.    The ion velocity is the product of the electrophoretic mobility and the applied 
electric field.  As the applied electric field is increased, the velocity increases.  The 
electrophoretic mobility depends on the electric force, which is the product of the charge of the 
ion and the applied electric field, and the counteracting frictional force. The two forces are 
opposite and result in the electrophoretic mobility being dependent on the charge and size of the 
ions.  This relationship is given in the following equation: 
                                                               µe = q / (6 π η r)                                             1.3 
where q is the charge of the ion, η is the solution viscosity, and r is the radius of the ion.  In a 
given sample, the charge-to-size ratio will determine the elution order of ionic species.  From 
equation 1.3, it can be concluded that larger solutes will have higher electrophoretic mobilities 
than smaller solutes of the same charge.  The elution order of solutes is determined by the 
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apparent mobility (µapp), which is simply the sum of the electrophoretic mobility of the ion and 
the mobility due to the EOF.  Figure 1.8 illustrates the elution order of ions of different charge 
and size in CZE.   
 
Figure 1.8 Solute elution order in CZE.  
 
As illustrated in Figure 1.8, neutral molecules migrate with the EOF because they have 
no electrophoretic mobility.  Therefore, it is not possible to separate neutral species by use of 
CZE.  In the mid 1980s, Terabe introduced MEKC, a mode of CE capable of separating neutral 
species with the addition of charged species to the running buffer.25,26 Separation of neutral and 
charged species for both achiral and chiral analytes can be accomplished by MEKC due to 
several factors including differences in electrophoretic mobility of the complex formed, 
hydrophobicity, ionic interactions, and hydrogen bonding between the charged selector and the 
analyte.20 
 The most widely used additives for the separation of neutral species are molecular 
aggregates known as micelles.  Surfactant monomers consist of a hydrophobic tail and a charged 
hydrophilic head group.  As the concentration of monomers increases in aqueous solution, 
anion cation neutral molecule EOF
anode cathode
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aggregates self assemble to form hydrophobic pockets.  This phenomena occurs for all types of 
surfactants, including nonionic, anionic, cationic, and zwitterionic.  At a certain concentration 
known as the critical micelle concentration (CMC), organized assemblies of surfactant 
monomers are formed.  Micellar aggregates consist of hydrophobic tails which are directed 
inside of the micelle and have limited interaction with the solvent, while the hydrophilic head 
groups form the outer shell of the micelle.  The hydrophobic core of the micelle provides an 
environment that can solubilize non-polar analytes.  Du-Nouy first introduced the apparatus for 
surface tension measurements27 that would later be used for CMC determination of surfactants.  
As the concentration of surfactant monomers increase, the surface tension decreases and at 

























 As previously noted, there are several conditions necessary for the separation of neutral 
analytes to occur using MEKC.  The presence of the micelle will result in complexes formed 
with the analytes based on hydrogen bonding, hydrophobic interactions, and/or electrostatic 
interactions.   The extent of the separation of all analytes can be altered by changing several 
experimental conditions including buffer concentration, micelle size, micelle charge, surfactant 
concentration, pH of the running buffer, operating temperature, mobile phase modifiers, and the 
applied voltage.  These experimental conditions will ultimately play an important role in the 
migration time as well as the resolution of the analytes.  
Baseline resolution (Rs = 1.5) in a reasonable migration time is the ultimate goal of any 
separation.  The resolution depends on the efficiency of the separation, the retention of the 
solutes, and the selectivity of the system.  Therefore, optimization studies of experimental 
parameters affecting these factors are important in MEKC separations.  Separations with high 
efficiency values (N) have sharp and symmetrical peaks.  Peak tailing or fronting can result in 
lower resolution values.  Experimentally, efficiency is determined by: 
                                                                                                   1.4 
where N is the number of theoretical plates, tn is the elution time for peak n, and w1/2 is the peak 
width at half height. 
 A solute partitions between the mobile phase and the micelle. The ratio of the molar 
concentration of the solute in the pseudostationary phase (or micellar phase) to the molar 
concentration of the solute in the mobile phase is given by the capacity factor (k`),  
                                                                                           1.5 








where tr is the retention time of the solute, to is the retention time of the unretained solute, tm is 
the retention time of the solute retained by the micellar phase. The capacity factor is related to 
the partition coefficient (K) which is determined by the volume of the micellar phase (Vs) and 
the volume of the mobile phase (Vm).   Solutes that elute with the EOF at to do not complex with 
the micellar phase however solutes that are completely solubilized by the micelle will elute at tm.  
All other solutes will elute between to and tm.  Separation of solutes is possible if the capacity 
factors of two solutes are not the same.  The selectivity factor (α) is used to determine if two 
solutes have different interactions with the pseudostationary phase. 
                                                        α = k′2 / k′1 , where k′2 > k′1                                                 1.6 
A system capable of resolving two species will have α > 1.  A selectivity of 1 means there is no 
separation and the resolution is 0 as given in the following equation: 
                                                                                                                                                       1.7 
where N is the number of theoretical plates, α is the selectivity, k′2 and k′1 are the capacity 
factors for solutes, to is the retention time of the unretained solute, and tm is the retention time of 
the solute retained by the micelle.  When calculating the experimental resolution, the following 
equation is used: 
                                                                                                                   1.8 
where w1 and w2 are the baseline widths of peaks 1 and 2, respectively.  
 Although many experimental factors affect the resolution during MEKC separations, the 
concentration of micelles, applied voltage, pH of the running buffer, and operating temperature 
were optimized as described in Chapter 2 of this dissertation.  Generally, the capacity factor can 
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lead to current problems.24 This limitation can be eliminated by the use of molecular micelles as 
opposed to conventional micelles.  A brief discussion of molecular micelles can be found in 
section 1.3.  Varying the electric field (applied voltage), buffer pH, and operating temperature 
can affect the magnitude of the EOF.  Changing the electric field will result in a change of the 
velocity of the EOF as given in equation 1.1.  Lower applied voltages results in a slower EOF 
which may cause lower separation efficiency, while higher applied voltages may cause Joule 
heating which is the heat generated as a result of electrical current.24 Changing the buffer pH has 
an affect on the magnitude of the EOF as well as the solute charge.  High pH values result in a 
higher percent of deprotonated silanol groups and a faster EOF while low pH values protonate 
the silanol groups and result in a slower EOF.  The operating temperature is important for 
reproducibility by controlling injection volume, minimizing Joule heating, and altering the 
viscosity of the buffer.  
1.2.2 Fluorescence Spectroscopy 
By definition, all spectroscopic techniques involve the interaction between radiation and 
matter and are used in analytical chemistry for the identification of substances.28 Fluorescence 
spectroscopy is a relatively inexpensive and highly sensitive spectroscopic method for accurate 
and rapid chiral analysis.  Fluorescence involves the absorption of light at a given wavelength 
followed by the emission of light at longer wavelengths.28 This process is demonstrated by the 
Jablonski Diagram which was proposed by the Polish physicist Alexander Jablonski in 1935 to 
describe the absorption and emission of light.28 Figure 1.10 illustrates possible transitions 
between electronic states of a molecule.  A molecule absorbs a photon of light which promotes 
an electron to a higher energy level.  Before relaxing back to the electronic ground state (S0) by 
fluorescence emission or phosphorescence, three nonradiative deactivation processes can occur, 
 17
including collisional quenching, internal conversion, and intersystem crossing.  Collisional 
quenching, also known as vibrational relaxation, occurs when energy is transferred from an 
excited molecule to another particle through collisions.  Internal conversion is the result of the 
transition between energy states of the same spin state while conversion from a singlet state (S) 
to a triplet state (T) is called intersystem crossing.  Phosphorescence is the emission of a photon 
















Figure 1.10   The Jablonski Diagram.28  Molecular electronic states are represented by black 
horizontal lines displaced vertically, radiative transitions are indicated with solid 






















When a molecule returns to the ground state, the photon has a different energy and the 
frequency corresponding to this energy difference can be measured and recorded by a 
spectrometer in an emission spectrum.  An excitation spectrum is measured at a single emission 
wavelength while an emission spectrum is measured at a single excitation wavelength.  George 
Gabriel Stokes first observed a shift between the excitation and emission spectra due to a loss of 
vibrational energy (Figure 1.11).28 This phenomena is known as the Stokes shift which states that 
the wavelength of fluorescent light is always greater than the wavelength of the exciting light.28 
Several factors may cause the Stokes shift including solvent effects, excited state reactions, 
energy transfer, and complex formation.  In Figure 1.11, it is apparent that the emission spectrum 
is a mirror image of the excitation spectrum.  This observation is due to the Franck-Condon 
principle which states that if a particular transition probability between the zeroth and second 
vibrational levels is largest in absorption, the reciprocal transition is also most probable in 
emission.28 The absorption and emission spectra of most fluorescent molecules are the mirror 
image of each other; however, all electronic transitions are not always vertical.  Thus, symmetry 























 Two types of fluorescence measurements are steady-state and time-resolved fluorescence.  
Steady-state is the more commonly used measurement where the sample is exposed to a 
continuous beam of light.  Time-resolved measurements are performed by exposing the sample 
to a pulse of radiation.  The work presented in this dissertation is based upon steady-state 
fluorescence measurements and observations. The basic instrumentation consists of a light 
source, excitation and emission monochromators, a sample chamber, and a detector or 
photomultiplier tube (Figure 1.12).  The excitation source produces light ranging from 200 to 
900 nm.28  
There are several light sources used in fluorescence spectroscopy including lasers, 
photodiodes, and lamps.  A 400W xenon (Xe) arc lamp was used as the light source for all 
fluorescence experiments in Chapters 3-5 of this dissertation.  Xe-arc lamps are the most 
versatile light sources because they provide continuous light output from 250 to 700 nm.29 
Monochromators decrease stray light, or light outside of the chosen excitation or emission 
wavelength, from the light source by the use of prisms or diffraction gratings.  Transmitted light 
from the excitation monochromator that ranges around the specified excitation wavelength is 
filtered through adjustable slits before passing through the sample.  The emission 
monochromator is at a 90° angle from the excitation light path to minimize excitation radiation 
detected.  Excitation radiation is much more intense than emitted fluorescence; therefore, 
fluorescence emission would not be detectable if the emission monochromator was in a straight 
line with sample holder and excitation monochromator.28 The light that exits the emission 
monochromator that ranges around the specified emission wavelength is filtered through 
adjustable slits before entering the detector.  The photomultiplier amplifies the signal and the 










Figure 1.12 Schematic diagram of a spectrofluorometer. 
 
Since chiral fluorescent sensors have become useful for enantioselective recognition of a 
variety of chiral molecules, fluorescence methods for determining the enantiomeric composition 
of chiral molecules have received growing interest.30  Busch and co-workers recently reported a 
new rapid, accurate, and robust method for determining the enantiomeric composition of chiral 
molecules using fluorescence spectroscopy and cyclodextrin guest-host chemistry.31  
Subsequently, Tran and co-workers used a similar approach with a chiral ionic liquid that 
functions as a solvent and chiral selector.32  In the studies reported in this dissertation, non-
fluorescent and novel fluorescent molecular micelles were used to determine the enantiomeric 
composition of a variety of analytes, both fluorescent and non-fluorescent.     
1.2.3 Other Techniques and Limitations 
There are several other methods (e.g. chiroptical methods,33,34 high performance liquid 
chromatography [HPLC],35 gas chromatography [GC],36 nuclear magnetic resonance [NMR],37 











composition of a variety of chiral molecules.  These techniques have proven to be effective; 
however, they have several drawbacks including analysis time, sensitivity, sample consumption, 
and expensive instrumentation (see Table 1.3).  As a result, development of a rapid, sensitive, 
accurate, and universal technique is of considerable interest. 
 




Measured optical rotation can be solvent dependent; not sensitive 
ORD Lacks specificity in differentiation of chiral molecules 
 



















Chiroptical methods use optical techniques which involve measurements of optical 
rotation at a fixed wavelength.  These methods include polarimetry, optical rotary dispersion 
(ORD), and circular dichroism (CD).  Polarimetry was one of the first analytical techniques for 
chiral analysis and determination of optical purity or enantiomeric excess.34 The two major 
drawbacks of this method include low sensitivity and low tolerance of impurities.  In addition, 
polarimetry is not useful for near racemic mixtures and the optical purity can be solvent 
dependent.  ORD is the measurement of change of optical rotation and wavelength.  This method 
is similar to polarimetry with the exception that rotation is determined at a fixed predetermined 
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wavelength, while ORD is measured over a range of wavelengths.  The use of ORD for chiral 
analysis is limited due to a lack of specificity in differentiating chiral molecules and there is high 
uncertainty in defining the baseline.  CD is a widely used chiroptical method observed when 
optically active molecules absorb left and right hand circularly polarized light slightly 
differently.  The instrumentation for this method is rather expensive and the technique is limited 
to molecules with a chromophore.  
Chiral separation is most often performed by use of chromatographic techniques.  
Separations using HPLC occur by adding a chiral selector to the mobile phase or immobilizing 
the chiral selector on the stationary phase.  Selectivity is achieved due to differences in chemical 
properties of the diastereomers formed between enantiomer and chiral selector. These 
separations require larger volumes of reagents and samples as compared to CE or spectroscopic 
techniques.  GC methods require volatile compounds for analysis and decomposition may often 
occur. 
The use of NMR chiral shift reagents, chiral derivatizing agents, or chiral solvating 
agents with enantiomers of a molecule results in diastereomeric complex formation.  Although 
NMR can discriminate between diastereomers, it is limited due to sensitivity and the requirement 
of a singlet proton on the chiral molecule that can be probed. In addition, the instrumentation for 
NMR is expensive and the solvent for analysis is limited. 
1.3 Chiral Selectors 
Several chiral selectors such as micelles, cyclodextrins (CDs), crown ethers, and protein 
antibiodies and have been widely used for chiral discrimination and for enantio-differentiation of 
chiral molecules.  Conventional micelles or monomeric surfactants are commercially available 
and are relatively inexpensive.  In the studies described in Chapters 2 through 5, molecular 
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micelles are used for chiral analysis instead of conventional micelles.  Figure 1.13 illustrates a 
conventional micelle and molecular micelle.  Molecular micelles, first introduced by Hara and 
Dobashi,39 have no CMC and can be used at much lower concentrations than conventional 
micelles; therefore, a wider range of concentrations can be used for chiral separations with 
MEKC.  In addition, molecular micelles have proven to be successful chiral selectors in various 
applications.40-46  Compared to other chiral selectors such as cyclodextrins, crown ethers or 
protein antibiotics, molecular micelles are more soluble in aqueous and organic solvents. 
Additionally, the polar head group as well as the number of stereogenic centers in the molecular 
micelle can easily be controlled and modified. In Chapter 4, novel fluorescent chiral molecular 
micelles (FCMMs) that allow for the chiral analysis of fluorescent and non-fluorescent chiral 
molecules are described.  Molecular micelles, therefore, have potentially wider applications and 










Figure 1.13  General structures of micelles. 
 






CDs are naturally occurring homochiral cyclic oligosaccharides and are the most widely 
used chiral selectors that were first discovered by Villiers in 1891.47,48  Figure 1.14 illustrates one 
of the three types of native CDs (α-, β-, and γ-) which all have hydroxyl groups at the rims of the 
cavity and the same cavity height (~7.9Å), but different chemical and physical properties.  The 
cavity diameter varies as a result of the number of glucose units for α-, β-, and γ- CDs, which 
gives for different cavity volumes.  The cavity diameters are 4.7 to 5.3Å, 6.0 to 6.5Å, and 7.5 to 
8.3Å for α-, β-, and γ-CD, respectively. Poor solubility of native CDs as well as highly 
hydrophobic guest molecules are shortcomings that can be overcome by the use of modified 
CDs.49 Modifications are possible by the substitution of hydroxyl groups and are usually 
designed for a specific purpose.  CDs have been used in a variety of analytical techniques for 












Figure 1.14 Structures of α-CD, which has 6 glucose units.  The structures of β- and γ-CD 
have 7 and 8 glucose units, respectively. 
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 Crown ethers and protein antibiotics (Figure 1.15) have also been used for chiral analysis.  
Crown ethers, which are macrocycles composed of ethylene groups, possess a central cavity and 
have been used for chiral analysis in HPLC,54 CE,55 MS,56,57 and NMR.58 Protein antibiotics are 
complex structures recently used in chiral analysis.59,60  Although several chiral selectors have 
been used in a variety of analytical techniques, development of a universal chiral selector is still 










Figure 1.15  Molecular structures of a crown ether (18-crown-6-tetracarboxylic acid ether) and 
a protein antibiotic (vancomycin). 
 
1.4 Chemometrics and Experimental Design 
Chemometrics is the science that uses mathematical and statistical techniques for the 
purposes of designing or selecting optimal measurements and experiments to provide maximum 
chemical information from chemical data.  There are two general branches of chemometrics, 
regression calibration and pattern recognition.  The term chemometrics was coined in 1972 by 











18-crown-6-tetracarboxylic acid ether vancomycin
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became more advanced and capable of generating more data in a shorter amount of time.  
Scientist began to have problems interpreting data until mathematical and statistical techniques 
were developed that were capable of extracting useful chemical information from complex data 
systems.  Commercial statistical software simplified the complicated mathematical methods 
making the numerical process practical for chemists.   
Regression calibration involves the formation of a regression model that will explain the 
experimental data.  This process is possible because of a mathematical relationship between 
independent and dependent variables.  Examples of independent variables or factors in chiral 
separations include operating temperature, applied voltage, buffer pH, and concentration of 
molecular micelle.  The dependent variables are the migration time and resolution.  The purpose 
of a regression model is to find a relationship between independent and dependent variables so 
that predictions of future responses can be made.   
Pattern recognition is essential to science in general, and chemistry in particular. Early 
classification of elements in the periodic table is based upon critical observable patterns among 
the elements. Groups or rows of elements have similar physical and chemical properties such as 
ionization energy, atomic radius, number of valence electrons, electron affinity, etc. In addition, 
compounds with similar functional groups tend to have similar physical characteristics and, in 
most cases, exhibit similar chemical reactivity. Hence, the grouping of chemical compounds into 
different classes, such as aromatic or aliphatic compounds, alcohols, esters, amines, carbonyls, or 
carboxylic acids, is based on the similarity of functional groups within the compounds.  
The experimental results presented in Chapters 2 through 5 were analyzed using 
regression calibration.  There are two types of regression analysis, including univariate linear 
regression and multiple regression modeling.  In univariate linear regression, a relationship exists 
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between a dependent variable (y) and a single independent variable (x) according to the 
following equation: 
                                                             y = b0 + b1x                                                                       1.9 
where b0 is the intercept and b1 is the slope.  For example, in MEKC experiments, an 
independent variable is applied voltage and the dependent variable is resolution.  The problem 
with univariate linear regression is that it only allows for the affect of one experimental factor or 
independent variable to be studied at a time.  Multi-factor systems are more common in 
analytical techniques and requires multiple regression modeling techniques, such as multiple 
linear regression (MLR), partial-least-squares regression (PLS-1), and principal component 
regression (PCR).62,63 
1.4.1 Multiple Regression Modeling 
The use of multiple regression modeling for correlating independent x-variables with a 
dependent y-variable is well known in chemistry.61,64-67 Classical MLR is a modeling technique 
widely used to correlate several x-variables in a linear combination with a corresponding y-
vector:62 
                                                   y = b0 + b1x1 + b2x2 + . . . + bpxp                                               1.10 
where the bp is the coefficient of the regression model, x is the independent variable (separation 
parameters in Chapter 2 of this dissertation) and y is the response or dependent variable 
(migration time, resolution and resolution per unit time of analytes in Chapter 2 of this 
dissertation). The above equation can be expressed in matrix notation: 
                                                                  Y = Xb + f                                                                  1.11 
where Y is the matrix data set containing the dependent variables, X is the matrix data set 
containing the independent variables, b is the vector containing the regression coefficients of the 
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model, and f is the residual error term. For MLR to have practical utility, the residual error term 
must be at a minimum.62,63 In addition, there must be no colinearity among the independent 
variables. Once the regression coefficient vectors are determined, the model can be used for the 
prediction of future responses.  The coefficient of the regression can be calculated using:62 
                                                           b = (XT·X)-1·XT·Y      1.12 
where XT is the transpose of X.  The coefficients are useful for determining the significance of 
the parameter.  Once the coefficients are calculated, it is possible to predict future values of Y 
using the following equation: 
                                                                 Y = Xfs·b      1.13 
where Xfs is the matrix response of future data.    
  When the x-variables are reasonably uncorrelated and the number of x-variables is much 
less than the number of samples or experimental runs, MLR is the chemometric method of 
choice for the investigation of the main effects of the x-variables on the y-response.63 Chapter 2 
of this dissertation uses MLR modeling for the prediction of migration time, resolution, and 
resolution per unit time for a variety of chiral and achiral analytes.  
1.4.2  Principal    Component    Regression    (PCR)    and    Partial-Least Square    (PLS-1)         
          Modeling 
 
Multivariate analysis in the form of PCR is widely used for pattern recognition or to 
study trends in analytical data. A fundamental assumption in multivariate analysis is that 
directions with maximum variance contain major information in the data.63 When colinearity or 
correlation between the variables exists, XTX are not always invertible.  To avoid problems of 
colinearity between variables involving a large number of independent variables (i.e. spectral 
data), an orthogonal basis set or coordinate system is formed to represent the data.  Both PCR 
and PLS-1 methods employ projection techniques to obtain a series of variance-scaled 
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eigenvectors that serve as a new coordinate system for the data.  Table 1.4 lists a response matrix 
for a set of the steady-state fluorescence emission intensity at varying concentrations of sample 
solutions. 
 
Table 1.4 An example response for a set of the steady-state fluorescence emission 








1 A1λ1 A1λ2 A1λ3 A1λ4 A1-- A1-- A1-- A1λm y1 
2 A2λ1 A2λ2 A2λ3 A2λ4 A2-- A2-- A2-- A2λm y2 
3 A3λ1 A3λ2 A3λ3 A3λ4 A3-- A3-- A3-- A3λm y3 
4 A4λ1 A4λ2 A4λ3 A4λ4 A4-- A4-- A4-- A4λm y4 
5 A5λ1 A5λ2 A5λ3 A5λ4 A5-- A5-- A5-- A5λm y5 
6 A6λ1 A6λ2 A6λ3 A6λ4 A6-- A6-- A6-- A6λm y6 
7 A7λ1 A7λ2 A7λ3 A7λ4 A7-- A7-- A7-- A7λm y7 
8 A8λ1 A8λ2 A8λ3 A8λ4 A8-- A8-- A8-- A8λm y8 
9 A9λ1 A9λ2 A9λ3 A9λ4 A9-- A9-- A9-- A9λm y9 
10 A10λ1 A10λ2 A10λ3 A10λ4 A10-- A10-- A10-- A10λm y10 
--- --- --- --- --- --- --- --- --- --- 
--- --- --- --- --- --- --- --- --- --- 
--- --- --- --- --- --- --- --- --- --- 
--- --- --- --- --- --- --- --- --- --- 
n-1 A(n-1)λ1 A(n-1)λ2 A(n-1)λ3 A(n-1)λ4 A(n-1)-- A(n-1)-- A(n-1)-- A(n-1)λm yn-1 
N Anλ1 Anλ2 Anλ3 Anλ4 An-- An-- An-- Anλm yn 
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To perform PCR, the data set is transformed and represented in a new orthogonal 
coordinate system to remove colinearity among the data set (Figure 1.16).63 The first principal 
component (PC1) is drawn through the data set in the direction of the maximum variance in the 
data. The second principal component (PC2) is then drawn through the data set in the direction 
of the next maximum variance in the data set, and the third principal component (PC3) is drawn 
in the next maximum variance in the data set and so on, such that PC1, PC2, and PC3 are all 
orthogonal to each other.  PC1, PC2, and PC3 now represent a set of variance-scaled 
eigenvectors that provide a new orthogonal coordinate system for representation of the data. In 
mathematical terms,62 the individual principal component of an n-component data set is 
calculated by: 
                    PCi = P11X1 + P21X2 + P31X3 + … + Pn1Xn                                     1.14 
where PCi is principal component i, Pij are the coefficients of the linear combination called 
loading, and X are the variables, i.e. the steady-state fluorescence emission intensity data in 
Chapters 3 through 5. Each principal component is a linear combination of the n-vectors that 
make up the original variable space.  The magnitude of loading is used to evaluate the 
importance of PCi to that data point, and the coordinates of the data in the new coordinate system 
are referred to as scores (see Figure 1.17).  In most cases, fewer PCs are needed to explain the 
majority of variance in the data.  As illustrated in Figure 1.18, higher PCs generally contain no 
useful information and can be regarded as associated with “noise” in the data set.63 It should also 
be apparent that elimination of higher PCs reduces the dimensionality of the data set, therefore 
fewer PCs are desired as the optimal number of factors (eigenvectors) to be used in regression 
analysis.  For all calibration data sets in Chapters 3 through 5, the optimal number of factors was 














Figure 1.16 Example of a (A) data swarm with colinearity plotted in an xyz coordinate system 
with (B) PC1; (C) PC1 orthogonal to PC2; (C) PC1, PC2, and PC3 all orthogonal 










Figure 1.17 Scores plot of data point on new coordinate system. (Modified from reference 63) 
Data Swarm





















Figure 1.18 Plot of unexplained variance versus principal components. (Modified from 
reference 63) 
 
Multiple regression in the form of PLS-1 is very effective because it is based upon 
successive extraction of linear combinations of the predictors.63 Thus, PLS-1 accounts for factors 
that explain both response and predictor variation by reducing sample response prediction error. 
Linear functions of the predictors explain as much variation in each response as possible, as well 
as accounts for variation in the predictors. Unlike PCR, PLS-1 regression methods include the 
dependent variable in the data compression. 
PLS-1 regression is generally used when there are fewer observations than predictor 
variables.  This regression technique has been widely used for correlating small spectral changes 
with known compositional changes, and the methods are well established in analytical 
chemistry.32,53,68-70 All multiple regression modeling involves a two-phase process. In stage one, 
or the calibration phase, spectra of a training set of known composition (i.e. the enantiomeric 
composition of the analyte in Chapters 3 through 5) are collected over a given wavelength range. 













1 2 3 4
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spectral data with the known compositions of the training set samples. In the second stage, or 
validation phase, the regression model developed in the calibration phase is validated with a new, 
independently prepared test- or validation-set of samples of known enantiomeric composition. In 
the validation phase, the spectra of the validation samples are taken over the same wavelength 
range that was used to prepare the model in the calibration phase. The enantiomeric 
compositions of the validation samples are then predicted from the spectral data using the model 
developed in the calibration phase. The performance of the model in predicting future samples is 
evaluated by how well the predicted enantiomeric compositions compare with their actual 
values. 
1.5 Scope of Dissertation 
 The goal of the research described in this dissertation is to improve chiral analysis by use 
of multiple regression modeling techniques in chromatographic and spectroscopic methods.  In 
addition, more universal chiral selectors for enantiomeric composition prediction of a variety of 
analytes by guest-host complexation and steady-state fluorescence measurements are explored.  
A multiple analysis in the form of MLR is used to optimize separation parameters and 
predict the migration behavior, resolution and resolution per unit time of achiral and chiral 
compounds using MEKC in Chapter 2.  Separations of achiral and chiral analytes were 
performed by use of an achiral molecular micelle, poly(sodium N-undecylenic sulfate), and 
chiral molecular micelles, poly(sodium N-undecanoyl-L-leucylvalinate) or poly(sodium N-
undecanoyl-L-isoleucylvalinate) at various operating temperatures, applied voltages, pH, and 
molecular micelle concentrations in the background electrolyte.  The separation parameters were 
subsequently used as input variables for MLR models validated with independent samples.  The 
root-mean-square percent relative error (RMS%RE) is used as a figure of merit for characterizing 
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the performance of the models of migration time, resolution and resolution per unit time.  The 
predicted migration time, resolution, and resolution per unit time of the chiral as well as the 
achiral analytes compare favorably with the experimental response values, indicating the 
versatility and wide applicability of this technique in MEKC. 
In the remaining chapters, steady-state fluorescence spectroscopy is employed to 
investigate the use of chiral molecular micelles as chiral selectors in chiral analysis by multiple 
regression modeling of spectral data.  In the research described in Chapter 3, PLS-1 is used to 
correlate changes in the fluorescence spectral data of 1,1’-bi-2-naphthol (BOH), 1,1’-binaphthyl-
2,2’-diamine (BNA), or 2,2,2-trifluoroanthrylethanol (TFA) in the presence of poly(sodium N-
undecanoyl-L-leucylvalinate), poly(sodium N-undecanoyl-L-leucinate) or poly(sodium N-
undecanoyl-L-valinate) as the enantiomeric composition of the chiral analytes was varied.  In the 
research described in Chapter 4, novel fluorescent chiral molecular micelles (FCMMs) are 
synthesized, characterized, and employed as chiral selectors for enantiomeric recognition of non-
fluorescent chiral molecules using steady state fluorescence spectroscopy.  PLS-1 is used to 
correlate changes in the fluorescence emission spectra of poly(sodium N-undecanoyl-L-
tryptophanate) due to varying enantiomeric compositions of glucose, tartaric acid, and serine for 
a set of calibration samples.  In an effort to develop a universal chiral selector, poly(sodium N-
undecanoyl-L-phenylalaninate), is employed for enantiomeric recognition and the determination 
of enantiomeric composition for four fluorescent and four non-fluorescent chiral molecules using 
steady-state fluorescence spectroscopy described in Chapter 5.  PLS-1 of the calibration samples 
containing the FCMM, poly(sodium N-undecanoyl-L-phenylalaninate), in the presence of BNA, 
TFA, propranolol, naproxen, chloromethyl menthyl ether, citramalic acid, tartaric acid, and 
limonene were obtained in buffer systems as well as methanol/water mixtures.  The validation of 
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the calibration models yielded low RMS%RE values ranging from 1.57 to 6.10% (Chapter 3), 
2.04 to 4.06% (Chapter 4), and 1.77 to 15.80% (Chapter 5). The methanol/water mixtures 
significantly reduced the error for the predictions with hydrophobic molecules: 1.26 to 7.95% 
(25:75 methanol/water), and 1.21 to 4.28% (75:25 methanol/water).  In addition, in terms of 
RMS%RE, the ability of the models to accurately predict the enantiomeric composition of future 
samples was found to be dependent on the chiral analyte, molecular micelle used, concentration 
of chiral selector, and the pH of the buffer medium. 
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USE OF MULTIPLE ANALYSES FOR OPTIMIZATION OF  
SEPARATION PARAMETERS AND PREDICTION OF MIGRATION TIME AND 




Resolution of enantiomeric compounds into individual optical isomers continues to be 
one of the most challenging separation problems in chemistry.  Isolation of the individual 
isomers of a chiral drug is an important problem because the pharmacokinetic characteristics of 
the individual enantiomers may be different1.  These differences may result in physiological 
problems; therefore, there are many ongoing efforts to improve chiral separations. 
Micellar electrokinetic chromatography (MEKC) is a widely used separation mode of 
capillary electrophoresis originally developed for the high resolution of neutral analytes.2 
Separation of neutral analytes is accomplished by use of surfactants that act as a 
pseudostationary phase in the running buffer.  However, the use and application of MEKC is no 
longer limited to separation of neutral molecules and has been successfully employed over the 
years for separation of diverse charged compounds as well as chiral molecules of pharmaceutical 
interest by various research groups.3-9 
Conventional micelles or monomeric surfactants have been widely used for the 
separation of analytes in MEKC because they are relatively simple to use, easy to prepare, 
commercially available, inexpensive and afford high reproducibility of analyte separation. 
Molecular micelles have also been employed for MEKC because they have no critical micelle 
concentration (CMC), allowing a wider range of concentration to be used during separation 
studies.10  Additionally, the covalent bonds between molecular micelle aggregates eliminates the 
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dynamic equilibrium that occurs between the surfactant monomers and the micelle.  Hence, 
molecular micelles have enhanced stabilities, rigidities, and controllable sizes.11,12 
In MEKC, the separation, resolution, and migration behavior of the analytes are 
influenced by parameters such as the molecular micelle concentration in the background 
electrolyte (BGE), applied voltage, pH, and operating temperature.  The traditional optimization 
of separation parameters in chromatography is laborious, time consuming and often performed 
by trial and error.  Thus, optimization of separation parameters for baseline resolution and short 
migration times has been the subject of many studies.   
Recently, the use of various chemometric experimental designs for optimization of 
separation parameters of analytes in MEKC involving full or fractional factorial design, Plackett-
Burman design, central composite design, Box Benken design, and artificial neural networks 
have been employed.13-24 A general application of chemometric experimental designs for 
capillary electrophoresis optimization methods has also been described.25,26 The Plackett-Burman 
design is a technique typically used for screening purposes before the optimization of parameters 
using a central composite or Box Benken design to reduce the number of required experiments. 
The use of full factorial design for optimization requires more experiments.  In the previous 
experimental design optimization studies, monomeric sodium dodecyl sulfate or monomeric 
chiral surfactant was used in the running buffer for the separations. In addition, most previous 
studies were used to investigate either a small number of samples or a small experimental design 
was used to optimize the migration time of the analyte.  In this chapter, experimental design and 
multiple analysis for optimization of separation parameters involving the use of chiral molecular 
micelles in MEKC for the prediction of migration time, enantiomeric resolution and resolution 
per unit time of chiral molecules of pharmaceutical and environmental interest is reported. 
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The multiple analysis for optimization of separation parameters for the prediction of 
migration time, resolution, as well as the resolution per unit time of chiral binaphthyl derivatives, 
(±)-1,1`-bi-2-naphthyl-2,2`-dihydrogen phosphate (BNP) and (±)-1,1`-bi-2-naphthol (BOH) is 
achieved by use of a chiral molecular micelle poly(sodium N-undecanoyl-L-leucylvalinate) 
(poly-L-SULV).  Binaphthyl derivatives are atropisomers because they possess a chiral plane of 
symmetry instead of an asymmetric carbon.  The separation of the enantiomers was performed at 
various separation parameters using a full factorial experimental design.  In addition, the same 
experimental procedure was used to optimize the separation parameters of six other chiral 
analytes with stereogenic carbon centers (benzoin, hydrobenzoin, coumachlor, warfarin, 
lorazepam, and temazepam) by use of the chiral molecular micelle poly(sodium N-undecanoyl-L-
isoleucylvalinate) (poly-L-SUILV). To demonstrate the robustness of the technique, the same 
experimental approach was used for the separation of four achiral compounds (4-chlorophenol, 
pentachlorophenol, clonazepam and diazepam) using an achiral molecular micelle, poly(sodium 
N-undecylenic sulfate) (poly-SUS). 
2.2 Methods 
 
2.2.1  Materials 
Pentachlorophenol (PCL), 4-chlorophenol (CPL), clonazepam (CZP), diazepam (DZP) 
and racemates of the chiral compounds (±)-1,1`-bi-2-naphthyl-2,2`-dihydrogen phosphate 
(BNP), (±)-1,1`-bi-2-naphthol (BOH), 2-hydroxy-2-phenylacetophenone (benzoin), 1,2-
diphenyl-1,2-ethanediol (hydrobenzoin), (±)-3-(a-acetonyl-p-chlorobenzyl)-4-hydroxycoumarin 
(coumachlor), 4-hydroxy-3-(3-oxo-1-phenylbutyl)coumarin (warfarin), 7-chloro-5-(2-
chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam), and temazepam 
were purchased from Sigma (St. Louis, MO, USA).  N-Hydroxysuccinimide, undecylenic acid, 
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sodium bicarbonate, dicyclohexylcarbodiimide were purchased from Fluka (Milwaukee, WI, 
USA).  Undecylenyl alcohol, sodium borate, monobasic sodium phosphate, dibasic sodium 
phosphate, chlorosulfonic acid, pyridine, sodium hydrogen carbonate, 
tris(hydroxymethyl)aminomethane (TRIS), sodium hydroxide (NaOH), hydrochloric acid (HCl), 
ethyl acetate, methanol, tetrahydrofuran (THF), and the dipeptide (L,L) isoleucyl-valinate were 
obtained from Sigma-Aldrich (Milwaukee, WI, USA).  The dipeptide (L,L) leucyl-valinate was 
purchased from Bachem Bioscience Inc (King of Prussia, PA, USA).  The purity of all analytes 
and reagents was 98% or higher and used as received. The molecular structures of the analytes 
investigated are illustrated in Figure 2.1. 
 
 




















































BNP BOH Warfarin (War) Coumachlor (Coum)
Hydrobenzoin (HB) Benzoin (Benz) Temazepam (TZP) Lorazepam (LZP)
4-chlorophenol (CPL) Pentachlorophenol (PCL) Clonazepam (CZP) Diazepam (DZP)
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2.2.2  Instrumentation 
MEKC separations were performed on a Hewlett-Packard 3D CE instrument (Model 
G1600AX) from Agilent (Palo Alto, CA, USA).  The CE instrument was equipped with a UV 
diode array detector, with UV detection at 254 nm, and ChemStation software for the processing 
and evaluating the experimental results.  The analytes were pressure injected at 30 mbar for 3 s.  
A fused silica capillary column (Polymicro Technologies, Phoenix, AZ, USA) of total length of 
58 cm and effective length of 50 cm was conditioned by flushing the column with 1 M NaOH for 
one hour, 0.1 M NaOH for 30 min, and water for 15 min.  In between each run, the column was 
flushed with 0.1 M NaOH for 2 min followed by buffer for 2 min. The pressure was maintained 
at 900-920 mbar during the column flushing steps. 
2.2.3  Syntheses of Molecular Micelles 
Sodium undecylenic sulfate (SUS) monomer was synthesized using Bergstrom’s 
procedure27 with modifications described by Shamsi et al.28 Scheme 2.1 shows the synthesis of 
poly(sodium undecylenic sulfate).  Chlorosulfonic acid (7.5 mL) was added dropwise to ω-
undecenyl alcohol (16.5 mL) and pyridine (75 mL) in a round-bottom flask.  The reactants were 
refluxed for three hours followed by the addition of 600 mL of deionized water containing 
sodium carbonate (4 g) and sodium hydroxide (80 g). The reaction was allowed to stir for 16 
hours and the resulting solution was extracted using n-butanol.  The SUS monomers were 
isolated following the evaporation of the n-butanol and pyridine using a rotary evaporator and a 
vacuum desiccator.  Recrystallization of the product was performed with hot isopropanol.  The 
solution was cooled to room temperature and refrigerated overnight.  The crystals were rinsed 







Scheme 2.1  Synthesis of SUS monomer. 
 
The chiral molecular micelles, poly-L-SULV and poly-L-SUILV, were synthesized 
according to the procedure described by Wang and Warner29 (Scheme 2.2).  Undecylenic acid 
(45 g), dicyclohexylcarbodiimide (DCC), and N-Hydroxysuccinimide (NHS) were added to 
anhydrous ethyl acetate in a round bottom flask and allowed to stir for 16 hours.  The NHS ester 
of undecylenic acid was isolated by filtering the white solid by-product, dicyclohexylurea, from 
the solution and evaporating the ethyl acetate using rotary evaporation.  Purification was 
achieved by recrystallization of the ester in hot isopropanol.  The refrigerated ester solution was 
washed with cold isopropanol and water then dried using a lyophilizer.  The surfactant monomer 
was synthesized by reacting the ester with sodium bicarbonate, THF, water and the amino acid 
dipetide (leucine valine or isoleucine valine).  THF was evaporated and the surfactant monomer 
was precipitated with dilute HCl.  An equimolar amount of sodium bicarbonate was reacted with 



































































Polymerization of the resulting sodium salts of SUS, SULV, and SUILV was achieved by 
exposing a 100 mM aqueous solution to 60Co γ-rays (0.7 krad/hr) for seven days.  H1NMR was 
used to monitor complete polymerization by the disappearance of the vinyl protons (6 – 5 ppm).    
2.2.4  Buffer and Analyte Preparation 
The BGE for the separation of 4-cholorophenol, pentachlorophenol, clonazepam and 
diazepam was 25 mM dibasic phosphate and 25 mM borate while racemic BNP, BOH, 
temazepam and lorazepam analytes were separated using 100 mM TRIS and 10 mM sodium 
borate.  The separation of coumachlor, warfarin, hydrobenzoin and benzoin was performed using 
50 mM phosphate (25 mM dibasic and 25 mM monobasic).  The buffer pH was adjusted by 
adding either 0.1 M NaOH or 0.1M HCl.  The BGE solutions were filtered through a 0.45-µm 
nylon syringe filter (Nalgene, Rochester, NY, USA) prior to the addition of molecular micelle.  
Varying molecular micelle concentrations were added to the BGE for separation of the analytes.  
Addition of the molecular micelle was followed by ultrasonication for 15 min to ensure proper 
degassing of the solutions.  Poly-SUS was used for the separation of achiral chlorophenol (4-
chlorophenol and pentachlorophenol) and achiral benzodiazepine (clonazepam and diazepam) 
analytes and poly-L-SULV was used for the separation of BNP and BOH.  Poly-L-SUILV was 
used for the separation of other chiral analytes.  All analytes, BNP and BOH (0.1 mg/ mL), 
hydrobenzoin and benzoin (0.5 mg/mL), and temazepam, lorazepam, coumachlor, warfarin, 4-
chlorophenol, pentachlorophenol, clonazepam and diazepam (0.2 mg/mL), were prepared in 
methanol. 
2.2.5  Data Analysis 
Multivariate data analysis was performed using The Unscrambler, (CAMO, Inc., 
Corvallis, OR, version 9.1) chemometric software system. 
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2.2.6  Experimental Design Procedure and Multiple Analysis  
The influence of four separation parameters: molecular micelle concentration, applied 
voltage, pH and operating temperature on migration behavior and resolution of analytes was 
investigated by performing the separations at various experimental conditions using a full 
factorial design. The design method employed for optimization usually depends upon the 
available time and resources. Plackett-Burman design is typically used for screening purposes 
while other design techniques such as central composite and Box Benken design are used for the 
optimization with a fewer number of experiments. Full factorial design requires more 
experiments; however, both the main effect of the design variables on the response as well as the 
interaction between the variables can be investigated. In this study, a full factorial design was 
used for the optimization of separation parameters to investigate the main effects of the variables 
on the migration behavior and resolution response as well as the interaction between the 
variables. In addition, this design technique was used in order to determine the best and global 
optimum separation conditions of various analytes which might be missed using fewer 
experiments.  
 The separations of the binaphthyl derivative enantiomers and chlorophenols were 
performed at four applied voltage levels (15, 20, 25 and 30 kV), three levels of operating 
temperatures (15, 20 and 25 °C), three levels of BGE pH (9.0, 9.5 and 10.0), and three levels of 
BGE molecular micelle concentration (0.5, 0.75 and 1.0 %). The small pH range (9-10) was 
chosen for the design because enantiomeric baseline resolution of BOH and BNP could only be 
obtained in this pH range. In addition, pH is not linearly related to migration time or resolution 
of analytes. A total of 108 experiments (4×3×3×3) were performed for the separation of BNP 
and BOH at the designed separation conditions.  Analyses were performed in triplicate at each 
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experimental design condition. The results of the separations were reproducible with low 
percentage standard deviation ranging between 0.1 and 5% obtained for the migration times of 
the analytes. The average results are reported and used in the data analysis. 
For each analyte, the result of the separation at various separation conditions was 
randomly divided into two data sets. The first data set was used as the training set for MLR 
calibration while the second data set was used for the validation and prediction of the migration 
time, resolution and resolution per unit time responses. Experimental data where separation of 
analytes could be achieved were not used for the calibration or the validation. 
Multilinear regression modeling (MLR) was used to investigate the main effects of the 
separation parameters on the migration behavior and resolution of the analytes. 
2.3 Results and Discussion 
 
2.3.1 Study with Chiral Analytes 
The separation of analytes at various molecular micelle concentrations, applied voltages, 
pH and operating temperatures had a marked effect on the migration behavior as well as the 
resolution of analytes.  A typical electropherogram for the separation of enantiomers of BNP and 
BOH under different separation conditions is illustrated in Figure 2.2.  In general, shorter 
migration times of BNP and BOH are obtained at high pH, high temperature, high voltage, and 
low molecular micelle concentration in BGE.  Figure 2.2A illustrates the influence of molecular 
micelle concentration on the migration time of the analyte. For all experimental runs, the 
migration time of the analyte increased with increasing molecular micelle concentration in BGE.  
This is because the analyte interacts more strongly with the molecular micelle resulting in longer 
migration times for higher poly-L-SULV concentrations.  The effect of applied voltage on the 
migration time of BNP and BOH is illustrated in Figure 2.2B. As expected, the migration times 
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of the analytes decrease with increasing applied voltage.  Higher applied voltages resulted in a 
faster electroosmotic flow, which ultimately caused shorter migration times for the analytes.  
Figure 2.2C illustrates the effect of running buffer pH on analyte migration time, where 
migration time decreased with an increase in pH.  Increasing the pH of the buffer solution caused 
an increase in anionic character of both the anionic BNP (pKa ~9) and partially anionic BOH 
(pKa = 9.5).  As a result, the binding of each analyte with the anionic poly-L-SULV decreased, 
ultimately resulting in a shorter migration times for the enantiomers of both analytes at the 
higher pH.  Increasing the operating temperature resulted in a shorter migration time for 
chlorophenols. Generally, separations at higher temperatures also resulted in shorter migration 
times for BNP and BOH (Figure 2.2D). However, increase in migration times at higher 
temperatures was observed in some cases for BNP and BOH, depending on the prevailing 
condition of other separation parameters.  In contrast with the migration times obtained for BNP 
and BOH, better enantiomeric resolutions were generally obtained at low pH, high molecular 
micelle concentration, low temperature, and low voltage. 
Enantiomeric resolution is a result of differences in strength of the interaction between 
enantiomers and the chiral molecular micelle or chiral selector.  The ultimate goal of chiral 
separation is to obtain baseline resolution of the analytes.  The optimization of separation 
parameters for the prediction of migration time and resolution of analytes is very important in 
analytical separation. However, optimization of separation parameters to predict the resolution 
per unit time (Rs/t) i.e. how much resolution can be achieved in a short migration time, 
particularly if the value of Rs/t reaches a maximum at a given point of the experimental 
multidimensional space, is probably the most interesting. The ultimate goal of chiral separation 
is to obtain baseline resolution of the analytes at reasonable migration times. Therefore, 
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resolution per unit time is a powerful parameter that can be used to evaluate the best design 
separation condition(s) where better resolution can be obtained at short migration time of 
analytes.  For that reason, I also optimize the separation parameters for the prediction of 




























Figure 2.2   Typical electropherograms for the separation of BNP and BOH at various 
separation parameters. MEKC conditions: 100 mM Tris/10 mM borate buffer, 0.2 
mg/mL BNP and BOH, pressure injection: 30 mbar for 3 s, UV detection at 254 
nm. (A) 0.5% or 1.0% w/v poly-L-SULV, 15°C, pH 9.0, +30 kV applied voltage,  
(B) +30 kV or +15 kV applied voltage, 0.5% w/v poly- L –SULV, 15°C, pH 10.0.  
(C) pH 9.0 or pH 10.0, +15 kV applied voltage, 0.5% w/v poly- L –SULV, 20°C.  
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When the x-variables are reasonably uncorrelated and the number of x-variables is much 
less than the number of samples (experimental runs in this study), MLR is the chemometric 
method of choice for the investigation of the main effects of the x-variables on the y-response in 
that MLR parameter estimates are directly chemically interpretable.  There was little correlation 
between the separation parameters for BNP, BOH and other chiral analytes (see Table 2.1) and 
the number of the x-variables in this study (four), is far less than the number of experimental 
runs.  
 
Table 2.1  Correlation coefficients among the design variables. * pH was constant, [conc] is 
the molecular micelle concentration. 
 
 BNP BOH HB BENZ WAR COUM TZP LZP 
Voltage α temp -0.013 -0.013 -0.011 -0.019 -0.230 -0.164 -0.330 -0.330 
 
Voltage α pH -0.010 -0.010 -0.153 -0.024 * -0.040  0.095 -0.059 
 
pH α [conc] -0.018 -0.018 -0.101 -0.010 * -0.110 -0.158 -0.212 
 
Voltage α [conc]  0.001  0.001  0.150  0.023  0.056 -0.148  0.235 -0.031 
 
Temp α [conc] -0.046 -0.046  0.062  0.030  0.287 -0.009  0.257 -0.107 
 
 
Modeling of the separation systems was performed as a two-stage process.  In the first 
(calibration) phase, a MLR model is developed from the training data set containing the 
separation parameters, migration times, resolutions and resolution per unit times of the analytes 
using full cross validation.  The data sets used for the calibration of BNP and BOH are illustrated 
in Table 2.2.  The data sets for the calibration of the remaining chiral analytes (benzoin and 
hydrobenzoin, coumachlor and warfarin, lorazepam and temazepam)  are found in Appendix I A-
F.  The use of statistical experimental design and multiple analysis for simultaneous optimization 
of separation parameters is advantageous over the traditional optimization of one separation 
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parameter or factor at a time in that simultaneous optimization of separation parameters will 
result in a more general or global optimum separation working conditions. In contrast, only local 
optimum separation conditions can be achieved with the traditional optimization of one factor at 
a time. In general, low values of Rs/t are obtained for the separation of BNP and BOH under 
most of the experimental design separation conditions, reaching the optimum value at the best 
separation conditions where better resolutions were achieved at short migration times of the 
analytes. The same general trend of Rs/t was obtained for the separation of other analytes. The 
summary of the best separation working condition(s) of the analytes based on their Rs/t values 
are listed in Table 2.3. 
 
 










Ave. Migration Time 
(t) (min) 
BNP           BOH 
Resolution 
(Rs) 
BNP        BOH 
(Rs/t) 
(per min) 
BNP        BOH 
  1 20 15   9.0 1.00 18.649 27.050 7.49 2.43 0.40 0.09 
  2 30 20   9.5 0.50    8.738 13.212 1.37 1.60 0.16 0.12 
  3 30 25 10.0 0.75 11.076 19.125 3.50 1.01 0.32 0.05 
  4 20 15 10.0 1.00   18.086 24.378 4.87 1.46 0.27 0.06 
  5 30 15   9.5 0.50    8.883 12.199 2.00 0.94 0.23 0.08 
  6 15 25   9.5 0.50 17.825 27.647 1.25 1.69 0.07 0.06 
  7 20 15 10.0 0.50   13.208 16.861 5.00 3.59 0.38 0.21 
  8 30 15 10.0 0.50    8.668 11.810 5.10 3.30 0.59 0.28 
  9 25 20 10.0 1.00 13.979 20.222 5.63 1.66 0.40 0.08 
10 20 25   9.0 1.00 19.472 35.292 2.74 1.21 0.14 0.03 
11 30 20   9.5 1.00 10.320 14.879 4.83 1.36 0.47 0.09 
12 20 20   9.0 1.00 18.759 29.057 7.02 1.61 0.37 0.06 
13 20 15   9.5 0.75 14.937 19.427 2.60 1.25 0.17 0.06 
14 30 20   9.5 0.75    9.627 14.460 3.29 1.21 0.34 0.08 
15 15 20 10.0 0.50 17.698 25.057 4.25 3.02 0.24 0.12 
16 30 25   9.5 0.50    8.577   13.833 1.14 1.48 0.13 0.11 
17 30 15   9.5 0.75    9.799 13.525 3.12 1.27 0.32 0.09 
18 15 20 10.0 0.75 21.104 31.594 4.24 1.95 0.20 0.06 
19 15 15   9.5 0.50 17.950 23.500 2.61 1.06 0.15 0.05 
20 20 15 10.0 0.75 14.742 18.672 5.85 3.38 0.40 0.18 
21 15 20   9.0 1.00 25.267 39.622 6.22 1.69 0.25 0.04 
22 25 20   9.0 1.00 15.023 23.424 6.94 1.49 0.46 0.06 
23 30 15   9.5 1.00 10.412 14.054 5.61 1.59 0.54 0.11 
24 20 20 10.0 0.50 13.096 18.729 4.62 2.96  0.35 0.16 
25 25 20   9.5 1.00 12.653 18.039 4.91 1.47 0.39 0.08 
Table 2.2 continued 
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26 20 15   9.5 0.50 13.490 17.841 2.33 0.94 0.17 0.05 
27 25 15   9.0 1.00 14.950 22.109 7.59 2.05 0.51 0.09 
28 25 25   9.0 0.75 10.513 14.522 3.05 1.18 0.29 0.08 
29 15 20   9.5 1.00 21.137 29.094 4.94 1.55 0.23 0.05 
30 15 25 10.0 0.50 18.388 29.336 3.75 2.84 0.20 0.10 
31 15 25   9.0 0.50 20.937 36.300 4.03 2.46 0.19 0.07 
32 20 20   9.5 0.50 13.319 18.616 1.61 0.95 0.12 0.05 
33 20 20 10.0 0.75 14.828 21.250 4.69 2.11 0.32 0.10 
34 30 15 10.0 0.75   9.823 13.514 4.87 2.65 0.50 0.20 
35 15 15   9.0 1.00 24.411 35.164 7.52 2.13 0.31 0.06 
36 15 15 10.0 0.75 19.432 23.926 5.00 3.06 0.26 0.13 
37 25 25 10.0 0.75 12.964 21.640 3.97 1.29 0.31 0.06 
38 25 20   9.0 0.50 12.286 19.963 4.87 2.52 0.40 0.13 
39 25 20   9.0 0.75 11.904 17.590 5.02 1.47 0.42 0.08 
40 15 15   9.5 1.00 21.418 27.334 4.74 1.65 0.22 0.06 
41 25 20 10.0 0.50 10.605 15.626 4.36 2.88 0.41 0.18 
42 25 20   9.5 0.75 11.727 17.269 3.48 1.24 0.30 0.07 
43 15 20 10.0 1.00 23.458 32.821 6.01 1.89 0.26 0.06 
44 30 20 10.0 1.00 11.738 17.568 5.23 1.48 0.45 0.08 
45 30 25   9.5 0.75   9.427 14.789 2.53 1.13 0.27 0.08 
46 20 20   9.0 0.75 15.241 22.633 6.04 1.84 0.40 0.08 
47 25 15   9.5 1.00 12.565 16.469 5.67 1.67 0.45 0.10 
48 15 15 10.0 0.50 18.570 23.067 4.41 3.11 0.24 0.13 
49 30 20 10.0 0.75   10.235 15.960 4.45 1.76 0.43 0.11 
50 15 25   9.0 0.75 18.766 27.003 4.22 1.59 0.22 0.06 
51 20 25   9.0 0.75 13.570 19.152 3.80 1.27 0.28 0.07 
52 25 25 10.0 0.50 10.677 17.317 3.39 2.28 0.32 0.13 
53 20 15   9.0 0.50 15.418 23.080 6.24 2.80 0.40 0.12 
54 30 20 10.0 0.50   8.963 13.857 4.19 2.47 0.47 0.18 
55 30 25   9.5 1.00 10.382 15.767 3.26 1.09 0.31 0.07 
56 25 20 10.0 0.75 12.053 17.837 4.61 2.01 0.38 0.11 
57 20 25 10.0 0.50 13.499 21.513 3.55 2.38 0.26 0.11 
58 25 25   9.5 1.00 12.684 19.080 3.93 1.19 0.31 0.06 
69 25 15 10.0 0.50 10.526 13.907 4.93 3.49 0.48 0.25 
60 15 20   9.0 0.75 20.842 31.075 5.08 2.08 0.24 0.07 
61 25 15 10.0 1.00 13.307 17.292 6.40 2.42 0.48 0.14 
62 20 25   9.5 0.50 13.418 21.307 1.23 1.44 0.09 0.07 
63 20 25 10.0 0.75 17.258 32.214 3.91 1.59 0.23 0.05 
64 15 20   9.5 0.75 19.983 29.031 3.32 1.15 0.17 0.04 
65 30 20   9.0 0.75   9.807 14.464 4.13 1.49 0.42 0.10 
66 25 25   9.0 1.00 15.327 29.432 2.94 1.09 0.19 0.04 
67 20 20   9.5 0.75 14.682 21.084 3.24 1.17 0.22 0.06 
68 25 15   9.0 0.75 13.058 19.074 7.71 2.48 0.59 0.13 
69 30 15   9.0 1.00 12.433 18.634 7.37 1.77 0.59 0.09 
70 25 15   9.5 0.50 10.808 14.619 2.16 0.85 0.20 0.06 
71 30 15   9.0 0.50 10.294 15.913 6.22 2.89 0.60 0.18 
72 30 25   9.0 0.50 10.588 18.531 3.31 1.59 0.30 0.09 
73 15 15   9.5 0.75 19.793 25.460 2.28 1.65 0.12 0.06 
           
 Table 2.2 continued 
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The plot of the regression coefficients of the design variables for the migration time, 
resolution and resolution per unit time of BNP, BOH and other chiral analytes investigated from 
the MLR analysis are illustrated in Figure 2.3.  High regression coefficients were obtained  
between the design variables and the migration times, resolution and resolution per unit time 
response for BNP, BOH and other analytes (migration time, R2 = 0.9542-0.9860; resolution, R2 = 
0.8016-0.9738; resolution per unit time, R2 = 0.7579-0.9712). In addition, the residual errors of 
calibration and validation models were also generally small. Statistical methods involving 
analysis of variance and surface response plots (Figure 2.4) were further used to evaluate the 
overall significance of the models and to determine the influence, contribution, and significance 
of the design variables on each response. All the models were highly significant (p < 0.005 at 95 
% confidence), indicating they were good enough for future response predictions. Although the 
four separation parameters do influence the migration time, enantiomeric resolution as well as 
the resolution per unit time, it is apparent from Figure 2.3 that the influence and contribution of 
the separation parameters were analyte dependent.  
In the second (validation) phase, the second data set was used to predict the migration 
time, resolution and resolution per unit time using the MLR model developed in the calibration 
phase.  The real test of any regression model is its capability to accurately predict the migration 
time and resolution of the analyte in future independent experimental runs.  The actual 
experimental migration times, the calculated experimental resolutions and experimental 
resolution per unit times as well as the predicted migration times, resolution and resolution per 
unit  times obtained for  the separation  of BNP and  BOH at various  separation conditions in the 






















Figure 2.3 The plot of scaled and centered regression coefficients from MLR model for 
responses of the analytes.  (A)  average migration time; (B) enantiomeric 
resolution; (C) resolution per unit time.  1. BNP; 2. BOH; 3. Benz; 4. HB; 5. 
Coum; 6. War; 7. LZP; 8. TZP. Insignificant coefficients are marked with *, 
coefficients marked ** are at the edge of being significant while unmarked 
































































































































Figure 2.4 Surface response plots for BNP. Effect of (A) concentration and voltage on 
migration time, (B) concentration and temperature on migration time, (C) 















































Table 2.4  Experimental and predicted migration time, resolution, and resolution per unit 










       Ave. MT  
       (t) (min) 
    Exp        Pred         Pred   
 
 
 Exp         Pred         Pred 
1 20 20 10.0 1.00 11.066 10.768 6.36 5.79 0.57 0.54 
2 25 25 10.0 1.00 17.468 17.536 5.78 5.16 0.33 0.29 
3 25 25   9.5 0.75 16.141 14.066 4.20 4.27 0.26 0.30 
4 30 25   9.0 0.75 11.488 12.866 2.71 3.49 0.24 0.27 
5 20 25 10.0 1.00   8.440   9.847 2.94 3.57 0.35 0.36 
6 25 15   9.0 0.50 19.649 17.479 4.63 4.35 0.24 0.25 
7 15 25   9.5 1.00 12.357 11.780 5.79 4.33 0.47 0.37 
8 30 20   9.0 1.00 21.285 21.285 4.13 4.61 0.19 0.22 
9 20 15   9.5 1.00 12.620 11.500 6.04 5.32 0.48 0.46 
10 15 15   9.0 0.75 15.980 17.987 5.63 6.13 0.35 0.34 
11 15 25   9.5 0.75 21.755 20.199 6.34 5.45 0.29 0.27 
12 25 15 10.0 0.75 19.931 19.691 2.92 3.67 0.15 0.19 
13 25 25   9.0 0.50 11.866 12.587 5.29 4.94 0.45 0.39 
14 20 25   9.5 0.75 12.547 11.665 3.82 2.72 0.30 0.23 
15 30 15   9.0 0.75 14.991 16.278 2.94 3.58 0.20 0.22 
16 20 20   9.0 0.50 10.786   9.961 6.39 5.19 0.59 0.52 
17 30 25 10.0 0.50 15.341 15.135 5.10 3.61 0.33 0.24 
18 20 25   9.0 0.50   6.556   7.466 2.05 2.30 0.31 0.31 
19 15 20   9.0 0.50 15.594 15.078 4.01 2.81 0.26 0.19 
20 20 25   9.5 1.00 20.562 18.548 4.65 3.70 0.23 0.20 
21 20 15   9.0  0.75 15.939 17.872 3.85 4.52 0.24 0.25 
22 20 20 10.0 1.00 16.451 16.786 6.94 5.36 0.42 0.32 
RMS%RE     8.78             18.99               15.76 
 
 
The root mean-square percent relative error (RMS%RE) is a useful figure of merit for 
quantitatively expressing the predictive utility of the models for migration time and resolution: 














%               2.1 
where yi is the experimentally observed result for the ith validation sample, iŷ  is the predicted 
result, and n is the number of validation samples in the set. The prediction capability of the 
model for the migration times of R- and S-enantiomers of the analytes is almost the same, 






addition, the average migration time was used to calculate the resolution per unit time of the 
analytes. The RMS%RE obtained for the predicted average migration times of BNP enantiomers 
was 8.8 %, with the RMS%RE of 19.0% for the predicted resolution of BNP enantiomers.  In the 
validation study for BOH, the RMS%RE for the predicted average migration time for BOH 
enantiomers was 12.3%, with RMS%RE of 16.5% for the predicted resolution of BOH.  In terms 
of RMS%RE, the models predicted the migration times of the analytes slightly better than the 
enantiomeric resolutions.     
 
Table 2.5 Experimental and predicted migration time, resolution and resolution per unit 









       Ave. MT  
       (t) (min) 
    Exp        Pred           Exp   
 
 
 Pred         Exp         Pred 
1 30 25   9.0 1.00 23.403 20.093 0.81 0.79 0.03 0.04 
2 30 15 10.0 1.00 14.876 14.001 2.07 1.86 0.14 0.13 
3 30 20   9.0 0.50 17.020 13.616 2.20 1.74 0.13 0.13 
4 20 20 10.0 1.00 24.965 25.205 1.78 1.79 0.07 0.07 
5 25 25 10.0 1.00 27.607 22.369 1.22 1.32 0.04 0.06 
6 20 25 10.0 1.00 31.009 27.046 1.21 1.45 0.04 0.05 
7 25 15   9.0 0.50 18.741 16.452 2.84 2.21 0.15 0.13 
8 15 25   9.5 1.00 31.278 32.924 1.41 1.39 0.05 0.04 
9 30 20   9.0 1.00 20.119 18.252 1.23 1.12 0.06 0.06 
10 20 15   9.5 1.00 20.698 24.564 1.74 1.93 0.08 0.08 
11 15 15   9.0 0.75 31.332 28.124 2.37 2.17 0.08 0.08 
12 25 15 10.0 0.75 15.784 16.369 2.72 2.30 0.17 0.14 
13 25 25   9.0 0.50 21.912 20.135 1.74 1.54 0.08 0.08 
14 20 20   9.5 1.00 21.983 26.405 1.60 1.59 0.07 0.06 
15 20 25   9.5 0.75 24.246 25.929 1.19 1.56 0.05 0.06 
16 30 15   9.0 0.75 16.011 14.093 1.91 1.77 0.12 0.13 
17 25 20   9.5 0.50 15.795 17.093 1.63 2.07 0.10 0.12 
18 20 20   9.0 0.50 24.775 22.970 3.18 2.01 0.13 0.09 
19 20 25   9.0 0.50 26.975 24.811 2.04 1.67 0.08 0.07 
20 15 20   9.0 0.50 32.944 27.647 2.50 2.14 0.08 0.08 
21 20 25   9.5 1.00 23.769 28.247 1.35 1.25 0.06 0.04 
22 20 15   9.0 0.75 23.926 23.447 2.52 2.03 0.11 0.09 









To investigate the versatility of MLR modeling of MEKC separation parameters, the 
same experimental procedure was used with six other chiral analytes (benzoin, hydrobenzoin, 
coumachlor, warfarin, lorazepam, and temazepam) of different molecular structures 
complexities, and compound class (Figure 2.1).  A different molecular micelle, poly-L-SUILV, 
was used for these chiral separations.  It must be emphasized that the baseline separations and 
enantiomeric resolutions of these analytes are very challenging; hence, separation parameter 
optimization of these compound classes is very difficult.  In fact, the separation of warfarin can 
only be achieved at pH 7.5; therefore, the pH was kept constant.  The separations of benzoin, 
hydrobenzoin, coumachlor, lorazepam, and temazepam were performed at two pH levels each: 
benzoin and hydrobenzoin at pH 7.2 and 7.5, coumachlor at pH 7.0 and 7.5, lorazepam and 
temazepam at pH 8.0 and pH 9.0. As previously described for the separation of BNP and BOH, 
the separation of other chiral analytes at various design separation conditions were divided into 
two data sets. The first data set was used as a training set for MLR calibration while the second 
data set was used for the prediction of the average migration time, the resolution as well as the 
resolution per unit time of the analytes. 
Figure 2.5 illustrates the summary of the validation results obtained for the average 
migration time, resolution and resolution per unit time of the analytes when independently 
validated. The actual experimental migration times, the calculated experimental resolutions and 
experimental resolution per unit times as well as the predicted migration times, resolution and 
resolution per unit times obtained for the separation of the remaining chiral analytes (benzoin 
and hydrobenzoin, coumachlor and warfarin, lorazepam and temazepam) at various separation 
conditions in the validation study are listed in Appendix II (A-F).  Although the prediction 
capability of the model for each analyte differs slightly, the predicted migration times, 
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enantiomeric resolutions and resolution per unit times compare favorably with the 
experimentally observed migration times, resolutions and resolution per unit times.  
 
 
















































































































































































































RMS% RE = 9.82 RMS% RE = 10.16 RMS% RE = 10.35
RMS% RE = 9.06 RMS% RE = 14.27 RMS% RE = 21.31
RMS% RE = 15.77 RMS% RE = 13.62 RMS% RE = 23.60
RMS% RE = 10.80 RMS% RE = 10.10 RMS% RE = 36.91
RMS% RE = 12.83 RMS% RE = 13.78 RMS% RE = 26.26
RMS% RE = 10.61 RMS% RE = 16.63 RMS% RE = 37.73



































































2.3.2 Study with Achiral Analytes 
To demonstrate the general utility of the technique in MEKC, the same experimental 
procedure was used to model the separation parameters and predict the migration times of achiral 
chlorophenols (4-chlorophenol and pentachlorophenol) and achiral benzodiazepines (clonazepam 
and diazepam). The achiral analytes were separated under similar experimental procedures 
described for BNP and BOH; however, an achiral, molecular micelle, poly-SUS, was used.  The 
calibration data sets of the achiral analytes are found in Appendix I G-H.  The results obtained 
for the 4-chlorophenol, pentachlorophenol, clonazepam and diazepam when the models were 
independently validated are illustrated in Figure 2.6. The actual experimental migration times, 
the calculated experimental resolutions and experimental resolution per unit times as well as the 
predicted migration times, resolution and resolution per unit times obtained for the separation of 
the achiral benzodiazepines (clonazepam and diazepam) and achiral phenols (4-chlorophenol and 
pentachlorophenol) at various separation conditions in the validation study are listed in Appendix 
II (G and H).  Once again, the predicted migration time, resolution and resolution per unit time 
obtained for the four achiral analytes compare well with the experimental values.  
 
Figure 2.6 Results of MLR validation study for achiral analytes.  
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2.3.3 Comparative Analysis Using PLS-1 and PCR Analysis 
The prediction capability of a MLR model can be limited if there is colinearity among the 
independent variables. Principal component regression (PCR) and partial-least-square (PLS-1) 
regression are the modern multiple regression techniques usually employed to remove colinearity 
among the independent variables.32,33,35  In contrast with MLR where the y-matrix and x-matrix 
data set are directly regressed, modern PCR and PLS-1 regression avoid colinearity between the 
independent variables by representing the data set in a new orthogonal coordinate system. In the 
case of PCR, the independent data set is first decomposed using a principal component analysis. 
PLS-1 regression is particularly useful in that both the independent and dependent data set are 
simultaneous decomposed, hence, the response prediction error is minimized. In a statistical 
term, PLS-1 attempts to maximize the covariance between the y- and x-data set.  The use of PCR 
and PLS-1 regression modeling for MEKC separation optimization has been previously 
demonstrated.20,37   
To further test the quality of the MLR models and their predictive capability, PCR and 
PLS-1 regression were used to model the training data set of the analytes for subsequent 
prediction of migration times, resolutions and resolution per unit times using the validation data 
set of the respective analyte. The summary of the prediction of average migration time, 
resolution and resolution per unit time from the validation study of various analytes using MLR, 
PLS-1 and PCR are illustrated in Figure 2.7. In terms of RMS%RE, there was no significant 
difference in the prediction ability of MLR, PCR and PLS-1 models for migration times, 
resolutions and resolution per unit time of most analytes. However, slightly better prediction of 
resolution and resolution per unit time for HB and TZP are obtained using PCR and PLS-1 
regression. Similar predictive power of MLR, PLS-1 and PCR models is expected since there 
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was little or no correlation between the design orthogonal variables for the analytes investigated 
(see Table 2.1). However, in the case where the design variables are highly correlated, PLS-1 





















Figure 2.7 Overall RMS%RE obtained from validation study of all analytes using MLR, PCR 
and PLS-1: (A) average migration time, (B) resolution, (C) resolution per unit 
time. 









































































2.4  Conclusions 
It is well established that the separation of analytes in MEKC is a function of separation 
parameters such as molecular micelle concentration in the BGE, applied voltage, pH buffer, and 
operating temperature.  These separation parameters were optimized by experimental design and 
multiple regression analysis to predict the migration times, the resolutions and resolution per unit 
times of the analytes.  These predicted values compared favorably with the experimental 
migration times and resolutions of the analytes.  This approach has proven to be versatile 
because the separation parameters of analytes with a chiral plane of symmetry, chiral molecules 
with stereogenic centers, as well as achiral molecules were optimized.  In addition, the use of 
multiple analysis modeling of separation parameters to predict migration time and resolution of 
analytes is advantageous over the traditional labor intensive and trial and error method for the 
optimization of separation parameters. 
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THE USE OF POLY(SODIUM N-UNDECANOYL-L-LEUCYLVALINATE), 
POLY(SODIUM N-UNDECANOYL-L-LEUCINATE), AND  
POLY(SODIUM N-UNDECANOYL-L-VALINATE) MOLECULAR MICELLES AS 
CHIRAL SELECTORS FOR DETERMINATION OF ENANTIOMERIC 
COMPOSITION OF SAMPLES BY MULTIVARIATE REGRESSION MODELING OF 




Chiral analysis continues to be a topic of keen interest in the pharmaceutical industry 
because of differences in pharmacological and physiological properties of enantiomers. While 
one enantiomer of a chiral drug may have therapeutic effects, the other enantiomer may be 
ineffective or toxic, leading to serious health problems for humans.1-3 These potentially harmful 
effects of different enantiomers have prompted serious health concerns from government and 
regulatory agencies.  This is particularly true for drugs that were initially approved as racemates, 
but are now being submitted for approval by the pharmaceutical industry as single-enantiomer 
drugs.  Because of these concerns, the pharmaceutical industry is required to document the 
pharmacological and physiological properties of all single-enantiomer drugs. 
Chiral analysis is often performed by use of chromatography or capillary 
electrophoresis,4-8 and nuclear magnetic resonance (NMR) using chiral solvents.9  Chiral 
stationary phases used in chromatographic separations frequently employ chiral cavitands that 
involve the formation of transient non-covalent guest-host complexes between the guest analyte 
and a selector.  Several chiral cavitands such as cyclodextrins,10-12 protein antibiotics13,14 and 
crown ethers15,16 have been widely used for chiral discrimination and for enantio-differentiation 
of chiral molecules. Chiroptical methods such as polarimetry, optical rotary dispersion, circular 
dichroism, and vibrational circular dichroism have also been used for chiral analysis.4,17,18  
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While most of these techniques are unquestionably effective, some of the current 
analytical techniques of chiral analyses have several major drawbacks. For example, 
chromatography and capillary electrophoresis are slow and not particularly attractive for high-
throughput- or rapid screening of chiral compounds.  Moreover, in the case of chiral 
chromatography, chiral columns are frequently expensive and can have relatively short lifetimes.  
Chiroptical methods, such as the polarimetric method of chiral analysis, require a relatively large 
sample size and the measured optical rotation by the polarimeter can be solvent dependent. In 
addition, the sensitivity of some techniques like circular dichroism is relatively low, while 
techniques like NMR and mass-spectrometric methods are very expensive in terms of 
instrumentation.  A relatively inexpensive spectroscopic method, like fluorescence spectroscopy, 
is therefore highly desirable in the pharmaceutical industry today, where accurate and rapid 
screening of chiral molecules is of considerable interest as the marketing of drugs switches from 
racemic mixtures to single-enantiomer formulations.  
Busch and co-workers recently reported a new rapid, accurate, and robust method for 
determining the enantiomeric composition of chiral molecules that combines ordinary 
ultraviolet/visible absorption- or fluorescence spectroscopy, cyclodextrin guest-host chemistry, 
and multivariate regression modeling.19-23 In these studies, chiral analysis by the regression 
modeling of spectral data was shown to be a reliable method for determining the enantiomeric 
composition of chiral samples using ordinary spectroscopic methods. Tran and co-workers used 
a similar approach with near-infrared spectroscopy for determination of the enantiomeric 
composition of molecules of pharmaceutical interest.24,25   
Poor solubility of native CDs as well as highly hydrophobic guests are major problems 
encountered in previous studies, and different strategies, such as the use of modified CDs21 or the 
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use of an achiral monomeric sodium dodecyl sulfate surfactant in combination with organic 
solvents20  have been employed in an attempt to ameliorate these problems.  
 In this chapter, the use of three chiral molecular micelles as chiral selectors for the 
determination of the enantiomeric composition of three chiral molecules (Figure 3.1) using 
steady-state fluorescence spectroscopy and multivariate regression modeling of the spectral data 
is reported.  The three chiral surfactants used were poly(sodium N-undecanoyl-L-leucylvalinate) 
[poly-L-SULV], poly(sodium N-undecanoyl-L-leucinate) [poly-L-SUL] and poly(sodium N-
undecanoyl-L-valinate) [poly-L-SUV].  The two chiral binaphthyl analyte molecules [1,1’-bi-2-
naphthol (BOH) and 1,1’-binaphthyl-2,2’-diamine (BNA), see Figure 3.1], as well as a chiral 
anthracene derivative, 2,2,2-trifluoroanthrylethanol (TFA), were selected for their fluorescence 
properties.  BOH and BNA, although they do not possess typical chiral centers, are, nevertheless, 
chiral because they have axial chirality.  Both compounds are stable to racemization. 
Molecular micellar agents, also known as surfactants, are amphiphilic in nature, 
containing an apolar long-chain hydrocarbon tail and polar head groups. Chiral surfactants may 
function as nearly ideal chiral selectors for analytes such as the binaphthyl and anthracene 
derivatives used in this study by providing a chiral micellar environment for the highly 
hydrophobic analytes.  Both chiral monomeric and molecular micelles have been used as 
selectors for chiral discrimination.26-31 However, the use of molecular micelles is desirable 
because they are more stable and more rigid than monomeric surfactants. In addition, because 
molecular micelles have controllable sizes and have no critical micelle concentration, the use of 
molecular micelles eliminates the dynamic equilibrium between the micelles and the monomer. 
Compared to other chiral selectors such as cyclodextrins, crown ethers or protein antibiotics, 
molecular micelles are relatively more soluble in aqueous and organic solvents. Additionally, the 
 70
polar head group as well as the number of stereogenic centers in the molecular micelles can 
easily be controlled and modified. Molecular micelles, therefore, have potentially wider 
applications and can be used for chiral analytes of various molecular size and polarity. 
 Poly-L-SULV, a negatively charged dipetide molecular micelles with two chiral centers, 
has a low aggregation number and is highly soluble in water. Furthermore, poly-L-SULV has 
good chiral discriminating capability and has been used successfully for the chiral separation of 
various analytes with different molecular structures in micellar electrokinetic chromatography 
(MEKC).32 In addition, the chiral recognition ability of poly- L-SULV, using fluorescence 
anisotropy, has been demonstrated.33 Poly-L-SUL and poly-L-SUV are single amino-acid-based 
molecular micelles, each with one chiral center, that have been used for enantiomeric separation 
of several analytes in MEKC.31  
3.2 Methods 
 
3.2.1  Materials 
Enantiomerically pure (R)-1,1’-bi-2-naphthol (R-BOH), (S)-1,1’-bi-2-naphthol (S-BOH), 
(R)-1,1’-binaphthyl-2,2’-diamine (R-BNA), (S)-1,1’-binaphthyl-2,2’-diamine (S -BNA), (R)-
2,2,2,-trifluoroanthrylethanol (R-TFA), and (S)-2,2,2,-trifluoroanthrylethanol (S -TFA), sodium 
borate, and tris(hydroxymethyl)aminomethane (TRIS) were purchased from Aldrich Chemical 
Company (Milwaukee, WI) and used as received. The methanol used in the study (ACS 
certified) was also obtained from Aldrich. Doubly-deionized water, used throughout in the study, 
was obtained from a PURELAB Ultra Genetic water polishing system (US Filter).  
3.2.2  Instrumentation 
The fluorescence emission of each sample was recorded using a spectrofluorometer 
(SPEX Fluorolog-3) equipped with double excitation and emission monochromators. A 400W 
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Xe arc-lamp was used for excitation and a thermoelectrically cooled Hamamatsu R-928 
photomultiplier tube, operating in the photon-counting mode, was used for detection. All data 
were collected using a 0.4 cm path length quartz cuvet.  
3.2.3  Syntheses of Molecular Micelles 
The synthesis and polymerization of poly-L-SULV was described in Chapter 2.  The 
monomers L-SUL and L-SUV followed the same synthetic procedure as described for L-SULV.  
The leucine-valine dipetide was replaced with either leucine or valine to yield the final 
monomers L-SUL or L-SUV, respectively.   
3.2.4  Sample Preparation 
A solution containing 1.5 % w/v of molecular micelles was made by dissolving 1.500 g 
of poly-L-SULV in 100 mL of doubly-deionized water or in a solution containing 100 mM Tris 
and 10 mM borate buffer at pH 10.0. Stock solutions of each enantiomer were made by weighing 
appropriate amounts of each enantiomer and dissolving them in methanol.  From the stock 
solution, appropriate concentrations (1 × 10-4 or 5 × 10-6 M) of the enantiomer solutions were 
made by transferring appropriate aliquots of the stock solution to a dry volumetric flask.  After 
transfer, the methanol was then gently evaporated under a stream of ultra-high-purity nitrogen 
gas. The solution was then made up to the mark with 1.5 % molecular micelles solution and 
sonicated for at least 20 min to ensure complete dissolution of analyte.  Following dissolution, 
the samples were allowed to equilibrate for 15 min.  
Training-set samples and calibration-set samples were made for each chiral analyte so 
that for a given experiment, all solutions contained a fixed molecular micelle concentration and a 
fixed concentration of chiral analyte.  The enantiomeric composition of the calibration samples 
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was varied from 0.1 to 0.9 mol fraction. The samples were allowed to equilibrate for at least 30 
min before the fluorescence emission spectra of the samples were recorded.  
3.2.5  Data Analysis 
The mean-centered spectral data were subjected to multivariate regression analysis using 
commercial chemometric software (The Unscrambler version 9.1; CAMO, Inc., Corvalis, OR). 
Partial-least-square-regression models (PLS-1) were developed from the spectral data using full-
cross validation. The regression models were validated with new independently-prepared sets of 
validation samples. 
3.3  Results and Discussion 
 
3.3.1  Study with Poly-L-SULV 
The fluorescent chiral analytes and molecular micelles used for this study are illustrated 
in Figure 3.1.  Figure 3.2A illustrates fluorescence emission spectra (λex = 380 nm) of 1 × 10-4 M 
(R)- and (S)-BOH enantiomers in 1.5 % w/v poly-L-SULV. Although the concentrations of both 
enantiomers are the same, they have notably different emission spectra in the presence of poly-L-
SULV. The differences in the spectra of the enantiomers illustrated in Figure 3.2A can be 
attributed to different noncovalent enantiomeric interactions within the micellar environment of 
the chiral molecular micelles.  Such differences in enantiomeric interactions with the chiral poly-
L-SULV surfactant will ultimately produce diastereomeric effects that influence the spectra.  As 
expected, there was no apparent difference in the spectra of the two enantiomers in the presence 
of achiral poly-(sodium N-undecylenic sulphate) surfactant.  
Figure 3.2B illustrates the fluorescence emission spectra obtained for a set of eight 
solutions containing a fixed BOH analyte concentration (1 × 10-4 M) of various enantiomeric 
composition in the presence of chiral poly-L-SULV surfactant. The samples have maximum 
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emission at 445 nm. Although the BOH concentration was fixed, the fluorescence emission 
intensity of the spectra varied with the enantiomeric composition of the BOH samples.  Samples 
containing different ratios of the (R)- and (S)-enantiomers will produce different diastereomeric 






















Figure 3.1     Molecular structures of: (I) BOH; (II) BNA; (III) TFA; (IV) poly-L-SULV (V) 








































































































































































































Figure 3.2 (A). Fluorescence emission spectra (λex = 380 nm) of 1×10-4 M BOH  enantiomers 
in the presence of 1.5 % w/v poly-L-SULV; (B)  Fluorescence emission spectra of 
solutions containing 1.5 % w/v poly-L-SULV and  1×10-4 M BOH of various 
enantiomeric compositions. Mol fraction of (R)-BOH: (1) 0.1; (2) 0.3; (3) 0.4; (4) 
0.6; (5) 0.7; (6) 0.8; (7) 0.9; (8) 0.95. (C). Mean-centered spectral plot of solutions 
containing 1.5 % w/v poly-L-SULV and 1×10-4 M BOH of various enantiomeric 
compositions.  Mol fraction of (R)-BOH: (1) 0.1; (2) 0.3; (3) 0.4; (4) 0.6; (5) 0.7; 























































































































































Better insight into the spectral variations that occur with different enantiomeric 
compositions can be gained from a plot of the mean-centered spectra (Figure 3.2C). The mean-
centered plot was obtained by averaging the spectra of the eight solutions and then subtracting 
this average spectrum from the spectrum of each individual sample on a wavelength-by-
wavelength basis. Figure 3.2C is interesting because the spectra of samples containing 
enantiomeric mol fractions of (R)-BOH less than 0.5 are above the origin of the graph while 
those containing mol fractions of (R)-BOH greater than 0.5 are below.  
  Fluorescence emission spectra (λex = 365 nm) of 1 × 10-4 M (R)- and (S)-BNA in the 
presence of poly-L-SULV are illustrated in Figure 3.3A.  As observed for BOH, the (R)- and (S)-
BNA enantiomers have different spectra in the presence of poly-L-SULV.  With this analyte, the 
two enantiomers have the same general spectral profile, but the fluorescent intensities observed 
for the two enantiomers are different.  In addition, while the (S)-BOH isomer produced the most 
fluorescence intensity in the study with poly-L-SULV (Figure 3.2A), the opposite was observed 
for BNA in the presence of poly-L-SULV.  
 Figure 3.3B illustrates the fluorescence emission spectra of the eight solutions containing 
1 × 10-4 M of BNA with varying enantiomeric composition in the presence of poly-L-SULV. The 
samples have a maximum fluorescence emission at 412 nm. Once again, a variation of emission 
spectral intensity with enantiomeric composition of BNA analyte is observed. The mean-
centered spectral plot for the BNA samples is illustrated in Figure 3.3C.  In contrast to the mean-
centered spectral plot obtained for the BOH samples, samples containing enantiomeric 
compositions of (R)-BNA less than 0.5 mol fraction are below the origin, while those containing 





















Figure 3.3 (A). Fluorescence emission spectra (λex = 365 nm) of 1×10-4 M BNA  enantiomers 
in the presence of 1.5 % w/v poly-L-SULV; (B)  Fluorescence emission spectra of 
solutions containing 1.5 % w/v poly- L –SULV and  1×10-4 M BNA of various 
enantiomeric compositions. Mol fraction of (R)-BNA: (1) 0.115; (2) 0.350; (3) 
0.450; (4) 0.500; (5) 0.650; (6) 0.750; (7) 0.820; (8) 0.980. (C). Mean-centered 
spectral plot of solutions containing 1.5 % w/v poly-L-SULV and 1×10-4 M BNA 
of various enantiomeric compositions.  Mol fraction of (R)-BNA: (1) 0.115; (2) 










































































































































































Figure 3.4 (A). Fluorescence emission spectra (λex = 380 nm) of 1×10-4 M TFA  enantiomers 
in the presence of 1.5 % w/v poly-L-SULV; (B)  Fluorescence emission spectra of 
solutions containing 1.5 % w/v poly-L–SULV and 1×10-4 M TFA of various 
enantiomeric compositions. Spectra too close to label individually. (C). Mean-
centered spectral plot of solutions containing 1.5 % w/v poly-L-SULV and 1×10-4 
M TFA of various enantiomeric compositions.  Mol fraction of (R)-BNA: (1) 














































































































































Figure 3.4A illustrates the fluorescence emission spectra of (R)- and (S)-TFA 
enantiomers in the presence of poly-L-SULV (λex = 380 nm).  In this case, only a slight change in 
emission intensity is observed for the two enantiomers. The emission spectra of seven solutions 
containing a fixed concentration of TFA analyte (1×10-4 M) of various enantiomeric 
compositions in the presence of poly-L-SULV is illustrated in Figure 3.4B.  The maximum 
fluorescence emission for the TFA samples was at 414 nm.  Again, the spectra of the various 
TFA samples depend upon the enantiomeric composition of the samples. Compared to the 
variations observed in the emission spectra of BOH and BNA (Figures 3.2B and 3.3B), changes 
in the emission intensity observed with the TFA samples are somewhat smaller. As with BOH, 
the mean-centered emission spectra of samples containing mol fractions of (R)-TFA less than 0.5 
are above the origin of the graph, while those containing more than 0.5 mol fraction of (R)-TFA 
are below. 
Multivariate regression methods have been widely used for correlating small spectral 
changes with known compositional changes, and the methods are well established in analytical 
chemistry.34-37 Multivariate regression modeling is a two-phase process. In stage one, or the 
calibration phase, spectra of a training set of known composition (i.e. the enantiomeric 
composition of the analyte in this study) are collected over a given wavelength range. Then a 
regression model is developed to correlate the changes in the fluorescence emission spectral data 
with the known compositions of the training-set samples. In the second stage, or validation 
phase, the regression model developed in the calibration phase is validated with a new, 
independently prepared test- or validation-set of samples of known enantiomeric composition. It 
must be stressed that while the analyte concentration in the validation- and calibration-sample 
sets must be the same (i.e., 1 × 10-4 M in this study), the two sets must contain samples with 
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different enantiomeric compositions.  In the validation phase, the spectra of the validation 
samples are taken over the same wavelength range that was used to prepare the model in the 
calibration phase. The enantiomeric compositions of the validation samples are then predicted 
from the spectral data using the model developed in the calibration phase. The performance of 
the model in predicting future samples is evaluated by how well the predicted enantiomeric 
compositions compare with their actual values. 
The regression coefficient, the slope, and the offset obtained from the PLS-1 regression 
modeling of the BOH samples in the presence of poly-L-SULV are listed in Table 3.1 A perfect 
model would have a regression coefficient of 1, a slope of 1, and an offset of 0.  As expected, 
better regressions of the spectral data with the enantiomeric composition of the analytes were 
obtained in the wavelength regions that showed the most variation in the spectral data obtained 
with the training set of samples.  While the regression parameters for the different models look 
quite good, the real test of any regression model is its ability to correctly predict the composition 
of unknown samples. To test the prediction ability, the models were validated with sets of 
independently prepared validation samples of known enantiomeric composition.  For this 
purpose, new sets of sample solutions containing 1 × 10-4 M of each analyte were prepared in 1.5 
% w/v poly-L-SULV, having different enantiomeric compositions from those used to prepare the 
regression models.  The spectra of these samples were then recorded over the same wavelength 
region as used to develop the regression models. The results of the validation study for each 
guest are listed in Tables 3.2. The ability of the model to correctly predict enantiomeric 
composition of the validation samples was evaluated by use of the root-mean-square percent 




Table 3.1 Figures of merit obtained from multivariate regression analysis of calibration 






















1.15 × 10-3 
 
 
Table 3.2 Actual and predicted mol fraction of (R)-BOH, (R)-BNA, (R)-TFA containing 1 × 





















0.233 0.290  2.47 0.125  0.131   4.80  0.101 0.093  -2.47 
0.318 0.320  0.63 0.347  0.337 -2.88  0.265 0.278    4.91 
0.465 0.444 -4.52 0.465 0.439 -5.59 0.310 0.315   1.61 
0.501 0.487 -2.79 0.511 0.493 -3.52 0.400 0.376 -6.00 
0.628 0.637  1.43 0.634  0.647   2.05  0.531 0.555  -5.80 
0.792 0.763 -3.66 0.792 0.787 -0.63 0.603 0.568   4.52 
0.846 0.876  3.55 0.846  0.807 -4.61  0.798 0.831    4.13 
0.957 0.978  2.19 0.978  1.027   5.01  0.955 0.932  -2.41 
0.978 1.008  3.07 0.995  0.974 -2.11  0.985 0.998    1.32 
0.989 0.982 -0.71 --- --- --- 0.995 1.080    8.54 
RMS%RE  2.78      3.81      5.21 
 
 
In the study with BOH, the RMS%RE for the ten validation samples was 2.78 %.  For the 
validation study with BNA, the RMS%RE was 3.81 %, and for the validation study with TFA, 
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the RMS%RE was 5.21 %. While the results of the validation studies for the three analytes are 
quite good, they do depend somewhat on the analyte.  In terms of RMS%RE, the validation result 
obtained for BOH was slightly better than those obtained for BNA and TFA.  The analyte 
dependence of the RMS%RE observed in this study will ultimately depend on the extent of the 
interaction between the chiral analyte and the chiral selector. In this study, for example, BOH 
and TFA are partially anionic whereas BNA is neutral.  Analyte differences such as this will 
ultimately influence the interactions with the negatively charged poly-L-SULV, resulting in 
models with different predictive capabilities.  
The ability of the model to accurately predict the enantiomeric composition of the 
validation samples depends on the extent of the spectral variation obtained with the test set of 
samples in the calibration phase.  For example, comparing the spectral data in Figures 3.2B, 
3.3B, and 3.4B for the calibration sets, the spectral variation with BOH and BNA in the presence 
of poly-L-SULV is much greater than that observed with the TFA samples. 
The spectral differences observed with the calibration samples as the enantiomeric 
composition of the samples is varied will ultimately depend on the diastereomeric interactions 
that occur between the analyte and the chiral selector. While the exact details of these 
diastereomeric interactions are not known at this time, factors like hydrophobicity of the analyte, 
solubility of the analyte in the chiral poly-L-SULV micellar environment, the possibility of 
multiple analyte/surfactant interactions, polarity, charge, and size of the analyte may all play a 
role in producing subtle spectral variations that depend upon the enantiomeric composition of the 
analyte.   
In the case of BOH and TFA, the hydrophilic hydroxyl groups can form hydrogen bonds 
with the carbonyl groups of poly-L-SULV.  In the case of BNA, strong electrostatic interactions 
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can also occur between the amine groups on BNA and the carbonyl groups of the poly-L-SULV 
molecular micelle.  Unlike TFA, which has only one hydroxyl group, the two hydroxyl groups of 
BOH and two amine groups of BNA can simultaneously interact with the two carbonyl groups of 
poly-L-SULV, which may result in stronger diastereomeric interactions (because two sites are 
involved) for BOH and BNA.  
3.3.2 Comparative Study of Single Amino Acid and Dipeptide Based Molecular Micelles 
The dipeptide poly-L-SULV molecular micelle used in the previous study has two chiral 
centers associated with the dipeptide composed of valine and leucine. To study the influence of 
the molecular micelle on the diastereomeric micellar interactions with the analyte, two single-
amino-based molecular micelles (poly-L-SUL and poly-L-SUV) were selected.  By contrast with 
poly- L-SULV, the two single-amino-based molecular micelles poly-L-SUL and poly-L-SUV 
each have only one chiral center associated with the single amino acids on the respective 
molecular micelles.   
In the studies with the single-amino-acid-based molecular micelles, the sample 
preparation and multivariate regression modeling were performed as described in the study with 
poly-L-SULV.  In these studies, spectral variations were observed with test sets of BOH, BNA, 
and TFA of varying enantiomeric composition for samples containing poly-L-SUL.  By contrast, 
no notable spectral variations were observed with test sets of BOH and BNA when poly-L-SUV 
was used as chiral selector.  As a result, it was not surprising that no reasonable model could be 
developed from the spectral data obtained with BOH and BNA in the presence of poly-L-SUV. 
Similar poor enantiomeric resolution was observed for BOH and BNA in MEKC studies31 when 
poly-L-SUV was used as a chiral selector.  By contrast, when poly-L-SUV was used as a chiral 
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selector with TFA, reasonable spectral variations were observed for samples with various 
enantiomeric compositions. 
Figure 3.5 illustrates a bar graph that compares the RMS%RE values obtained for the 
regression models for BOH, BNA, and TFA in the presence of single-amino acid poly-L-SUL 
and dipetide poly-L-SULV. In all cases, better predictions of the enantiomeric composition of 
samples were obtained when dipetide poly-L-SULV was used as a chiral selector.  While the two 
molecular micelles have slightly different hydrophobicities and molecular sizes, the major 
difference in the prediction ability of the regression models made with poly-L-SULV may be due 
to the fact that poly-L-SULV has two chiral centers.  It is expected that better chiral 
discrimination would result with a chiral selector that could simultaneously interact at two chiral 






























3.3.3 Guest-Host Complexation in Tris/Borate Buffer Medium 
To study the influence of the solvent medium on the chiral discrimination with molecular 
micelles, a series of experiments was performed in Tris/borate buffered solutions.  It is known, 
for example, that in MEKC, the buffer medium and pH can play a prominent role in the chiral 
discrimination capability of molecular micelles. Once again, sample preparation and multivariate 
regression modeling were performed as described previously for studies using poly-L-SULV.  
However, in this study, the molecular micelle chiral selectors were prepared in a 100 mM Tris 
and 10 mM borate buffer solution at pH 10.0. This buffer medium was chosen for the study 
because Tris/borate buffer at pH 10.0 has been previously shown to be the optimum buffer 
condition for the separation of BOH and BNA in MEKC.32  
 Figure 3.6 illustrates the summary of the RMS%RE values obtained from the validation 
studies when buffered and unbuffered solutions of the molecular micelle were used as chiral 
selectors.  As shown in the figure, in all cases better predictions were obtained when Tris/borate 
buffered solutions were used.  In agreement with the results of the comparative study of poly-L-
SULV and poly-L-SUL for BOH and BNA in ordinary aqueous solution, better predictions were 
obtained for BOH and BNA when poly-L-SULV was used as a chiral selector in a Tris/borate 
buffered solution (Figure 3.6C).  Figure 3.6D illustrates the results of the validation study 
conducted for TFA when poly-L-SUV was used as a chiral selector in both aqueous and 
Tris/borate buffered solutions.  As with the results obtained for BOH and BNA, better results 
were obtained for TFA in the buffered solutions.  The better regression models obtained in the 


























Figure 3.6   RMS%RE for BOH, BNA, and TFA with various molecular micelles in buffered 
and unbuffered solutions using (A) poly-L-SULV, (B) poly-L-SUL, (C) poly-L-
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3.3.4 Effect of Molecular Micelle-to-Analyte Ratio 
To determine the effect of molecular micelle concentration on the results obtained by 
regression modeling, a series of experiments was performed with BNA and TFA where the chiral 
analyte concentration was reduced to 5 × 10-6 M while keeping the concentration of poly-L-
SULV constant at 1.5 % w/v as in the previous studies.  This was possible because of the high 
sensitivity afforded by using fluorescence spectroscopy with the highly fluorescent polynuclear 
aromatic chiral analytes. Once again, the sample preparation and multivariate regression 
modeling were performed as described previously.  By lowering the chiral analyte concentration 
while keeping the concentration of the molecular micelle constant at 1.5 w/v %, the ratio of the 
surfactant concentration to the chiral analyte concentration is increased.  In other words, there is 
more poly-L-SULV per mol of chiral analyte. 
Figure 3.7 illustrates the predicted versus actual plots obtained from the regression 
models prepared with BNA and TFA.  Validation studies conducted with these models for BNA 
and TFA gave RMS%RE values of 2.1 % and 2.3 %, respectively.  Compared with the previous 
studies where higher analyte concentrations were used (1 x 10-4 M), the regression models made 
with lower chiral analyte concentrations (5 × 10-6 M) actually had better prediction capabilities 
(lower RMS%RE values).  This result might be attributed to having a higher surfactant-to-analyte 
ratio, particularly if more surfactant leads to more micellar interactions with the analyte.  In 
Chapter 2 of this dissertation, better selectivity and enantiomeric discrimination of chiral 
analytes were reported in MEKC at high molecular micelle concentration in the BGE.38  
Admittedly, further study of the diastereomeric micellar interactions is needed to fully 
understand how chiral molecular micelles serve as chiral selectors.  The use of fluorescence 
anisotropy and fluorescence lifetime studies to investigate these micellar interactions might give 
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additional information and a clearer understanding of their nature.  Potentially, with further 
development, this technique may be useful for the rapid- and high-throughput screening of 
hundreds of potential drug candidates by the pharmaceutical industry and for routine analysis of 
racemates, pure enantiomers, and any intermediates in the manufacturing process.  In addition, 
this technique is expected to be useful for the determination of enantiomeric composition of 












Figure 3.7 Predicted mol fraction composition versus actual known composition for 5 × 10-6 M 
 of R-enantiomer in 1.5% w/v poly-L-SULV chiral selector. (A) R-BNA, (B) R-TFA. 
 


















































3.4.  Conclusions 
Chemometric modeling by PLS-1 regression analysis of steady-state fluorescence 
spectral data obtained for chiral analytes in the presence of chiral molecular micelles has been 
shown to produce regression models with good predictive abilities.  The ability of the model to 
correctly predict the enantiomeric composition of unknown samples was found to depend upon 
the chiral analyte being analyzed, the chiral molecular micelle used, and the solvent medium 
used.  Generally, better predictions were obtained when the dipetide molecular micelle, poly-L-
SULV, was used as a chiral selector and when the samples were prepared in Tris/borate buffered 
solutions.  Better predictions were also obtained when the concentration ratio of molecular 
micelle to chiral analyte was increased.  Compared with chiral selectors like cyclodextrin, the use 
of chiral molecular micelles facilitated easy solubility of highly hydrophobic analytes that would 
not have been possible with cyclodextrin alone. 
3. 5 References 
 
[1]  Buxton, S.; Roberts, S., Organic Stereochemistry, Longman, Singapore, 1996.  
 
[2]  F. Jamali, R. Mehvar, F. M. Pasutto J. Pharm. Sci. 1989, 78, 695-715. 
 
[3]   Caldwell, J. J. Chromatogr. A. 1996, 719, 3-13. 
 
[4]    Schreier, P.; Bernreuther, A.; Huffer, M. Analysis of Chiral Organic Molecules,    
        Walter de Gruyter, New York, 1995. 
 
[5]   Aboul-Enein, H. Y.; Ali, I. Chiral Separations by Liquid Chromatography and   
      Related Technologies, Marcel Dekker, New York 2005. 
 
[6]   Zief, M.; Crane, L. Chromatographic Chiral Separations, Marcel Dekker,  
      New York, 1998. 
 
[7]  Subramanian, G. Chiral Separation Techniques: A Practical Approach, Wiley-VCH, 
Weinheim, 2001. 
 
[8]   Schmid, M.; Laffranchini, M.; Gubitz, G. Electrophoresis, 1999, 20, 2458-2461. 
 
 89
[9]    Liu, X.; Ilankumaran, P.; Guzei, I.; Verkade J. J. Org. Chem. 2000, 65, 701- 706. 
 
[10]   Szejili, J.; Osa, T. Eds. Supramolecular Chemistry—Cylcodextrins, Volume 3, Oxford, 
Pergamon. 1996. 
 
[11]   Easton, C.; Lincoln, S. Modified Cyclodextrins, Imperial College Press, London, 1999. 
 
[12]   Wang, J.; Warner, I.  J. Chromatogr. A. 1995, 711, 297-304. 
 
[13]   Maichel, B.; Potocek, B; Gas, B.; Chiari, M.; Kenndler, E. Electophoresis 1998, 19, 
2124-2128. 
 
[14]   Desiderio, C.; Fanali, S. J. Chromatogr. A. 1998, 807, 37-56. 
 
[15]   Pascoe, R.; Peterson, A.; Foley, J. Electrophoresis 2000, 21, 2033-2042. 
 
[16]   Hyun, M.; Jin, J.; Lee, W. J. Chromatogr. A. 1998, 822, 155-161. 
 
[17]   Finn, M. Chirality 2000, 14, 534-540. 
 
[18]   Lightner, D.; Gurst, J. Organic Conformation Analysis and Stereochemistry from 
Circular Dichroism Spectroscopy, Wiley-CVH, New York, 2000. 
 
[19]   Fakayode, S.; Busch, M.; Bellert, D.; Busch, K. Analyst 2005, 130, 233-241. 
 
[20]   Fakayode, S.; Busch, M.; Busch, K. Talanta 2006, 68, 1574-1583. 
 
[21]   Fakayode, S.; Swamidoss, I.;  M. A. Busch, K. W. Busch Talanta  2005, 65, 838-845. 
 
[22]   Busch, K.; Swamidoss, I.; Fakayode, S.; Busch, M. Anal. Chim. Acta, 2004, 525, 53-62. 
 
[23]   Busch, K.; Swamidoss, I.; Fakayode, S.; Busch, M. J. Am. Chem. Soc. 2003, 125, 1690-
1691.  
 
[24]   Tran, C.; Grishko, V.; Oliveira D. Anal. Chem. 2003, 75, 6455-6462. 
 
[25]   Tran, C.; Oliveira, D.; Grishko, V. Anal.Biochem. 2004, 325, 206-214. 
 
[26]   Edward, S.; Shamsi S.  J. Chromatogr. A. 2000, 903, 227-236. 
 
[27]   Wang, J.; Warner, I. J. Chromatogr. A. 1995, 711, 297-304. 
 
[28]   Agnew-Heard, K.; Pena, M.; Shamsi, S.; Warner, I. Anal. Chem. 1997, 69, 958-964. 
 
[29]   Yarabe, H.; Shamsi, S.; Warner, I. Anal. Chem. 1999, 71, 3992-3999. 
 
 90
[30]   Shamsi, S.; Warner, I. Electrophoresis 1997, 18, 853-872. 
 
[31]   Billiot, H.; Billiot, E.; Warner, I. J. Chromatogr. A. 2001, 922, 329-338.  
 
[32]   Shamsi, S.; Valle, B.; Billiot, F.; Warner, I. Anal. Chem. 2003, 75, 379-387. 
 
[33]   McCarroll, M.; Billiot, F.; Warner, I. J. Am. Chem. Soc. 2001, 123, 3173-3174. 
 
[34]   Malinowski, E. Factor Analysis in Chemistry, John Wiley, New York, 1991. 
 
[35]   Adams, M. Chemometrics in Analytical Spectroscopy, Royal Society of Chemistry, 
Cambridge, 1995. 
  
[36]   Martens, H.; Naes, T. Multivariate Calibration, John Wiley, New York, 1989. 
 








DETERMINATION OF ENANTIOMERIC COMPOSITIONS OF ANALYTES USING 





The number of chiral chemicals used in the pharmaceutical industry as starting materials, 
intermediates, and prescribed drugs, continues to increase each year.  As a result of the differing 
biological activity of individual enantiomers, rapid chiral analysis of these chemicals continues 
to be extremely important in the pharmaceutical industry.1-3 Considerable differences in the 
toxicological, pharmacological, or pharmacokinetic properties of individual enantiomers also 
highlight the importance of assessing the stereochemical purity of a compound in the cosmetic 
and fragrance industries and environmental analysis.  In an effort to eliminate potential toxic side 
effects, most approved new chiral chemicals are marketed worldwide as single-enantiomer drugs 
rather than as racemates.4 Thus, as a consequence of policies of the United States Food and Drug 
Administration, accurate determination of enantiomeric composition and purity is necessary for 
production of drugs containing only the therapeutically active enantiomers, which requires 
sensitive and accurate analytical techniques.5 
Chiral analysis has previously been achieved by use of various chiral selectors such as 
cyclodextrins (CDs),6-10 antibiotics,11-14 and crown ethers.15-18  However, despite good chiral 
recognition ability, these chiral selectors have several limitations resulting from low solubility, 
high cost, and difficult synthetic procedures.  Several recent advances have been made in an 
attempt to address some of these problems. For example, the use of modified or substituted CDs, 
rather than native CDs, has led to improved guest selectivity.6 Another often encountered 
problem is the limited solubility of large hydrophobic chiral molecules. However, this problem 
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can be alleviated by use of surfactants that form micelles with apolar pockets and a polar surface.  
Use of these micelles enhances the solubilization and interaction of highly hydrophobic 
molecules.   
 Molecular micelles, also known as polymeric surfactants, have been used in numerous 
analytical approaches such as chiral discriminators for the analysis of chiral molecules of 
different molecular size and polarity.19-25  In Chapter 3 of this dissertation, the utility of 
molecular micelles as chiral selectors for determining the enantiomeric composition of three 
highly hydrophobic fluorescent chiral molecules using steady-state fluorescence spectroscopy 
and multivariate regression analysis of spectral changes in chiral guest-host complexes was 
demonstrated.  In this study, differences in analyte fluorescence emission were observed due to 
the formation of diastereomeric complexes between the chiral molecular micelle and chiral 
analyte. These observed spectral differences correlated well with enantiomeric composition 
because of the stability of guest-host complexes formed between the enantiomers and the chiral 
selector.  This analytical approach offered several advantages for chiral analyses, including 
rapidity and accuracy, high sensitivity, and low sample consumption.   
Although the chiral selector employed in the previous chapter of this dissertation was 
non-fluorescent, a more useful approach using fluorescent chiral selectors would be attractive for 
the analysis of non-fluorescent chiral analytes.  In addition, the limitation of statistical analysis of 
differences in fluorescence spectra due to the requirement that chiral analytes be fluorescent 
would be eliminated.  A significant number of chiral molecules do not fluoresce; therefore, 
fluorescent sensors with diverse molecular structures have been applied in chiral analysis.26 
Chiral fluorescent sensors, i.e. fluorescent chiral molecular micelles (FCMMs), should allow the 
enantioselective recognition of chiral molecules which may or may not contain a fluorophore.  
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Therefore, the use of FCMMs for the analysis of non-fluorescent chiral compounds of 
pharmaceutical and biological interest is explored. 
 In this chapter, the synthesis, characterization, and chiral selectivity of novel amino acid 
based FCMMs are reported.  By varying the chiral head group of the molecular micelle, we were 
able to design FCMMs capable of discriminating non-fluorescent chiral analytes.  The use of the 
fluorescent amino acids tryptophan, tyrosine, and phenylalanine, enabled the analysis of a wider 
variety of chiral analytes using spectroscopic techniques.  The syntheses of six FCMMs, the L- 
and D-enantiomers of poly(sodium N-undecanoyl tryptophanate) [poly-SUW], poly(sodium N-
undecanoyl tyrosinate) [poly-SUY], and poly(sodium N-undecanoyl phenylalaninate) [poly-
SUF], was accomplished using a two step process from the corresponding amino acid and 
undecylenic acid.  Characterization of FCMMs was performed using 1H and 13C nuclear 
magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), circular dichroism (CD), and 
surface tension measurements.   Fluorescence spectroscopy, including fluorescence quantum 
yield, lifetime, and steady-state fluorescence emission, as well as UV/vis absorption were used 
for the evaluation of FCMMs spectral properties.  Finally, the chiral recognition ability of 
selected FCMMs with non-fluorescent chiral molecules (glucose, tartaric acid, and serine) as 
well as the determination of enantiomeric composition was evaluated using steady-state 




4.2.1  Materials 
N-Hydroxysuccinimide, undecylenic acid, sodium bicarbonate, and 
dicyclohexylcarbodiimide were purchased from Fluka (Milwaukee, WI).  Undecylenyl alcohol, 
monobasic sodium phosphate, dibasic sodium phosphate, sodium hydroxide, hydrochloric acid, 
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ethyl acetate, and tetrahydrofuran were obtained from Sigma-Aldrich (Milwaukee, WI).  
Enantiomerically pure serine, tartaric acid, glucose, and α-pinene were also purchased from 
Sigma-Aldrich (Milwaukee, WI).  The amino acids, D-tryptophan, L-tryptophan, D-tyrosine, L-
tyrosine, D-phenylalanine, and L-phenylalanine were purchased from Bachem Bioscience Inc. 
(King of Prussia, PA).  All chemicals were used as received. The purity of all analytes and 
reagents was 99% or higher. 
4.2.2  Instrumentation 
1H and 13C NMR spectra were acquired in d6-DMSO on a Bruker ARX-300 spectrometer 
(Bruker BiosSpin, Billerica, MA).  Chemical shift (δ) values are reported in ppm.  Coupling 
constants are reported in Hz.   CD was performed using a Jasco J-710 spectropolarimeter (Jasco 
Inc., Easton, MD) and recorded at room temperature. Absorbance measurements were performed 
on a Shimadzu UV-3101PC UV-Vis-near-IR scanning spectrometer (Shimadzu, Columbia, MD) 
using a 1 cm2 quartz cuvette.  Steady-state fluorescence spectra and lifetime measurements were 
acquired using a SPEX Fluorolog-3 (model FL3-22TAU3; Jobin Yvon, Edison, NJ) equipped 
with double excitation and emission monochromators (slit widths, 2 nm), a 400 W Xe-arc lamp, 
and a Hamamatsu R-928 photomultiplier tube.  A 0.4 cm path length quartz fluorescence cuvet 
was used for fluorescence emission data collection.  Absorption and fluorescence emission were 
collected at room temperature and the blank was subtracted from each spectrum. 
4.2.3  Syntheses of Molecular Micelles 
The monomers of FCMMs were synthesized with minor changes according to the 
previously reported procedure.27 Scheme 4.1 shows the two step synthesis from the 
corresponding amino acid and undecylenic acid.  A more detailed synthetic procedure of the 
synthesis scheme can be found in Chapter 2 of this dissertation.  The monomers SUW, SUY, and 
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SUF followed the same synthetic procedure as described for L-SULV.  The leucine-valine 
dipetide was replaced with either tryptophan, tyrosine, or phenylalanine to yield the final 
monomers L-SUW, D-SUW, L-SUY, D-SUY, L-SUF, and D-SUF, respectively.  1H-NMR and 









Scheme 4.1 Syntheses of SUW, SUY, and SUF monomers. 
 
 
Characterization of Undecanoyl-L-Tryptophan. m.p.: 126-129°C, yield: 72%. CMC: 
6.9 mM. 1H-NMR (300 MHz, DMSO-d6) δ (ppm):  1.20-1.42 (m, 12H), 2.01 (bs, 4H), 3.01 (dd, 
J = 14.40, 6.28 Hz, 1H), 3.25 (dd, J = 14.47, 4.66 Hz, 1H), 4.21 (d, J = 5.52 Hz, 1H), 6.91 (t, J = 
7.12 Hz, 1H), 7.00 (t, J = 7.04 Hz, 1H), 7.08 (s, 1H), 7.25 (d, J = 7.4 Hz, 1H), 7.29 (d, J = 8.0 
Hz, 1H), 7.50 (d, J = 7.71 Hz, 1H), 10.85 (bs, 1H). 13C-NMR (62.5 MHz, DMSO-d6) δ (ppm): 
26.1, 28.5, 29.1, 29.4, 29.6, 29.7, 34.0, 36.6, 55.9, 111.8, 112.5, 115.4, 118.5, 119.4, 121.0, 
124.0, 129.1, 136.7, 139.7, 171.1, 175.8.  
Characterization of Undecanoyl-L-Tyrosine. m.p.: 179-182°C, yield: 61%. CMC: 3.4 
mM. 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 1.24-1.42 (m, 12H), 2.03 (bs), 2.79 (dd, J = 6.07, 







































1H), 5.01 (d, J = 18.09 Hz, 1H), 5.81 (ddt,  J = 16.87, 10.08, 6.80 Hz, 1H), 6.59 (d, J = 7.85 Hz, 
2H), 6.91 (d, J = 7.94 Hz, 2H), 7.12 (d, J = 7.06 Hz, 1H), 9.72 (bs, 1H). 13C-NMR (62.5 MHz, 
DMSO-d6) δ (ppm): 26.0, 26.2, 29.1, 29.4, 29.5, 29.6, 29.7, 34.0, 36.6, 37.6, 56.2, 115.4, 129.9, 
131.0, 139.6, 156.4, 171.7, 175.1.   
Characterization of Undecanoyl-L-Phenylalanine. m.p.: 109-112°C, yield: 86%. 
CMC: 8.0 mM. 1H-NMR (300 MHz, DMSO-d6) δ (ppm): 1.18-1.31 (m, 12H), 1.98 (d, J = 5.37 
Hz, 4H), 4.91 (d, J = 10.82 Hz, 1H), 4.96 (d, J = 17.35 Hz, 1H), 7.13 (s, 5H), 7.30 (d, J = 7.05, 
1H). 13C-NMR (62.5 MHz, DMSO-d6) δ (ppm): 26.2, 29.1, 29.3, 29.5, 29.6, 29.7, 29.8, 34.0, 
36.5, 38.6, 56.1, 115.4, 126.2, 128.3, 130.2, 139.6, 140.4, 171.9, 175.6. 
CMC Determination.  Surface tension measurements were collected in pure water for 
the determination of CMC values of each FCMM using a Sigma 703 Digital Tensiometer 
(Monroe, CT).  Polymerization of FCMMs at five times the CMC was achieved by γ-irradiation 
using a 60Co source (model 484 R, from J. O. Shepherd, San Fernando, CA) of 0.7 krad/h for 168 
h (total dose, 118 krad).  1H-NMR was performed to verify complete polymerization of the 
products by the loss of the vinyl proton signals at 6.0 – 5.0 ppm. 
4.2.4  Sample Preparation 
All FCMM samples for CD, steady-state fluorescence spectroscopy and UV absorption 
studies were prepared in 50 mM dibasic sodium phosphate buffer.  The buffer was filtered 
through a 0.45-µm nylon syringe filter (Nalgene, Rochester, NY) and the pH was adjusted using 
an ORION model 410A pH meter (Pulse Instruments, Van Nuys, CA) to pH 7 with 0.1 M NaOH 
prior to the addition of FCMM.  Calibration and validation samples for steady-state fluorescence 
measurements containing FCMM chiral selector and varying analyte enantiomeric composition 
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were prepared from stock solutions (1 × 10-4 M) dissolved in buffer.  Final concentrations were 
made by transferring appropriate volumes of FCMM and analyte to dry volumetric flasks and 
diluting with buffer solution.  All solutions were sonicated 15 min to ensure proper dissolution 
and were allowed to equilibrate for 30 minutes. 
4.2.5 Data Analysis 
The Unscrambler, (CAMO, Inc., Corvallis, OR, version 9.1) chemometric software 
system was used for multivariate regression analysis of all fluorescence emission spectra.  PLS-1 
calibration models were developed using full-cross validation.  The regression models were 
validated using an independent set of validation samples with different mole fractions from 
calibration samples. 
4.3   Results and Discussion 
 
4.3.1  Circular Dichroism Measurements 
The optical configuration of D-SUW, L-SUW, D-SUY, L-SUY, D-SUF, and L-SUF 
monomers was confirmed by CD measurements performed with a 1.0-cm path-length cell.  D-
SUW had a positive band with a maximum at ~232 nm. Optical configuration was confirmed 
from the L-SUW spectra showing a similar negative CD band at the same wavelength.  Similar 
trends were observed for D-SUY and L-SUY (wavelength maximum ~231 nm) and D-SUF and 
L-SUF (wavelength maximum ~220 nm) allowing for the unambiguous determination of 
opposite configuration of each chiral monomer.  Following polymerization, CD measurements 
were repeated for each FCMM.  Figure 4.1A-C illustrates the structures for poly-L-SUW, poly-L-
SUY, and poly-L-SUF.  The CD bands of FCMMs showed the same wavelength maxima and 
ellipticity as corresponding monomers, confirming the retention of L and D configurations of 


















Figure 4.2   CD spectra of (A) poly-D-SUW and poly-L-SUW; (B) poly-D-SUY and poly-L-
SUY; (C) poly-D-SUF and poly-L-SUF. 
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4.3.2  FCMM Spectroscopic Characteristics 
Both configurations of poly-SUW (2.0 × 10-5 M), poly-SUY (7.0 × 10-5 M), and poly-
SUF (2.6 × 10-4 M) showed maximum absorption at 280 nm, 276 nm, and 259 nm, respectively. 
The corresponding monomers for both configurations had the same absorption maxima as the 
polymerized molecular micelles.  Molar absorptivity (ε) values calculated at the absorbance 
maximum are listed in Table 4.1.  Poly-SUW had the strongest absorption as compared to the 
other FCMMs. The observed molar absorptivities of FCMMs followed similar trends as for 
known absorptivity values for the corresponding free amino acids.28 Phenylalanine has the 
weakest fluorescence and the simplest structure as compared to tyrosine, which has an added 
hydroxyl group, and tryptophan having an added indole ring.  As expected, these structural 
variations resulted in a significant difference in fluorescence emission spectra for the FCMMs.  
Fluorescence emission spectra were collected for each FCMM, using an excitation wavelength 
(λex) close to the maximum absorption wavelength.  Poly-SUW (λex = 280), poly-SUY (λex = 
280), and poly-SUF (λex = 260) had a maximum fluorescence emission at 370 nm, 320 nm, and 
305 nm, respectively.   
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 Fluorescence quantum yields for the FCMMs were determined by Williams’ 
comparative method.29 A series of dilute solutions of poly-L-SUW (2.0 × 10-6 M - 2.0 × 10-5 M), 
poly-L-SUY (2.5 × 10-5 M - 7.0 × 10-5 M), and poly-L-SUF (1.4 × 10-4 M - 2.6 × 10-4 M) were 
prepared in 50 mM phosphate buffered at pH 7.  Tryptophan in water was used as the 
fluorescence standard (Φ = 0.12, pH 7)28 for poly-L-SUW and poly-L-SUY.  All solutions, 
including the standard, were excited at 280 nm.  In the case of poly-L-SUF, phenylalanine in 
water was used as the fluorescence standard (Φ = 0.022, pH 7),28  and each were excited at 260 
nm.  Both UV-vis absorption and fluorescence spectra were recorded for five solutions where the 
FCMM concentration was varied such that the absorbance remained below 0.05. The following 
equation29 was used to calculate the quantum yield of each FCMM: 
          Φx  = Φst (Gradx / Gradst) (ηx2 / ηst2)           4.1 
where Φ is the fluorescence quantum yield, Grad is the gradient from the plot of integrated 
fluorescence intensity vs. absorbance, η is solvent refractive index (water = 1.33),29 and 
subscripts st and x refer to the standard and unknown, respectively.  The calculated quantum 
yields for poly-L-SUW, poly-L-SUY, and poly-L-SUF were 0.08, 0.04, and 0.11, respectively 
(Table 4.1).  Poly-L-SUW and poly-L-SUY had a lower quantum yield than the pure amino acid.  
However, the fluorescence quantum yield of poly-L-SUF was five times higher than 
phenylalanine, indicating that the FCMM is a more sensitive fluorophore. 
The fluorescence lifetimes of poly-L-SUW, poly-L-SUY, and poly-L-SUF were measured 
in 50 mM dibasic sodium phosphate (pH 7).  A 320 nm long-pass filter was used to optically 
isolate the signals for each FCMM.  Thirty logarithmically spaced frequencies were collected 
over a frequency range of 10 to 100 MHz using five averages and a 99 s integration time.  
Frequency-domain measurements were collected for all FCMMs versus p-terphenyl which has a 
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lifetime of 1.17 ns.  Frequency-domain phase and modulation decay profiles were analyzed using 
the Globals software package developed at the Laboratory for Fluorescence Dynamics 
(University of Illinois at Urbana-Champaign).  Enantiomerically pure  tryptophan, tyrosine, and 
phenylalanine have been reported to have single lifetime values of 2.6 ns, 3.6 ns, and 6.4 ns, 
respectively.28  In contrast, each FCMM had more than one significant lifetime component as 
listed in Table 4.1.  Generally, it is expected that the fluorescence quantum yields and lifetimes 
of the FCMMs are likely to be different from the corresponding amino acid standard due to 
polymerization, aggregation, structure, cavity size, dynamic equilibrium, and hydrophobicity.  
Also, multiple fluorophores brought into close proximity because of polymerization have been 
reported to have increased quantum yields and different fluorescence lifetimes as compared to 
the corresponding monomer.30,31 
4.3.3  Chiral Recognition 
Steady-state fluorescence spectroscopy was used to investigate the chiral recognition 
ability of the FCMMs with non-fluorescent chiral analytes.  The analytes glucose, tartaric acid, 
and serine were selected due to the differences in structure and non-fluorescent properties.  
Glucose is a carbohydrate used as a source of energy by the human body and is critical in the 
production of proteins.  Tartaric acid is a known antioxidant, food additive, and an intermediate 
in chiral molecule synthesis.  Serine is an amino acid commonly found in proteins. 
The fluorescence emission spectra of 5.0 × 10-6 M D- and L- forms of glucose, tartaric 
acid, and serine in the presence of 3.0 × 10-5 M FCMM are illustrated in Figure 4.3A, 4.3B, and 
4.3C, respectively.  Chiral recognition can be confirmed by observing a difference in 
fluorescence emission intensity of each FCMM in the presence of D- and L-enantiomers of the 
analyte.  This spectral difference is due to the formation of diastereomeric complexes between 
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enantiomer and FCMM chiral selector.  Several factors, such as analyte size, solubility, and 
shape, as well as hydrophobicity and hydrogen-bonding capability affect the magnitude of 
interactions between analyte and chiral selector.  In addition, the obtained results indicated that 
such interactions were analyte and chiral selector dependent, which determined the extent of 
spectral variation.  The concentration of FCMMs was held constant; however, it is clear that 
poly-L-SUW had the largest spectral difference in the presence of each analyte (Figure 4.3I-A1, 
B1, C1).  The emission intensity of poly-L-SUW in the presence of D-glucose and D-serine was 
higher than the emission intensity of poly-L-SUW in the presence of L-glucose and L-serine.  The 
opposite trend was observed for the emission of poly-L-SUW in the presence of D- and L- tartaric 
acid.  There was no apparent variation in the fluorescence emission spectra of the D- and L-
enantiomers of any analyte in the presence of poly-L-SUY (Figure 4.3II-A1, B1, C1) and only a 
slight difference was observed in the presence of poly-L-SUF (Figure 4.3III-A1, B1, C1).   
The variations in fluorescence emission spectra illustrated in Figure 4.3I can be attributed 
to the diastereomeric complex formed between chiral selector and each analyte enantiomer. The 
enantiomeric interactions are different and analyte/chiral selector dependent ultimately leading to 
differences in the spectra.  Figure 4.3I (A2, B2, C2) illustrates the mean-centered spectra plots 
for each enantiomer in the presence of FCMMs.  In general, the mean-centered spectra plot 
provides better insight into the spectral variations and chiral recognition ability of each FCMM.  
The plots were obtained by subtracting the spectrum of D- and L- form in the presence of FCMM 
from the D- and L- mean spectra at each wavelength.  The poor chiral recognition ability of poly-
L-SUY and poly-L-SUF is further confirmed by the noisy centered lines close to the origin of the 





















Figure 4.3 Fluorescence emission spectra (1) and mean-centered spectral plots (2) of 3.0 × 
10-5 M (I) poly-L-SUW [λex = 280 nm]; (II) poly-L-SUY [λex = 280 nm]; (III) 
poly-L-SUF [λex = 260 nm] in the presence of 5.0 × 10-6 M enantiomers of (A) 
Glucose; (B) Tartaric acid; (C) Serine. 
 







































































































































































































































































































































































































































 The hydrogen-bonding interactions between poly-L-SUW and the multiple hydroxyl 
groups of glucose, tartaric acid and serine were likely stronger than the hydrogen-bonding 
interactions with poly-L-SUY and poly-L-SUF.  This suggests that poly-L-SUY and poly-L-SUF 
do not have hydrogen-bonding driven complexations.  As a result, chiral recognition studies 
were performed with a hydrophobic molecule, α-pinene, in order to determine if hydrophobic 
interactions were possible with poly-L-SUY and poly-L-SUF.  Pinene is a terpene, which plays 
an important role in the fragrance and pharmaceutical industries.32 Figure 4.4 illustrates the 
fluorescence emission spectra and mean-centered spectra plots for 1.0 × 10-5 M α-pinene in the 
presence of 3.0 ×10-5 M poly-L-SUY (Figure 4.4A) and 3.0 × 10-5 M poly-L-SUF (Figure 4.4B). 
Hydrophobic compounds interact more strongly with the hydrophobic core of the micelle.  One 
enantiomer of α-pinene may dissolve deeper into the hydrophobic pockets of poly-L-SUY and 
poly-L-SUF, resulting in chiral discrimination.  For both FCMMs, the fluorescence emission 









Figure 4.4   Fluorescence emission spectra (1) and mean-centered spectral plots (2) of 3.0 × 
10-5 M (A) Poly-L-SUY [λex = 280 nm]; (B) Poly-L-SUF [λex = 260 nm] in the 
presence of 5.0 × 10-6 M enantiomers of α-pinene. 
 
































































































4.3.4 Determination of Enantiomeric Composition 
As previously noted, poly-L-SUW exhibited the most spectral difference in the presence 
of analyte enantiomers for glucose, tartaric acid and serine.  As a result, this FCMM was chosen 
for enantiomeric composition studies with these three analytes.  Studies have shown 
enantiomeric purity can be determined by partial-least-square-regression modeling of steady-
state fluorescence spectral data of fluorescent chiral analytes.33,34 Multivariate regression 
modeling for enantiomeric composition prediction is a two-phase process.  First, during the 
calibration phase, fluorescence emission spectra of a set of samples with known analyte 
enantiomer compositions in the presence of chiral selector are collected.  The changes in the 
spectra are correlated to the known enantiomeric compositions and a regression model is 
developed.   
Figure 4.5.IA illustrates the fluorescence emission spectra (λex = 280 nm) of calibration 
solutions containing a fixed total glucose concentration (5.0 × 10-6 M) with various enantiomeric 
composition and fixed concentration of poly-L-SUW (3.0 × 10-5 M).  As illustrated in Figure 
4.3.1A, the fluorescence emission spectra for poly-L-SUW in the presence of 5.0 × 10-6 M D-
glucose has a higher intensity than L-glucose.  Although the glucose concentration was fixed, as 
the enantiomeric composition of L-glucose increased, the fluorescence emission intensity 
decreased.   
The mean-centered spectra plots for the set of calibration solutions of various 
enantiomeric compositions of glucose in the presence of poly-L-SUW was obtained by 
subtracting the average spectra of all solutions from the spectrum of each individual sample 
(Figure 4.5.IIA).  Additional information can be obtained from a mean-centered spectra plot 
when compared to the fluorescence emission spectra.  Sample 6 contained 0.50 D- and 0.50 L- 
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and the mean-centered plot overlayed the origin.  In Figure 4.5.IIA, the mean-centered plots of 
solutions containing more than 0.50 D- were above the origin and solutions containing less than 
0.50 D- were below the origin.  Quick screening of future samples containing an unidentified 
enantiomeric composition is possible by obtaining the fluorescence emission spectra of an 
unknown sample and incorporating the spectra into the mean-centered spectra plot.  Using this 















Figure 4.5   Fluorescence emission spectra (I) and mean-centered spectral plots (II) of 3.0 × 
10-5 M Poly-L-SUW [λex = 280 nm] in the presence of 5.0 × 10-6 M enantiomers 
of (A) Glucose; (B) Tartaric acid; (C) Serine with varied mole fractions: (1) 1.0 
D; (2) 0.9 D; (3) 0.8 D; (4) 0.7 D; (5) 0.6 D; (6) 0.5 D; (7) 0.4 D; (8) 0.3 D; (9) 












































































































































































Fluorescence emission spectra of poly-L-SUW (λex = 280 nm) in the presence of a fixed 
total tartaric acid concentration (5.0 × 10-6 M) of eleven solutions with various enantiomeric 
compositions are illustrated in Figure 4.5.IB.  In contrast to the fluorescence emission spectra 
obtained for glucose, the fluorescence emission spectra for poly-L-SUW in the presence of 5.0 × 
10-6 M D-tartaric acid had lower emission intensity than L-tartaric acid.  Likewise, the mean-
centered spectra plot for the samples containing greater than 0.50 D-tartaric acid were below the 
origin and solutions containing less than 0.50 D-tartaric acid were above the origin (Figure 
4.5.IIB). 
Figure 4.5.IC illustrates the fluorescence emission spectra for eleven solutions of poly-L-
SUW (λex = 280 nm) in the presence of serine at a fixed concentration (5.0 × 10-6 M) with 
varying enantiomeric compositions.  Similar to glucose, the fluorescence emission spectra for 
poly-L-SUW in the presence of 5.0 × 10-6 M D-serine has higher emission intensity than L-serine.  
As expected, the solution containing 0.50 D-serine and 0.50 L-serine is on the origin in the mean-
centered spectral plot while  solutions containing more than 0.50 D-serine are above the origin 
and solutions containing less than 0.50 D-serine are below (Figure 4.5.IIC).  In addition, samples 
containing serine had a slight shift in maximum fluorescence emission (λmax = 375 nm) as 
compared to the samples containing glucose or tartaric acid (λmax = 370 nm).   
The predictive ability of the calibration model can be tested by analyzing several figures 
of merit including the regression coefficient, the slope, and the offset from the PLS-1 regression 
modeling of the calibration samples.  Table 4.2 summarizes the figures of merit for the 
regression models obtained for D-glucose, D-tartaric acid, and D-serine in the presence of poly-L-
SUW.  A perfect model would have a regression coefficient of 1, a slope of 1, and an offset of 0.  
A second phase in multivariate regression modeling is the validation phase, which follows the 
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calibration phase.  During this phase, fluorescence emission spectra of a new set of samples 
having the same concentrations as the samples prepared in the calibration phase are collected.  
Although total analyte concentration of validation samples must be the same as calibration 
samples, enantiomeric compositions should be different.  The enantiomeric compositions for the 
validation samples are predicted using the calibration regression model.  The performance of the 
calibration model to accurately predict validation sample enantiomer composition is determined 
by the root-mean-square percent relative error (RMS%RE). A detailed equation for the 
calculation of the RMS%RE is found in Chapter 2. Ten validation samples having the same 
analyte concentration and various enantiomeric compositions were used to calculate RMS%RE.  
The RMS%RE values obtained for the ten validation samples of D-glucose, D-tartaric acid, and 
D-serine were 1.88%, 2.43% and 2.64%, respectively (Table 4.3).  The RMS%RE for L-glucose 
(2.07%), L-tartaric acid (3.48%), and L-serine (3.60%) was slightly higher than the error obtained 
for the D-enantiomer of each analyte. Previously reported literature has shown that one 
enantiomer can bind more strongly to the chiral selector.35,36  Fluorescence anisotropy 
measurements have concluded that the interaction between the chiral selector and the analyte are 
due to both stereoselective and nonstereoselective interactions.35  The results indicated that the 
D-enantiomer of glucose, tartaric acid, and serine may form a more rigid and stronger complex 
with poly-L-SUW.  Also, the difference in the chiral selectivity for each enantiomer can lead to a 
difference in predictive capability of the regression model. 
Table 4.2   Figures of merit obtained from multivariate regression analysis of calibration 
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Table 4.3   Actual and predicted mole fraction of 5.0 × 10-6 M D- and L- enantiomers of 





                           Glucose                                         Tartaric Acid                                       Serine 
            Predicted               Relative               Predicted               Relative              Predicted            Relative  
         mole fraction           error (%)           mole fraction            error (%)         mole fraction         error (%) 
 
0.950 0.947 0.316 0.951 -0.105 0.951 -0.105 
0.850 0.851 -0.118 0.844 0.706 0.843 0.824 
0.750 0.746 0.533 0.741 1.200 0.739 1.467 
0.650 0.650 0.000 0.684 -5.231 0.681 -4.769 
0.550 0.548 0.364 0.556 -1.091 0.557 -1.273 
0.450 0.450 0.000 0.436 3.111 0.434 3.556 
0.350 0.351 -0.286 0.353 -0.857 0.354 -1.143 
0.250 0.248 0.800 0.244 2.400 0.243 2.800 
0.150 0.153 -2.000 0.148 1.333 0.147 2.000 
0.050 0.053 -5.500 0.048 3.220 0.048 4.100 





                            
                           Glucose                                         Tartaric Acid                                       Serine 
            Predicted               Relative               Predicted               Relative              Predicted            Relative  
         mole fraction           error (%)           mole fraction            error (%)         mole fraction         error (%) 
0.050 0.053 -6.280 0.047 6.700 0.047 6.880 
0.150 0.149 0.667 0.146 2.667 0.146 2.667 
0.250 0.254 -1.600 0.240 4.000 0.239 4.400 
0.350 0.350 0.000 0.356 -1.714 0.356 -1.714 
0.450 0.452 -0.444 0.426 5.333 0.425 5.556 
0.550 0.550 0.000 0.560 -1.818 0.561 -2.000 
0.650 0.649 0.154 0.673 -3.538 0.672 -3.385 
0.750 0.752 -0.267 0.734 2.133 0.734 2.133 
0.850 0.847 0.353 0.840 1.176 0.839 1.294 
0.950 0.947 0.316 0.952 -0.211 0.952 -0.211 




Studies in Chapter 3 of this dissertation demonstrated that the extent of spectral variation 
will determine the prediction accuracy for enantiomeric composition. Serine had the highest 
RMS%RE value and the lowest degree of spectral variation.  This can possibly be due to a fewer 
number of hydroxyl groups on serine as compared to glucose and tartaric acid.  It is also well 
known that the %RE is analyte dependent as a result of the diastereomeric complex formation 
between chiral selector and chiral analyte.33,34  Studies evaluating the chiral interaction with 
dipeptide molecular micelle head groups have been reported.37 Steady-state fluorescence 
anisotropy was used to explain chiral separation mechanisms for the separation of various 
analytes using poly-L-SULV.  However, further studies are necessary to understand the details of 
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the diastereomeric interaction between the novel FCMMs and chiral analytes.  The chiral 
analyses performed in this chapter were completed by use of non-fluorescent chiral analytes.  In 
the next chapter, the investigation of the use of FCMMs for the enantiomeric composition 
prediction of fluorescent chiral analytes is reported.   
4.4  Conclusions 
The two enantiomers of three novel FCMM chiral selectors (poly-SUW, poly-SUY, and 
poly-SUF) were synthesized and characterized using several analytical techniques.  Steady-state 
fluorescence spectroscopy was used as a rapid and sensitive technique for chiral analysis using 
FCMMs.  These chiral selectors were capable of the recognition of non-fluorescent chiral 
analytes and offered several advantages as compared to current available selectors.  Poly-L-SUW 
showed enhanced chiral recognition with analytes capable of hydrogen bonding, while poly-L-
SUY and poly-L-SUF showed good chiral recognition with a more hydrophobic molecule.  
Conventional fluorescence instrumentation as opposed to specialized polarization 
instrumentation was used for the prediction of enantiomer composition of three non-fluorescent 
chiral analytes (glucose, tartaric acid, and serine). PLS-1 regression models of steady-state 
fluorescence emission spectral data for poly-L-SUW in the presence of the three analytes has 
been shown to have good prediction capability.  Better predictions were obtained for the analytes 
with the greatest spectral variation in fluorescence emission. Previously, molecular micelles were 
limited to chiral recognition of fluorescent analytes; however, these FCMMs show promise as 
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POLY(SODIUM N-UNDECANOYL-L-PHENYLALANINATE):  A VERSATILE 
CHIRAL SELECTOR USING STEADY-STATE FLUORESCENCE SPECTROSCOPY 
 
5.1  Introduction 
It is well known that the determination of enantiomeric purity continues to receive 
growing interest due to the different activities or effects of the enantiomers of chiral 
compounds.1-3 In general, one enantiomer may reverse or limit the desired effects of the 
therapeutic, active, or fragrant enantiomer. Therefore, chiral analysis continues to be a challenge 
because the number of chiral molecules and the demand for enantiomerically pure compounds 
continues to grow every year.4 A versatile chiral selector is desired for the analysis of chiral 
molecules with a variety of functional groups and with or without fluorescent properties.  In 
addition, fluorescent sensors with diverse molecular structures have been applied in chiral 
analysis and have received growing attention for their interaction with chiral molecules.5  
Chiral fluorescent sensors, i.e. fluorescent chiral molecular micelles (FCMMs), should 
allow the enantioselective recognition of chiral molecules which may or may not contain a 
chromophore.  Molecular micelle chiral selectors contain an apolar hydrocarbon tail and a polar 
head group.  A pair of enantiomers (fluorescent or non-fluorescent) will interact with a chiral 
selector to form a complex.  The interaction can vary depending on the extent of the host-guest 
complexation and binding between the enantiomer and chiral selector.  As a result, variations of 
fluorescence emission spectra are expected.   
Molecular micelles have proven to be successful chiral selectors in various applications 
with a variety of analytes.6-11  In an effort to use an FCMM as a versatile chiral selector in 
steady-state fluorescence measurements, four fluorescent (1,1`-binaphthyl-2,2`-diamine (BNA), 
1-(9-Anthryl)-2,2,2-trifluoroethanol (TFA), propranolol (PROP), and naproxen (NPRX)) and 
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four non-fluorescent (chloromethyl menthyl ether (CME), citramalic acid (CIT), tartaric acid 
(TAR), and limonene (LIM)) chiral molecules with diverse structure and hydrophobicity were 
chosen. These compounds have a variety of uses in several industries.  BNA and CME are used 
in chiral compound synthesis and TFA is a chiral NMR solvating agent for the discrimination of 
enantiomeric purity of optically active compounds.  PROP, a beta blocker used for the treatment 
of hypertension, and NPRX, an anti-inflammatory drug, are found in the pharmaceutical 
industry.  CIT has been reported to be found in cerebrospinal fluid of humans with bacterial 
meningitis.12 TAR is a known antioxidant, food additive, and an intermediate in chiral molecule 
synthesis and LIM is a terpene found in citrus fruit and a fragrance in cleaning products. 
Although molecular micelles have been capable of chiral analysis for fluorescent and 
non-fluorescent techniques, the use of molecular micelles in spectroscopy has been limited to 
particular analytes.  In Chapter 3, the use of non-fluorescent amino acid based molecular 
micelles for the chiral recognition and the determination of enantiomeric composition of 
fluorescent chiral analytes using steady-state fluorescence spectroscopy and regression modeling 
was reported. Novel FCMMs were synthesized and characterized in Chapter 4.  Chiral analysis 
of non-fluorescent chiral analytes was investigated by use of three FCMMs.  Regression 
modeling has proven to be a reliable method for determining the enantiomeric composition of 
chiral molecules using a spectroscopic technique.13-18 Steady-state fluorescence spectroscopy is a 
rapid and relatively inexpensive analytical technique, allowing of fast screening and 
determination of the enantiomeric composition of chiral molecules. In this chapter, the use of 
poly-L-SUF as a chiral selector for the determination of the enantiomeric composition of four 




5.2.1  Materials 
N-Hydroxysuccinimide, undecylenic acid, sodium bicarbonate, and 
dicyclohexylcarbodiimide were purchased from Fluka (Milwaukee, WI).  Undecylenyl alcohol, 
monobasic sodium phosphate, dibasic sodium phosphate, sodium hydroxide, hydrochloric acid, 
ethyl acetate, and tetrahydrofuran were obtained from Sigma-Aldrich (Milwaukee, WI).  
Enantiomerically pure enantiomers of 1,1`-binaphthyl-2,2`-diamine (BNA), 1-(9-anthryl)-2,2,2-
trifluoroethanol (TFA), propranolol (PROP), tartaric acid (TAR), citramalic acid (CIT), limonene 
(LIM), chloromethyl menthyl ether (CME), and S-naproxen (NPRX) were also purchased from 
Sigma-Aldrich (Milwaukee, WI).  Enantiomerically pure R-naproxen was purchased from 
Albermarle (Baton Rouge, LA).   The amino acid L-phenylalanine was purchased from Bachem 
Bioscience Inc. (King of Prussia, PA).  All chemicals were used as received. The purity of all 
analytes and reagents was 99% or higher.  
5.2.2  Instrumentation 
Steady-state fluorescence spectra were acquired using a SPEX Fluorolog-3 
spectrofluorometer (model FL3-22TAU3; Jobin Yvon, Edison, NJ) equipped with double 
excitation and emission monochromators (slit widths, 2 nm), a 400 W Xe-arc lamp, and a 
thermoelectrically cooled Hamamatsu R-928 photomultiplier tube.  A 0.4 cm path length quartz 
fluorescence cuvet was used for fluorescence emission data collection.  Absorption and 
fluorescence emission were collected at room temperature and the blank was subtracted from 




5.2.3  Synthesis of the Molecular Micelle 
The monomer L-SUF was synthesized according a previously reported procedure19 and 
details of the synthesis have been discussed in Chapter 4 of this dissertation. Polymerization was 
achieved by exposing a 40 mM aqueous solution to 60Co γ-rays (0.7 krad/hr) for 168 hrs.  
H1NMR was used to monitor complete polymerization of poly-L-SUF by the disappearance of 
the vinyl protons (6-5 ppm). Characterization of poly-L-SUF and its photophysical properties 
have also been reported in Chapter 4.  
5.2.4  Sample Preparation   
Poly-L-SUF samples for fluorescence study were prepared in 50 mM dibasic sodium 
phosphate buffer or a mixture of water and methanol.  The buffer was filtered through a 0.45-µm 
nylon syringe filter (Nalgene, Rochester, NY) and the pH was adjusted using an ORION model 
410A pH meter (Pulse Instruments, Van Nuys, CA)  with 0.1 M NaOH  or 0.1 M HCl prior to 
the addition of molecular micelle.  Calibration and validation samples for steady-state 
fluorescence measurements were prepared from 1 M poly-L-SUF and 0.1 M analyte stock 
solutions dissolved in buffer or methanol.  The structures of the fluorescent and non-fluorescent 
analytes are illustrated in Figure 5.1.  Final concentrations were made by transferring appropriate 
volumes of poly-L-SUF and analyte to dry volumetric flasks and diluting with buffer solution or 
methanol and water.  All solutions were sonicated 15 min to ensure proper dissolution and were 
allowed to equilibrate for 30 minutes.   
5.2.5  Data Analysis  
The Unscrambler, (CAMO, Inc., Corvallis, OR, version 9.1) chemometric software 











Figure 5.1   Molecular structures of the fluorescent and non-fluorescent analytes. 
 
5.3  Results and Discussion 
5.3.1  Effect of Poly-L-SUF Concentration 
 Figure 5.2.1 illustrates the effect of changing the poly-L-SUF concentration on the 
percent difference of fluorescence intensity at a particular wavelength for 1.0 × 10-5 M R- and S- 
fluorescent analyte.  In this figure, the concentration of poly-L-SUF varies from 1 mM to 15 mM.  
The optimum concentration of poly-L-SUF is the concentration that maximizes the spectral 
difference of each enantiomer.  The spectral difference is represented as fluorescence intensity 
percent difference at a particular wavelength and is found by taking the percent difference 
between the fluorescence intensity of the emission spectra containing one enantiomer from the 
fluorescence intensity of the emission spectra of the opposite enantiomer at the same 
wavelengths.  It is clear that there is an optimum concentration of poly-L-SUF to achieve the 
highest fluorescence intensity percent difference of R- and S- analyte.  The general trend of 














































fluorescent compounds. Initially, increasing the poly-L-SUF concentration increased the 
differences in emission spectra for each enantiomer.  At a particular optimum concentration, 
further increases in the concentration of poly-L-SUF led to a significant decrease of fluorescence 
intensity differences.  BNA and PROP have maximum enantiomeric fluorescence spectra 
differences at 4 mM poly-L-SUF (Figure 5.2.1A and 5.2.1C).  TFA and NPRX have maximum 
emission differences at 5 mM poly-L-SUF (Figure 5.2.1B and 5.2.1D).   The fluorescence 














Figure 5.2   Concentration study of poly-L-SUF on the percent difference of fluorescence 
intensity for 1.0 × 10-5 M R- and S- BNA (1A), TFA (1B), PROP (1C), and 
NPRX (1D).  The effect of changing the poly-L-SUF concentrations on the 
fluorescence intensity of BNA, TFA, PROP, and NPRX are shown in the insets of 
1A-1D.  Steady-state fluorescence emission spectra at optimum poly-L-SUF 
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As expected, the two enantiomers of each fluorescent compound have identical 
fluorescence emission spectra with a significantly lower intensity in the absence of chiral 
selector.  Complexation of poly-L-SUF with fluorescent analytes increases the fluorescence 
intensity of analytes. These observations are well known and can be explained by several factors 
including the reduction of quenching modes, alteration of photophysical rates, and/or shielding 
mechanisms.20 In addition, the ability of micelles to increase the fluorescence intensity of solutes 
has been used to lower the detection limits and increase the sensitivity of spectrofluorimetric 
methods for the determination of a variety of analytes.21-23  
Figure 5.3.1 illustrates the effect of changing the concentration of poly-L-SUF on the 
percent difference of fluorescence intensity at 330 nm for 1.5 × 10-5 M of non-fluorescent analyte 
enantiomers.  The concentration of poly-L-SUF varies from 2 mM to 20 mM and the optimum 
concentration of poly-L-SUF to achieve the highest fluorescence intensity percent difference was 
12 mM for TAR, 7.5 mM for LIM, and 10.5 mM for CIT and CME.  The same general trend of 
percent difference, while changing the concentration of poly-L-SUF is observed for the non-
fluorescent analytes.  The steady-state fluorescence emission spectra at optimum poly-L-SUF 
concentrations are illustrated in Figure 5.3.2 (A-D).  The emission spectral differences of the 
enantiomers of CME and LIM are significantly less than TAR (Figure 5.3.2 C) and CIT (Figure 
5.3.2 D) using poly-L-SUF as a chiral selector in buffer.  The spectral variations depend on 
several possible factors including the solubility, size, charge and hydrophobicity of the analyte.  
The water solubility of CME and LIM is very low, which could possibly lead to less interaction 
with the chiral selector.  In addition, the hydrophobic interactions between the molecular micelle 
chiral selector and CME and LIM analytes are weaker than the hydrophilic complexations with 


















Figure 5.3 Concentration study of chiral selector on the percent difference of fluorescence   
intensity for poly-L-SUF in the presence of 1.0 × 10-5 M enantiomers of TAR 
(1A), CIT (1B), LIM (1C), and CME (1D).  Steady-state fluorescence emission 
spectra at optimum poly-L-SUF concentration for TAR (2A), CIT (2B), LIM 
(2C), and CME (2D).   
 
5.3.2  Effect of Different Buffer Solutions 
 In this study, the pH of the buffer plays a very important role.  As illustrated in Figure 
5.4, the spectral variation of the enantiomers for both fluorescent and non-fluorescent chiral 









































































0 3 6 9 12 15 18


































































































































280 330 380 430 480 520
5
0
0 3 6 9 12 15 18
0



















polymerized micelles reported by Chu and Thomas.24 At acidic pH, the spectral variation may be 
reduced due to the compact conformation of the molecular micelle, allowing for less interaction 
between the enantiomer and chiral selector.  As the pH increases, electrostatic repulsion may 
cause the molecular micelle to have a looser conformation which may provide better interactions 
with the enantiomers.  It is noted that the percent difference of fluorescence intensity increased 
from pH 4 to pH 7 for all fluorescent and non-fluorescent analytes.  Further increases in the pH 
did not change the spectral variation from pH 7 to pH 12.  Therefore, the pH 7 buffer solution 













Figure 5.4 Effect of pH on the percent difference of fluorescence intensity for (A) 1.0 × 10-5 
M of fluorescent analytes in the presence of poly-L-SUF at the optimum 
concentration and (B) optimum concentration of poly-L-SUF in the presence of 



















































5.3.3  Determination of Enantiomeric Composition Using Optimized Conditions 
 Optimization studies, including the concentration of chiral selector and pH of the buffer, 
are necessary to develop a calibration model capable of predicting the enantiomeric composition 
of unknown samples.  Previous studies in Chapter 3 of this dissertation with non-fluorescent 
chiral molecular micelles confirmed that the ability of the calibration model to accurately predict 
the enantiomeric composition of unknown samples depends upon the extent of the spectral 
variation. All analytes have the same total concentration (1.0 ×10-5 M) but different emission 
spectra with varying enantiomeric compositions in the presence of poly-L-SUF.  Table 5.1 lists 
the compositions of 12 solutions for the calibration of all eight analytes. Figure 5.5 illustrates the 
spectra of the 12 solutions of each analyte in the optimum concentration of poly-L-SUF.  It is 
interesting to observe that different enantiomeric compositions of each analyte led to relatively 
small changes in the emission spectra.  As expected, the spectral differences are due to 
diastereomeric interactions between poly-L-SUF and both enantiomeric forms of each analyte.   
 
Table 5.1 Compositions of 12 solutions used for calibration studies. 
 
Sample 
         BNA 
    S             R  
         TFA 
    S             R     
        PROP 
    S             R 
       NPRX 
    S             R 
         TAR 
    D            L 
CIT,LIM,CME 
























































































































































































Figure 5.5 Fluorescence emission spectra of 12 solutions containing optimum concentration 
of poly-L-SUF and 1.0 × 10-5 M of (A) BNA, (B) TFA, (C) PROP, (D) NPRX, 
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 A multivariate method of analysis, partial least-square-regression modeling (PLS-1), was 
used to correlate the small spectral changes with known compositional changes to form a 
calibration model.  Calibrations were performed on emission spectra of the 12 samples of poly-L-
SUF in the presence of analyte and better regressions between spectral data and enantiomeric 
composition were obtained for each analyte in the wavelength regions with the most variation 
(see Table 5.2).  A perfect calibration model would have a regression coefficient and slope of 1 
and an offset of 0.  Table 5.2 lists the figures of merit within the given spectral range.  The 
regression parameters for 6 of the analytes are very close to a perfect model; however, the 
regression models for LIM and CME have a lower regression coefficient and slope and a higher 
offset than the other analytes.   
 
Table 5.2  Figures of merit obtained from multivariate regression analysis of calibration 





































2.88 × 10-3 
6.78 × 10-3 
8.01 × 10-3 
4.08 × 10-3 
9.87 × 10-3 
2.74 × 10-3 
9.17 × 10-2 













 To evaluate the prediction ability of the calibration models, 10 independently prepared 
validation samples with the same analyte concentration as the calibration set but different 
enantiomeric compositions were evaluated over the same wavelength region used for the 
regression models.  Figure 5.6 illustrates the plots for all fluorescent (Figure 5.6 A-D) and non-
fluorescent compounds (Figure 5.6 E – H), where the actual mole fraction was plotted against the 
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predicted mole fraction.  The predicted mole fractions for each analyte enantiomer were plotted 
separately and as expected, were linearly related with regression coefficients ranging from 
0.9834 – 0.9999.  In addition, the linear relationship still exists when predicted and actual mole 
fractions were plotted together for both enantiomers with regression coefficients ranging from 
0.9834 – 0.9989.  As expected from a small spectral variation, the regression for LIM and CME 
are lower than the other analytes.  
 The prediction ability of the calibration models for the validation samples was evaluated 
by use of the root-mean-square percent relative error (RMS%RE), which was introduced in 
Chapter 2 of this dissertation.  The RMS%RE for the ten validation samples for S-BNA, S-TFA, 
S-PROP, and S-NPRX were 1.77, 2.95, 3.17, and 2.90%, respectively, while the values for R-
BNA, R-TFA, R-PROP, and R-NPRX were 2.31, 2.57, 3.03, and 3.20, respectively (Table 5.3).  
The results indicate that the validation studies depend on the analyte.  Furthermore, it is known 
that one enantiomer can bind more strongly to the chiral selector, leading to different 
enantiomeric validation results.25, 26  
Table 5.4 lists the RMS%RE for the non-fluorescent analytes.  As listed, the values for S-
LIM and S-CME (14.53 and 15.80%) are much higher than the values for D-TAR and S-CIT 
(4.37 and 3.79%).  The same trend is observed for the opposite enantiomer and once again, the 
results indicate that the validation is analyte dependent.  As previously noted, the extent of the 
spectral variation obtained during the calibration phase plays an important role in the prediction 
ability of the model.  Spectral differences are based on diastereomeric interactions between the 
analyte and the chiral selector.  Several factors including solubility of the analyte in the 
molecular micelle, hydrophobicity of the analyte, charge of the analyte, and size of the analyte 
determine the extent of the interactions.  TAR and CIT are more soluble in water as compared to 
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LIM and CME.  As a result, there may be less interaction between enantiomer and chiral selector 
for the more hydrophobic molecules.  Less interaction will lead to lower spectral variation as 
seen in the calibration studies for these two molecules. 
5.3.4  Study of Guest-Host Complexation in Buffer and Methanol/Water Medium 
To study the influence of the solvent on the chiral discrimination and enantiomeric 
prediction by use of molecular micelles, a series of experiments was performed using methanol 
and water mixtures.   Although it is well known that the water solubility of many terpenes and 
ethers is very poor27 the solubility of the hydrophobic compounds LIM and CME was expected 
to increase with the use of methanol.  In addition, the following experiments demonstrated that 
the method is not limited to water only. It would be expected that better chiral discrimination 
would result with a solvent medium that allows for increased solubility of chiral selector and 
analyte.   
Samples were prepared as described previously and the multiple regression modeling was 
performed.  Once again, the enantiomeric composition of 12 calibration samples was varied from 
1.0 to 0.0 mol fraction.  All experiments were performed using the same analyte concentration (1 
× 10-5 M) and the optimum concentration of poly-L-SUF in the buffer medium.  However, in this 
study, the calibration and validation samples were prepared in 25:75 methanol/water and 75:25 
methanol/water. As expected, the use of organic solvent increased the solubility of the 
hydrophobic molecules, which also increased the interaction between the chiral selector and the 
analyte. As a result, the observed figures of merit for the calibration models improved as 
compared to those obtained in buffer (Appendix IV).  This was an indication that the validation 
























Figure 5.6 Actual mole fraction composition versus predicted mole fraction composition for 
optimum concentration of poly-L-SUF and (A) BNA, (B) TFA, (C) PROP, (D) 
NPRX, (E) TAR, (F) CIT, (G) LIM, and (H) CME. □, S or D enantiomer; ■, R or 
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Table 5.3 Actual and predicted mole fraction of 1.0 × 10-5 M enantiomers of fluorescent 



















































Act S TFA 
mol frac 
Pred S TFA 
mol frac 
S TFA 























  1.86 
-1.09 
  1.93 
  1.88 
-3.25 
-2.40 
  3.33 
  6.67 
  2.95 
Act R TFA 
mol frac 
Pred R TFA 
mol frac 
R TFA 


















































































Act S PROP 
mol frac 
Pred S PROP 
mol frac 
S PROP 
rel error % 
Act S NPRX 
mol frac 
Pred S NPRX 
mol frac 
S NPRX 































































Act R PROP 
mol frac 
Pred R PROP 
mol frac 
R PROP 
rel error % 
Act R NPRX 
mol frac 
Pred R NPRX 
mol frac 
R NPRX 






















  4.76 
-2.63 
-3.43 












































Table 5.4   Actual and predicted mole fraction of 1.0 × 10-5 M enantiomers of non-







Act S CIT 
mol frac 
Pred S CIT 
mol frac 
S CIT 





















  0.95 
 -1.06 
  1.60 
  2.15 
  1.45 





  3.79 
Act R CIT 
mol frac 
Pred R CIT 
mol frac 
R CIT 






















   4.67 
   2.80 
   3.14 
   2.44 
   0.73 
   1.85 
  -0.90 
   2.47 
  -1.26 
   4.49 
Act S LIM 
mol frac 
Pred S LIM 
mol frac 
S LIM 
rel error % 
Act S CME 
mol frac 
Pred S CME 
mol frac 
S CME 





















  -4.00 
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   3.85 
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  -7.11 
  -7.71 
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  -5.73 
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   5.82 






Act R LIM 
mol frac 
Pred R LIM 
mol frac 
R LIM 
rel error % 
Act R CME 
mol frac 
Pred R CME 
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R CME 

























   6.89 
   4.36 
  -5.23 
   4.26 
   2.59 























  17.33 
-21.60 
  17.14 
    6.67 
    6.91 
    6.31 
   -5.42 
   -5.29 
   -4.00 
  16.01 
D TAR 
rel error % 
   0.84 
  -1.29 
  -1.20 
   1.38 
  -2.36 
  -3.11 
  -2.86 
  -2.67 
    3.33 
-12.00 
   4.37 
L TAR 
rel error % 
-10.00 
  -4.67 
  -4.80 
   2.29 
  -2.44 
  -2.18 
   1.38 
   2.06 
   1.88 
  -1.16 
   4.14 
























































The summary of the results obtained from the validation studies are illustrated in Figure 
5.7 (and in Appendix V), where the RMS%RE values decreased for all analytes as the amount of 
methanol increased.   The most significant changes were observed for the regression models for 
poly-L-SUF in the presence of LIM and CME.  As previously reported in Table 5.4, the 
RMS%RE obtained for LIM using buffer was 14.43%.   Addition of methanol resulted in a 
significant difference in the spectral difference for poly-L-SUF in the presence of each 
enantiomer and ultimately lowers the RMS%RE values.  The RMS%RE for LIM and CME using 
25:75 methanol/water was 7.95 and 6.18%, respectively, while it decreased further using 75:25 















Figure 5.7 RMS%RE obtained for all analytes with optimum poly-L-SUF concentration in 
buffered solutions, 25:75 methanol/water, and 75:25 methanol/water. 
 


















PLS-1 regression analysis of fluorescence spectral data obtained for poly-L-SUF in the 
presence of fluorescent and non-fluorescent chiral analytes has demonstrated the versatility of 
the present method.  The use of fluorescence spectroscopy allowed for the enantiomeric 
determination of analytes with varying functionally groups, solubility, size and hydrophobicity at 
low concentrations. Analysis of non-fluorescent analytes is possible because a fluorescent chiral 
selector was used for chiral recognition studies.  The ability of the chiral selector to differentiate 
between analyte enantiomers is based on diastereomeric interactions.  Spectral variation was 
found to depend on the concentration of poly-L-SUF and the pH of the buffer used.  The 
calibration models for more hydrophobic compounds were found to have poor prediction 
capabilities using a buffer medium.  Addition of organic solvent demonstrated the versatility of 
the method and better predictions were obtained when methanol/water mixtures were used as a 
solvent medium for guest-host complexation. Furthermore, poly-L-SUF has proven to be a 
versatile chiral selector for the enantiomeric determination of fluorescent and non-fluorescent 
molecules. 
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CONCLUSIONS AND FUTURE STUDIES 
 
In this dissertation, chiral analysis by use of molecular micelles and experimental design 
techniques using chromatographic and spectroscopic methods is described. Molecular micelles 
are proven to be versatile chiral selectors because the studies include a variety of chiral analytes 
with varying size, solubility, hydrophobicity, and compound class.  The significance of chiral 
analysis, types of chiral selectors, experimental design, and instrumental theory including CE as 
well as fluorescence spectroscopy were introduced in Chapter 1.   
In Chapter 2, MEKC separation parameters (molecular micelle concentration, applied 
voltage, pH, and operating temperature) were optimized by use of multiple regression analysis 
for the calibration of migration time and resolution of achiral and chiral analytes.  Several 
multiple regression techniques including MLR, PCR, and PLS-1 were used for prediction 
studies.  As expected, the validation of independently prepared samples was similar for each 
analyte using all regression techniques.     
The dipeptide molecular micelle poly-L-SULV proved to be a good chiral selector for the 
resolution of chiral analytes in MEKC as well as for the chiral recognition studies using a 
spectroscopic technique.  In Chapter 3, steady-state fluorescence spectroscopy was employed to 
investigate the use of poly-L-SULV, poly-L-SUL, or poly-L-SUV for the chiral analysis of BOH, 
BNA, and TFA.  Better chiral discrimination of the analytes was obtained for studies using poly-
L-SULV as the chiral selector.  PLS-1 was used to correlate changes in the fluorescence spectral 
data of the chiral analytes as the enantiomeric composition was varied.  The regression models 
produced from the spectral data were validated by determining the enantiomeric composition of 
independently prepared test solutions. The RMS%RE ranged between 1.57 and 6.10 %.  In 
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addition, chiral analyte concentrations as low as 5 x 10-6 M were found to give regression models 
with good predictability. 
  In Chapter 4, novel FCMMs including poly-SUW, poly-SUY, and poly-SUF were 
synthesized and characterized using a variety of analytical techniques.  In addition, the L-form of 
each FCMM was used for the chiral analysis of glucose, tartaric acid and serine.  Poly-L-SUW 
had a significant fluorescence emission spectral difference as compared to poly-L-SUY and poly-
L-SUF for the enantiomeric recognition of glucose, tartaric acid, and serine.  Studies with the 
hydrophobic molecule α-pinene suggested that poly-L-SUY and poly-L-SUF had better chiral 
discrimination ability for hydrophobic analytes as compared to hydrophilic analytes.  
Chemometric modeling by PLS-1 regression analysis of steady-state fluorescence emission 
spectral data for the enantiomeric composition prediction of the chiral hydrophilic analytes in the 
presence of poly-L-SUW was reported. The sensitivity of the fluorescence technique allowed for 
investigation of low concentrations of chiral selector (3.0 × 10-5 M) and analyte (5.0 × 10-6 M) to 
be used in these studies.  Validation of the calibration regression models was determined by use 
of a set of independently prepared samples of the same concentration of chiral selector and 
analyte with varying enantiomeric composition and the RMS%RE was found to range from 
2.04% to 4.06%.   
FCMMs have an inherent advantage over non-fluorescent molecular micelles.  The chiral 
recognition of four fluorescent and four non-fluorescent molecules by use of poly-L-SUF chiral 
selector was reported in Chapter 5.  The influence of FCMM concentration, buffer pH and 
complexation medium on FCMM-analyte host-guest complexation and the emission spectral 
properties of the resulting complexes were investigated. The figures of merit obtained from the 
PLS-1 regression modeling of the calibration samples suggested good prediction ability for the 
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validation of six of the eight chiral analytes.  Better host-guest complexation of the more 
hydrophobic molecules, CME and LIM was obtained in methanol/water mixtures, resulting in 
better predictability of the regression models.  The RMS%RE for all eight chiral analytes was 
found to range from 1.77 to 15.80% (buffer), 1.26 to 7.95% (25:75 methanol/water), and 1.21 to 
4.28% (75:25 methanol/water).   
Dipeptide molecular micelles have proven to have good chiral recognition ability in 
chromatographic (Chapter 2) and spectroscopic (Chapter 3) techniques.  As noted in Chapter 2, 
enantiomeric resolution of chiral analytes is a big challenge in separation science and the 
conventional method of determining the optimum separation conditions of analytes may be time 
consuming and labor intensive. Thus, development of dipeptide FCMMs may have increased 
chiral selectivity of fluorescent and non-fluorescent chiral molecules.  Additional studies 
pertinent to MEKC can be extended to the investigation of the use of dipeptide FCMMs as chiral 
selectors.  In addition, a more sensitive detection method (indirect laser-induced fluorescence 
detection) other than conventional UV-absorbance detection may be used with FCMMs as the 
additive in the background electrolyte. This approach would allow for the rapid detection of 
analytes without derivatization using a fluorescent probe. 
Multiple regression modeling of spectral data of a one-component solution is the simplest 
form of enantiomeric determination.  Chapters 3 through 5 reported the enantiomeric 
composition prediction of a one-component chiral solution including only the enantiomers of one 
chiral molecule.  Additional studies can be extended to accurate and simultaneous determination 
of multi-component fluorescent or non-fluorescent solutions by use of FCMMs.  The chiral 
analysis of several mixtures of two different chiral molecules can be monitored simulating the 
progress of an asymmetric synthesis chemical reaction over time.   
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Ave. Migration Time      Rs 
        (t) (min) 
            
    Rs/t 
 (per min) 
  1 15 15 7.2 1.00 21.424 1.52 0.07 
  2 20 25 7.2 0.75   9.314 0.92 0.10 
  3 25 15 7.2 1.00 10.521 1.59 0.15 
  4 15 15 7.5 0.75 18.399 1.14 0.06 
  5 20 15 7.2 0.75 12.895 1.32 0.10 
  6 25 15 7.2 0.50   8.284 0.96 0.12 
  7 25 20 7.5 0.75   8.865 0.83 0.09 
  8 30 20 7.5 1.00   7.632 0.92 0.12 
  9 30 20 7.5 0.75   7.345 0.68 0.09 
10 20 20 7.5 0.50 10.651 0.70 0.07 
11 20 15 7.2 0.50 11.351 0.88 0.08 
12 30 15 7.2 0.50   6.270 0.94 0.15 
13 25 20 7.2 1.00   8.610 1.20 0.14 
14 20 25 7.5 1.00 16.966 0.88 0.05 
15 30 15 7.5 0.75   7.400 1.06 0.14 
16 30 15 7.5 0.50   6.751 0.77 0.11 
17 25 20 7.5 0.50   8.132 0.45 0.06 
18 20 20 7.2 1.00 11.631 1.18 0.10 
19 30 25 7.2 1.00   5.860 0.99 0.17 
20 30 20 7.2 1.00   6.531 1.29 0.20 
21 30 20 7.2 0.50   5.412 0.79 0.15 
22 15 15 7.2 0.75 18.696 1.18 0.06 
23 20 25 7.5 0.50 11.004 0.47 0.04 
24 25 15 7.5 0.75 10.088 0.96 0.10 
25 15 20 7.5 1.00 19.490 0.98 0.05 
26 15 20 7.5 0.50 15.039 0.56 0.04 
27 25 25 7.2 1.00    7.643 1.11 0.15 
28 15 20 7.2 0.75 15.032 0.95 0.06 
29 20 15 7.5 0.75 13.185 1.20 0.09 
30 20 25 7.2 0.50   8.395 0.74 0.09 
31 25 25 7.5 0.50   8.829 0.33 0.04 
32 25 25 7.5 1.00 10.623 0.82 0.08 
33 15 25 7.2 0.50 11.721 0.62 0.05 
34 20 15 7.5 0.50 12.001 1.04 0.09 
35 25 15 7.5 0.50   8.979 0.77 0.09 
36 20 15 7.5 1.00 14.875 1.32 0.09 
37 25 15 7.5 1.00 11.388 1.04 0.09 
38 15 25 7.5 1.00 27.274 0.93 0.03 
39 20 20 7.2 0.75 10.508 1.08 0.10 
40 30 15 7.2 1.00   7.802 1.35 0.17 
41 30 20 7.2 0.75   5.892 1.21 0.21 
42 30 25 7.5 1.00   8.758 0.54 0.06 
43 20 25 7.2 1.00 10.227 1.02 0.10 
44 15 25 7.5 0.50 19.404 0.59 0.03 
45 30 25 7.2 0.50   4.923 0.60 0.12 
46 30 25 7.5 0.50   6.482 0.24 0.04 
47 15 15 7.2 1.00 21.424 1.52 0.07 
 












Ave. Migration Time      Rs 
        (t) (min) 
            
    Rs/t 
 (per min) 
  1 15 20 7.5 0.50 13.539 0.31 0.02 
  2 20 25 7.2 0.50   7.692 0.28 0.04 
  3 25 25 7.2 1.00   6.663 1.06 0.16 
  4 15 25 7.2 0.75 11.664 0.48 0.04 
  5 30 20 7.2 1.00   5.706 0.59 0.10 
  6 20 20 7.2 0.75   9.317 0.56 0.06 
  7 20 15 7.5 1.00 12.530 0.72 0.06 
  8 30 15 7.2 0.75   6.217 1.04 0.17 
  9 20 15 7.2 0.75 11.250 0.62 0.06 
10 30 15 7.5 1.00   7.090 0.68 0.10 
11 20 20 7.5 0.50   9.609 0.29 0.03 
12 30 15 7.2 1.00   6.721 0.80 0.12 
13 30 25 7.2 1.00   5.157 0.77 0.15 
14 15 15 7.2 0.50 14.617 0.41 0.03 
15 30 20 7.2 0.50   4.972 0.36 0.07 
16 25 25 7.2 0.75   6.257 0.49 0.08 
17 15 20 7.5 0.75 14.881 0.51 0.03 
18 25 15 7.5 0.75   8.775 0.64 0.07 
19 15 20 7.2 1.00 14.667 0.63 0.04 
20 25 15 7.2 1.00   8.990 0.77 0.09 
21 25 25 7.2 0.50   5.821 0.39 0.07 
22 25 20 7.5 0.75   7.798 0.32 0.04 
23 15 15 7.2 1.00 17.981 0.72 0.04 
24 15 15 7.5 0.75 16.026 0.46 0.03 
25 20 15 7.2 0.50 10.263 0.45 0.04 
26 25 20 7.2 1.00   7.487 0.64 0.09 
27 25 15 7.5 0.50   8.073 0.38 0.05 
28 15 20 7.2 0.75 13.315 0.45 0.03 
29 25 15 7.2 0.50   7.533 0.43 0.06 
30 20 15 7.5 0.50 10.773 0.54 0.05 
31 25 20 7.5 1.00   8.534 0.38 0.04 
32 20 20 7.2 1.00 10.076 0.67 0.07 
33 20 15 7.5 0.75 11.490 0.59 0.05 
34 30 15 7.2 0.50   5.721 0.44 0.08 
35 15 20 7.5 0.50 13.539 0.31 0.02 
 











Ave. Migration Time      Rs 
        (t) (min) 
            
    Rs/t 
 (per min) 
  1 20 20 7.5 0.50 14.149 1.21 0.09 
  2 30 25 7.5 0.75   7.073 0.57 0.08 
  3 15 20 7.0 0.75 20.555 0.57 0.03 
  4 30 15 7.0 0.75   9.887 0.47 0.05 
  5 20 20 7.0 1.00 20.649 0.40 0.02 
  6 15 20 7.0 0.50 19.205 0.28 0.01 
  7 25 25 7.5 0.75   9.807 0.96 0.10 
  8 30 15 7.5 0.50   8.677 1.14 0.13 
  9 15 15 7.5 0.75 27.229 1.83 0.07 
10 30 15 7.0 1.00 12.613 0.42 0.03 
11 30 15 7.5 0.75 10.796 1.35 0.13 
12 30 15 7.0 0.50   9.333 0.27 0.03 
13 20 15 7.5 0.75 16.891 1.86 0.11 
14 25 15 7.0 1.00 17.969 0.64 0.04 
15 25 15 7.5 0.75 12.226 1.69 0.14 
16 20 25 7.0 1.00 14.610 0.26 0.02 
17 15 25 7.5 0.75 18.598 1.26 0.07 
18 15 20 7.0 1.00 29.882 0.59 0.02 
19 30 20 7.5 1.00   8.596 1.35 0.16 
20 15 15 7.5 1.00 26.622 1.96 0.07 
21 15 15 7.0 1.00 44.759 0.98 0.02 
22 20 25 7.0 0.75 11.612 0.21 0.02 
23 15 25 7.5 1.00 20.463 1.38 0.07 
24 25 20 7.5 0.50 10.528 1.13 0.11 
25 15 15 7.0 0.75 33.037 0.96 0.03 
26 20 20 7.5 1.00 15.560 1.66 0.11 
27 15 25 7.5 0.50 15.045 0.81 0.05 
28 25 20 7.0 0.50   9.697 0.22 0.02 
29 25 15 7.0 0.50 13.006 0.49 0.04 
30 20 15 7.0 0.50 18.957 0.66 0.03 
31 25 20 7.5 0.75 10.963 1.49 0.14 
32 15 20 7.5 0.50 19.342 1.21 0.06 
33 25 20 7.0 0.75 10.131 0.33 0.03 
34 30 25 7.5 0.50   7.023 0.80 0.11 
35 25 15 7.0 0.75 14.052 0.75 0.05 
 











Ave. Migration Time      Rs 
        (t) (min) 
            
    Rs/t 
 (per min) 
  1 20 20 7.5 1.00 13.567 0.80 0.06 
  2 20 25 7.5 1.00 12.441 0.40 0.03 
  3 15 20 7.5 1.00 19.210 0.80 0.04 
  4 25 20 7.5 0.75 9.844 0.54 0.05 
  5 30 25 7.5 1.00 6.882 0.32 0.05 
  6 30 15 7.5 1.00 8.608 0.76 0.09 
  7 30 20 7.5 1.00 7.713 0.39 0.05 
  8 25 25 7.5 1.00 9.447 0.33 0.03 
  9 25 15 7.5 0.75 10.806 0.75 0.07 
10 20 25 7.5 0.75 12.026 0.34 0.03 
11 15 20 7.5 0.75 18.269 0.66 0.04 
12 25 25 7.5 0.75 8.932 0.25 0.03 
13 25 20 7.5 1.00 10.225 0.96 0.09 
14 30 15 7.5 0.50 8.008 0.27 0.03 
15 20 20 7.5 0.50 12.895 0.32 0.02 
 











Ave. Migration Time      Rs 
        (t) (min) 
            
    Rs/t 
 (per min) 
  1 30 25 9 0.75 13.521 0.95 0.07 
  2 25 15 8 1.00 34.082 0.60 0.02 
  3 30 15 8 0.50 24.087 0.49 0.02 
  4 20 15 9 0.50 32.174 0.85 0.03 
  5 20 25 8 1.00 37.356 0.40 0.01 
  6 15 20 9 0.50 40.786 0.78 0.02 
  7 25 20 9 0.75 26.110 0.82 0.03 
  8 20 25 9 0.50 25.216 0.71 0.03 
  9 25 15 9 0.75 38.776 0.86 0.02 
10 30 15 8 1.00 27.594 0.40 0.01 
11 15 25 9 0.50 35.999 0.72 0.02 
12 30 15 9 0.50 19.124 0.86 0.04 
13 25 25 9 0.50 18.141 0.72 0.04 
14 15 20 8 1.00 60.212 0.66 0.01 
15 20 20 9 1.00 33.998 0.97 0.03 
16 30 15 9 0.75 18.712 0.99 0.05 
17 30 20 9 0.75 15.770 0.98 0.06 
18 20 15 8 0.75 52.247 0.55 0.01 
19 20 20 9 0.75 31.291 0.95 0.03 
20 25 20 9 1.00 24.150 1.02 0.04 
21 30 20 8 0.50 19.711 0.60 0.03 
22 25 15 9 1.00 37.462 0.62 0.02 
23 25 20 9 0.50 20.339 0.77 0.04 
24 25 15 8 0.50 32.464 0.53 0.02 
 











Ave. Migration Time      Rs 
        (t) (min) 
            
    Rs/t 
 (per min) 
  1 15 25 8.0 1.00 30.552 0.77 0.03 
  2 25 15 8.0 0.50 17.203 0.47 0.03 
  3 20 25 8.0 1.00 20.984 0.55 0.03 
  4 15 15 9.0 0.50 31.922 0.80 0.03 
  5 30 20 9.0 0.75 11.026 0.45 0.04 
  6 25 15 8.0 1.00 19.940 0.98 0.05 
  7 15 25 9.0 0.50 24.575 0.37 0.02 
  8 30 15 9.0 1.00 16.380 0.53 0.03 
  9 20 15 9.0 0.50 22.923 0.83 0.04 
10 15 20 8.0 0.75 43.785 0.64 0.01 
11 15 20 9.0 0.50 28.285 0.63 0.02 
12 20 20 8.0 0.75 28.533 0.42 0.01 
13 20 20 8.0 1.00 23.842 0.73 0.03 
14 20 20 9.0 0.75 21.388 0.74 0.03 
15 20 15 9.0 0.75 26.255 0.94 0.04 
16 30 15 9.0 0.75 13.253 0.72 0.05 
17 15 15 8.0 1.00 42.533 0.96 0.02 
18 20 25 9.0 1.00 20.941 0.38 0.02 
19 30 20 8.0 1.00 11.959 0.36 0.03 
20 15 20 9.0 1.00 48.303 0.65 0.01 
21 20 15 8.0 0.50 34.833 0.50 0.01 
22 30 20 9.0 1.00 11.856 0.39 0.03 
23 25 15 9.0 1.00 21.806 0.84 0.04 
24 20 20 9.0 0.50 19.681 0.53 0.03 
25 25 20 9.0 1.00 16.316 0.62 0.04 
26 15 25 9.0 1.00 28.871 0.53 0.02 
 











Ave. Migration Time     Rs  
          (t) (min) 
 
    Rs/t 
     (per/min) 
 
  1 30 20   9.0 0.50 10.921 25.37 2.32 
  2 15 15 10.0 0.50 33.263 29.13 0.88 
  3 30 15 10.0 0.75 12.515 21.63 1.73 
  4 20 15   9.0 0.75 31.594 24.52 0.78 
  5 20 15 10.0 0.50 21.445 29.28 1.37 
  6 20 25 10.0 0.75 19.901 42.50 2.14 
  7 30 20   9.0 0.75 12.011 27.47 2.29 
  8 25 25 10.0 1.00 18.460 41.64 2.26 
  9 20 25   9.0 0.50 18.765 25.00 1.33 
10 15 25 10.0 0.50 22.759 22.37 0.98 
11 30 15   9.5 0.75 12.250 30.58 2.50 
12 15 20   9.0 1.00 45.630 28.71 0.63 
13 20 25   9.5 0.75 16.993 23.44 1.38 
14 20 20   9.0 0.50 21.112 24.45 1.16 
15 15 15 10.0 0.75 36.719 27.03 0.74 
16 20 15   9.0 0.50 28.013 19.40 0.69 
17 25 20   9.0 0.75 18.035 27.63 1.53 
18 15 25 10.0 0.75 28.863 22.57 0.78 
19 20 15   9.5 0.50 19.588 31.94 1.63 
20 15 15   9.0 0.75 45.354 22.25 0.49 
21 20 15 10.0 1.00 28.763 30.72 1.07 
22 30 20 10.0 1.00 17.181 21.12 1.23 
23 20 25   9.5 0.50 14.787 27.69 1.87 
24 30 15   9.0 0.50 13.366 21.79 1.63 
25 20 20   9.5 1.00 23.421 42.32 1.81 
26 25 15   9.0 1.00 34.204 20.60 0.60 
27 15 25   9.5 1.00 31.171 54.94 1.76 
28 30 25   9.5 0.50   8.016 24.73 3.09 
29 25 20   9.5 1.00 18.211 51.24 2.81 
30 30 20   9.0 1.00 14.428 20.48 1.42 
31 20 15   9.0 1.00 47.726 35.40 0.74 
32 25 25   9.0 1.00 16.870 15.17 0.90 
33 15 25   9.5 0.75 24.222 23.34 0.96 
34 15 15   9.5 0.50 27.896 27.70 0.99 
35 25 15   9.5 1.00 22.370 27.96 1.25 
36 15 20   9.5 0.75 28.649 26.06 0.91 
37 15 15   9.0 0.50 41.200 20.26 0.49 
38 15 25   9.0 0.50 25.505 24.49 0.96 
39 30 15 10.0 0.50 10.916 27.96 2.56 
40 30 15   9.5 0.50 10.668 23.97 2.25 
41 15 25   9.5 0.50 21.392 27.93 1.31 
42 25 15 10.0 0.75 18.282 23.87 1.31 
43 25 25 10.0 0.50 11.968 28.43 2.38 
44 20 25   9.5 1.00 21.207 55.86 2.63 
45 25 20 10.0 0.75 15.859 28.48 1.80 
46 30 25 10.0 0.50   8.715 23.20 2.66 
47 20 25   9.0 0.75 21.378 27.20 1.27 
48 25 20   9.0 1.00 20.723 30.96 1.49 
49 30 15   9.0 0.75 14.304 24.84 1.74 
50 25 15   9.5 0.75 17.357 25.94 1.49 
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51 15 20 10.0 1.00 44.866 33.63 0.75 
52 15 20   9.5 0.50 24.796 27.96 1.13 
53 25 25 10.0 0.75 14.658 37.15 2.53 
54 30 15   9.5 1.00 14.084 25.30 1.80 
55 25 15   9.0 0.50 19.336 20.85 1.08 
56 30 25 10.0 0.75 10.816 49.23 4.55 
57 25 20   9.0 0.50 14.736 22.88 1.55 
58 30 25   9.0 0.75 10.217 26.03 2.55 
69 20 15 10.0 0.75 25.881 24.77 0.96 
60 15 20   9.0 0.50 30.529 24.53 0.80 
61 20 20   9.0 0.75 25.730 24.95 0.97 
62 20 25 10.0 1.00 26.895 51.64 1.92 
63 15 20   9.5 1.00 35.415 44.95 1.27 
64 20 25 10.0 0.50 16.448 26.87 1.63 
65 30 25   9.5 0.75   9.182 24.72 2.69 
66 20 20   9.5 0.75 19.952 23.80 1.19 
67 25 20 10.0 0.50 13.314 26.35 1.98 
68 15 15   9.5 0.75 35.669 21.84 0.61 
69 25 20 10.0 1.00 20.807 25.31 1.22 
70 20 15   9.5 1.00 30.805 26.68 0.87 
71 30 15 10.0 1.00 15.026 32.79 2.18 
 
Appendix I.G Calibration of achiral chlorophenols. 











Ave. Migration Time      Rs 
        (t) (min) 
            
    Rs/t 
 (per min) 
  1 15 25 10.0 1.00 44.940 34.63 0.77 
  2 15 20 9.0 0.75 31.928 15.08 0.47 
  3 15 25 9.0 1.00 36.113 23.40 0.65 
  4 25 25 9.0 0.50 22.661 28.71 1.27 
  5 25 15 9.0 0.75 26.040 24.38 0.94 
  6 20 20 10.0 0.75 28.557 28.38 0.99 
  7 15 20 10.0 0.75 30.622 20.33 0.66 
  8 25 25 9.5 0.50 19.481 25.30 1.30 
  9 20 20 9.5 0.50 25.534 29.16 1.14 
10 20 20 9.0 1.00 33.694 28.21 0.84 
11 30 20 10.0 0.50 19.674 26.99 1.37 
12 30 20 9.5 0.75 19.111 25.36 1.33 
13 30 25 9.0 0.50 20.200 29.19 1.45 
14 30 20 9.5 0.50 18.879 26.53 1.41 
15 30 15 9.0 1.00 27.221 31.56 1.16 
16 25 25 9.0 0.75 20.999 23.10 1.10 
17 25 20 9.5 0.50 22.156 28.65 1.29 
18 15 15 10.0 1.00 39.133 20.14 0.51 
19 20 15 9.5 0.75 27.256 23.24 0.85 
20 30 20 10.0 0.75 19.407 23.48 1.21 
21 25 15 10.0 0.50 25.385 30.84 1.21 
22 25 15 9.5 0.50 20.671 23.81 1.15 
23 25 20 9.5 0.75 23.125 28.15 1.22 
24 20 20 10.0 1.00 32.518 24.93 0.77 
25 15 20 10.0 0.50 25.555 19.95 0.78 
26 30 25 9.0 1.00 22.098 24.34 1.10 
27 20 25 9.0 1.00 25.551 15.15 0.59 
28 25 25 9.5 0.75 20.828 25.92 1.24 
29 20 20 10.0 0.50 25.003 25.95 1.04 
30 25 25 9.5 1.00 39.149 58.06 1.48 
31 15 25 9.0 0.75 29.797 21.07 0.71 
32 25 15 10.0 1.00 27.050 25.07 0.93 
33 15 25 10.0 1.00 44.940 34.63 0.77 
34 15 20 9.0 0.75 31.928 15.08 0.47 
35 15 25 9.0 1.00 36.113 23.40 0.65 
 





VALIDATION STUDIES:  MIGRATION TIME, RESOLUTION, AND RESOLUTION 
PER UNIT TIME FOR CHIRAL AND ACHIRAL ANALYTES 
 
Exp Average Migration Time (t) 
(min) 
    Exp          Pred     Pred-Exp 
Resolution (Rs) 
 
    Exp          Pred     Pred-Exp 
Rs/t (per min) 
 
    Exp          Pred     Pred-Exp 
1   9.350  10.728   1.378 0.72 0.86   0.14 0.08 0.08   0.00 
2 14.539 15.753   1.214 1.04 1.11   0.07 0.07 0.07   0.00 
3 16.523 16.616   0.093 0.98 0.88 -0.10 0.06 0.05 -0.01 
4 14.564 13.948 -0.616 1.66 1.48 -0.18 0.11 0.11   0.00 
5   9.405   9.363 -0.042 1.24 1.24   0.00 0.13 0.13   0.00 
6   5.394   4.436 -0.958 0.97 0.79 -0.18 0.18 0.18   0.00 
7   7.048   5.997 -1.051 1.35 1.20 -0.15 0.19 0.20 -0.01 
8 13.107 14.533  1.426 0.86 0.90   0.04 0.07 0.06 -0.01 
9 17.117 17.056 -0.061 0.85 0.88   0.03 0.05 0.05   0.00 
10 11.844 13.690  1.846 0.99 0.84 -0.15 0.08 0.06 -0.02 
11 13.466 14.910  1.444 0.95 1.05   0.10 0.07 0.07   0.00 
12   7.825   8.582  0.757 1.12 1.03 -0.09 0.14 0.12 -0.02 
13 12.616 12.910  0.294 0.63 0.63   0.00 0.05 0.05   0.00 
14   6.729   6.179 -0.550 0.53 0.56   0.03 0.08 0.09   0.01 
15   8.365   8.960  0.595 1.02 1.18   0.16 0.12 0.13   0.01 
16   6.329   6.582  0.253 0.63 0.62 -0.01 0.10 0.09 -0.01 
17 10.044 11.545  1.501 0.90 1.01   0.11 0.09 0.09   0.00 
18 20.577 19.056 -1.521 1.20 1.29   0.09 0.06 0.07   0.01 
19 10.188   9.544 -0.644 0.63 0.60 -0.03 0.06 0.06   0.00 
20   7.006   7.802  0.796 0.92 0.83 -0.09 0.13 0.11 -0.02 
21   7.008   7.362  0.354 0.82 0.83   0.01 0.12 0.11 -0.01 
RMS%RE     9.82   10.16   10.35 
 




Exp Average Migration Time (t) 
(min) 
    Exp          Pred     Pred-Exp 
Resolution (Rs) 
 
    Exp          Pred     Pred-Exp 
Rs/t (per min) 
 
    Exp          Pred     Pred-Exp 
1   6.958   7.484   0.526 0.63 0.53 -0.10 0.09 0.07 -0.02 
2 16.212 14.340 -1.872 0.57 0.59   0.02 0.04 0.04   0.00 
3 14.830 14.177 -0.653 0.34 0.38   0.04 0.02 0.03   0.01 
4   8.304   9.145   0.841 0.50 0.45 -0.05 0.06 0.05 -0.01 
5 16.370 14.358 -2.012 0.92 0.58 -0.34 0.06 0.04 -0.02 
6   5.640   4.643 -1.000 0.59 0.54 -0.05 0.10 0.12 -0.02 
7   6.020   5.655 -0.365 0.39 0.40   0.01 0.06 0.07   0.01 
8   8.934   9.827   0.893 0.66 0.59 -0.07 0.07 0.06 -0.01 
9 11.409 11.517   0.108 0.70 0.59 -0.11 0.06 0.05 -0.01 
10   9.569  9.852   0.283 0.81 0.67 -0.14 0.08 0.07 -0.01 
11 10.358 10.839   0.481 0.41 0.45   0.04 0.04 0.04   0.00 
12 17.328 15.533 -1.795 0.59 0.65   0.06 0.03 0.04   0.01 
13   6.489   6.333 -0.156 0.60 0.54 -0.06 0.09 0.09   0.00 
14   8.559   9.646   1.087 0.36 0.39   0.03 0.04 0.04   0.00 
15 12.345 12.177 -0.168 0.78 0.74 -0.04 0.06 0.06   0.00 
RMS%RE     9.06   14.27   21.31 
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Exp Average Migration Time (t) 
(min) 
    Exp          Pred     Pred-Exp 
Resolution (Rs) 
 
    Exp          Pred     Pred-Exp 
Rs/t (per min) 
 
    Exp          Pred     Pred-Exp 
1 13.323 13.740   0.417 1.27 1.07 -0.20 0.10 0.08 -0.02 
2 11.619 13.853   2.234 1.70 1.41 -0.29 0.15 0.10 -0.05 
3 14.829 16.827   1.998 1.62 1.39 -0.23 0.11 0.08 -0.03 
4   7.898   5.024 -2.874 1.01 0.98 -0.03 0.13 0.12 -0.01 
5 11.600 13.036   1.436 1.42 1.43   0.01 0.12 0.11 -0.01 
6 14.009 15.692   1.683 1.26 1.22 -0.04 0.09 0.08 -0.01 
7 20.943 20.658 -0.285 0.94 0.73 -0.21 0.04 0.04   0.00 
8   9.797 12.015   2.218 1.72 1.60 -0.12 0.18 0.13 -0.05 
9 16.544 19.410   2.866 0.26 0.21 -0.05 0.02 0.01 -0.01 
10 14.795 16.940   2.145 1.81 1.73 -0.08 0.12 0.10 -0.02 
11 15.561 17.962   2.401 1.55 1.56   0.01 0.10 0.09 -0.01 
12 22.246 23.704   1.458 1.64 1.67   0.03 0.07 0.07   0.00 
13 10.552 10.766   0.214 1.29 1.09 -0.20 0.12 0.10 -0.02 
14 26.820 22.887 -3.933 1.30 1.69   0.39 0.05 0.07   0.02 
15 12.747 11.788 -0.959 0.83 0.92   0.09 0.07 0.08   0.01 
16 28.589 22.610 -5.979 0.78 0.88   0.10 0.03 0.04   0.01 
17 20.666 21.752  1.086 1.58 1.52 -0.06 0.08 0.07 -0.01 
RMS%RE    15.77   13.62   23.60 
 
Appendix II.C Validation of coumachlor. 
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Exp Average Migration Time (t) 
(min) 
    Exp          Pred     Pred-Exp 
Resolution (Rs) 
 
    Exp          Pred     Pred-Exp 
Rs/t (per min) 
 
    Exp          Pred     Pred-Exp 
1 22.650 18.721 -3.929 0.88 0.92   0.04 0.04 0.05   0.01 
2 14.688 15.150  0.462 0.83 0.81 -0.02 0.06 0.05  -0.01 
3 17.866 16.658 -1.208 0.59 0.63   0.04 0.04 0.04   0.00 
4 22.141 19.345 -2.796 1.04 1.14   0.10 0.05 0.06   0.01 
5   7.387   6.040 -1.347 0.11 0.12   0.01 0.01 0.02   0.01 
6 13.180 13.810   0.630 0.68 0.56 -0.12 0.05 0.04  -0.01 
7 16.701 16.034 -0.667 0.39 0.42   0.03 0.02 0.03   0.01 
8 12.533 12.202 -0.331 0.83 0.91   0.08 0.07 0.07   0.00 
9 13.990 14.526   0.536 0.55 0.59   0.04 0.04 0.04   0.00 
10   9.465   8.001 -1.464 0.49 0.58   0.09 0.05 0.07   0.02 
11   9.719   9.611 -0.108 0.24 0.23 -0.01 0.02 0.02   0.00 
12   7.631   6.663 -0.968 0.34 0.33 -0.01 0.04 0.05   0.01 
13 22.647 18.098 -4.549 0.60 0.71   0.11 0.03 0.04   0.01 
14 17.611 16.754 -0.857 0.42 0.45   0.03 0.02 0.03   0.01 
15 10.551 10.955   0.404 0.50 0.48 -0.02 0.05 0.04  -0.01 
RMS%RE    15.77   13.62   23.60 
 
Appendix II.D Validation of warfarin. 
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Exp Average Migration Time (t) 
(min) 
    Exp          Pred     Pred-Exp 
Resolution (Rs) 
 
 Exp          Pred     Pred-Exp 
Rs/t (per min) 
 
    Exp          Pred     Pred-Exp 
1 44.933 44.383   -0.550 0.86 0.86   0.00 0.02 0.02   0.00 
2 20.770 24.893    4.127 0.58 0.58    0.00 0.03 0.02  -0.01 
3 18.756 19.571    0.815 0.92 0.85  -0.07 0.05 0.04  -0.01 
4 23.656 27.385    3.729 0.87 0.87   0.00 0.04 0.03  -0.01 
5 43.177 46.835    3.658 0.78 0.84   0.06 0.02 0.02   0.00 
6 49.311 49.705    0.394 0.62 0.59  -0.03 0.01 0.01   0.00 
7 59.368 42.931 -16.437 0.88 0.97   0.09 0.01 0.02   0.01 
8 53.178 49.746   -3.432 0.87 0.89   0.02 0.02 0.02   0.00 
9 26.756 29.256    2.500 0.41 0.52   0.11 0.02 0.02   0.00 
10 37.667 40.020    2.353 0.89 0.91   0.02 0.02 0.02   0.00 
11 14.967 12.297   -2.670 0.85 0.84  -0.01 0.06 0.07   0.01 
12 22.081 24.933    2.852 0.95 0.89  -0.06 0.04 0.04   0.00 
13 45.142 41.932   -3.210 0.81 0.88   0.07 0.02 0.02   0.00 
14 29.297 34.618    5.321 0.55 0.56   0.01 0.02 0.02   0.00 
15 53.350 48.706   -4.644 0.34 0.49   0.15 0.01 0.01   0.00 
16 28.453 31.748    3.295 0.79 0.81   0.02 0.03 0.03   0.00 
17 17.546 18.119    0.573 0.94 0.96   0.02 0.05 0.05   0.00 
18 26.275 30.296    4.021 0.78 0.93   0.15 0.03 0.03   0.00 
RMS%RE    12.83    13.78   26.26 
 
 
Appendix II.E Validation of lorazepam. 
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Exp Average Migration Time (t) 
(min) 
    Exp          Pred     Pred-Exp 
Resolution (Rs) 
 
    Exp          Pred     Pred-Exp 
Rs/t (per min) 
 
    Exp          Pred     Pred-Exp 
1 18.514 19.760  1.246 0.87 0.71 -0.16 0.05 0.04 -0.01 
2 17.969 18.787  0.818 0.48 0.39 -0.09 0.03 0.02 -0.01 
3 38.459 38.753  0.294 0.83 0.89   0.06 0.02 0.02  0.00 
4 26.278 26.533  0.255 0.57 0.50 -0.07 0.02 0.02  0.00 
5 30.902 30.892 -0.010 0.79 0.72 -0.07 0.03 0.02 -0.01 
6 28.778 32.684  3.906 0.95 0.89 -0.06 0.03 0.03  0.00 
7 16.763 18.083  1.320 0.76 0.60 -0.16 0.05 0.03 -0.02 
8 37.487 35.252 -2.235 0.95 0.93 -0.02 0.03 0.03  0.00 
9 35.079 36.071  0.992 0.80 0.78 -0.02 0.02 0.02  0.00 
10 12.980 11.041 -1.939 0.33 0.27 -0.06 0.03 0.02 -0.01 
11 14.211 13.723 -0.488 0.42 0.38 -0.04 0.03 0.03  0.00 
12 16.929 20.580  3.651 0.61 0.56 -0.05 0.04 0.03 -0.01 
13 15.248 15.400  0.152 0.66 0.49 -0.17 0.04 0.03 -0.01 
14 26.735 31.007  4.272 0.73 0.78  0.05 0.03 0.03  0.00 
15 24.412 24.971  0.559 0.36 0.46  0.10 0.01 0.02  0.01 
16 14.992 15.515  0.523 0.41 0.55  0.14 0.03 0.04  0.01 
17 12.992 10.336 -2.656 0.56 0.49 -0.07 0.04 0.05  0.01 
18 14.922 16.220  1.298 0.33 0.34  0.01 0.02 0.02  0.00 
19 45.145 37.076 -8.069 0.64 0.79  0.15 0.01 0.02  0.01 
20 32.552 29.182 -3.370 1.09 0.93 -0.16 0.03 0.03  0.00 
RMS%RE     10.61   16.63   37.63 
 
Appendix II.F Validation of temazepam. 
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Exp Average Migration Time (t) 
(min) 
    Exp          Pred     Pred-Exp 
Resolution (Rs) 
 
    Exp          Pred     Pred-Exp 
Rs/t (per min) 
 
    Exp          Pred     Pred-Exp 
 
1 35.059 35.295 0.236 26.91 34.89 7.98 0.77 0.76  -0.01
2 13.152 15.239 2.087 30.03 24.95 -5.08 2.28 2.50  0.21
3 21.368 21.548 0.180 26.52 23.94 -2.58 1.24 1.29 0.05
4 21.787 22.548 0.761 30.56 31.38 0.82 1.40 1.49 0.09
5 10.958 11.958  1.001 26.40 27.00 0.60 2.41 2.97 0.56
6 17.556 15.239 -2.317 30.92 25.03 -5.89 1.76 1.97 0.21
7 29.447 33.548  4.102 31.15 31.56 0.41 1.06 1.65 0.59
8 10.243 11.485 1.243 26.38 27.97 1.59 2.58 2.98 0.40
9 9.127 9.219 0.092 27.44 23.67 -3.77 3.01 3.21 0.20
10 17.211 20.395 3.185 33.28 27.56 -5.72 1.93 1.95 0.01
11 14.711 16.493 1.782 24.57 29.24 4.67 1.67 1.29  -0.38
12 12.605 14.389 1.785 29.91 24.35 -5.56 2.37 2.87 0.50
13 24.697 25.485 0.788 25.71 26.68 0.97 1.04 1.06 0.02
14 11.484 13.210 1.726 24.63 30.02 5.39 2.14 2.50 0.35
15 15.374 17.590 2.216 32.38 23.76 -8.62 2.11 2.96 0.85
16 14.305 14.395 0.090 25.24 21.70 -3.54 1.76 2.14 0.37
17 14.321 15.340 1.019 29.58 28.65 -0.93 2.07 2.05 -0.01
18 29.420 29.596 0.176 27.87 35.67 7.80 0.95 1.35 0.40
19 24.787 30.493 5.707 22.43 27.77 5.34 0.90 1.39 0.49
20 13.681 14.398 0.717 25.71 32.86 7.15 1.88 2.98 1.10
21 12.263 12.495 0.233 27.15 31.30 4.15 2.21 2.60 0.38
22 18.412 22.495 4.083 27.79 27.09 -0.70 1.51 1.97 0.46
23 30.311 34.590 4.279 24.10 30.60 6.50 0.80 1.39 0.60
24 22.052 24.609 2.557 27.28 32.34 5.06 1.24 1.55 0.31
RMS%RE     11.97       17.92       31.08 
 
Appendix II.G Validation of achiral chlorophenols. 
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Exp Average Migration Time (t) 
(min) 
    Exp          Pred     Pred-Exp 
Resolution (Rs) 
 
    Exp          Pred     Pred-Exp 
Rs/t (per min) 
 
    Exp          Pred     Pred-Exp 
 
1 42.289 43.294  1.005 38.47 38.19 -0.28 0.91 1.24  0.33 
2 38.299 38.298 -0.001 18.91 19.29  0.38 0.49 0.59  0.10 
3 35.059 35.392  0.333 26.91 34.39  7.48 0.77 0.94  0.17 
4 13.152 16.492  3.340 30.03 31.29  1.26 2.28 2.39  0.11 
5 21.368 24.345  2.977 26.52 29.39  2.87 1.24 1.59  0.35 
6 21.787 25.395  3.609 30.56 39.29  8.73 1.40 1.59  0.18 
7 31.316 33.482  2.166 23.46 20.29 -3.17 0.75 0.93  0.18 
8 10.958 12.220  1.262 26.40 29.39  2.99 2.41 2.59  0.18 
9 17.556 15.385 -2.171 30.92 35.39  4.47 1.76 1.94  0.18 
10 29.447 32.495  3.048 31.15 39.29  8.14 1.06 1.50  0.44 
11  9.500   9.284 -0.216 27.94 28.39  0.45 2.94 3.29  0.35 
12 10.243 12.492  2.250 26.38 29.39  3.01 2.58 2.85  0.27 
13  9.069   9.492  0.423 30.10 30.19  0.09 3.32 3.20 -0.11 
14  9.127   9.293  0.166 27.44 21.39 -6.05 3.01 3.45  0.44 
15 17.211 18.393  1.182 33.28 38.48  5.20 1.93 2.21  0.28 
16 14.711 14.296 -0.415 24.57 28.49  3.92 1.67 1.84  0.17 
17 12.605 13.248  0.644 29.91 35.49  5.58 2.37 2.94  0.57 
18 44.504 45.395  0.891 24.59 28.49  3.90 0.55 0.69  0.14 
19 24.697 25.394  0.697 25.71 25.28 -0.43 1.04 1.40  0.36 
20 11.484 11.592  0.108 24.63 25.39  0.76 2.14 2.35  0.20 
21 15.374 16.394  1.020 32.38 34.29  1.91 2.11 2.39  0.29 
22 14.305 15.292  0.987 25.24 27.49  2.25 1.76 1.39 -0.37 
23 14.321 16.393  2.072 29.58 31.29  1.71 2.07 2.49  0.43 
24 29.420 32.194  2.774 27.87 29.39  1.52 0.95 1.39  0.45 
25 24.787 25.308  0.522 22.43 26.49 4.06 0.90 1.49  0.59 
RMS%RE     10.12    14.37     25.63 
 



















































































FIGURES OF MERIT OBTAINED FROM MULTIPLE REGRESSION ANALYSIS OF 






Slope Offset Wavelength 
range 
BNA (25:75 MeOH/H20) 
BNA (75:25 MeOH/H20) 
 
TFA (25:75 MeOH/H20) 
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Appendix V. A Actual and predicted mole fraction of 1.0 × 10-5 M enantiomers of
fluorescent analytes with optimum concentration of poly-L-SUF in 25:75 
methanol/water. 
Act S TFA 
mol frac 
Pred S TFA 
mol frac 
S TFA 
































Act R TFA 
mol frac 
Pred R TFA 
mol frac 
R TFA 
































Act S PROP 
mol frac 
Pred S PROP 
mol frac 
S PROP 
rel error % 
Act S NPRX 
mol frac 
Pred S NPRX 
mol frac 
S NPRX 
































































Act R PROP 
mol frac 
Pred R PROP 
mol frac 
R PROP 
rel error % 
Act R NPRX 
mol frac 
Pred R NPRX 
mol frac 
R NPRX 




























































































































































































Appendix V.B  Actual and predicted mole fraction of 1.0 × 10-5 M enantiomers of non-
fluorescent analytes with optimum concentration of poly-L-SUF in 25:75 
methanol/water. 
Act S CIT 
mol frac 
Pred S CIT 
mol frac 
S CIT 
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Act S LIM 
mol frac 
Pred S LIM 
mol frac 
S LIM 
rel error % 
Act S CME 
mol frac 
Pred S CME 
mol frac 
S CME 





















    2.21 
    1.88 
    1.73 
   -2.92 
   -4.00 
    3.33 
  -4.57 
  -2.22 
  -8.67 
-22.00 





















   1.29 
   4.12 
  -2.93 
   2.31 
  -3.82 
  -2.22 
   3.14 
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   5.33 
16.00 
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mol frac 
Pred R LIM 
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rel error % 
Act R CME 
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Appendix V.C Actual and predicted mole fraction of 1.0 × 10-5 M enantiomers of 
fluorescent analytes with optimum concentration of poly-L-SUF in 75:25 
methanol/water. 
Act S PROP 
mol frac 
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S PROP 
rel error % 
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Appendix V.D Actual and predicted mole fraction of 1.0 × 10-5 M enantiomers of non-
fluorescent analytes with optimum concentration of poly-L-SUF in 75:25 
methanol/water. 
 
Act S LIM 
mol frac 
Pred S LIM 
mol frac 
S LIM 
rel error % 
Act S CME 
mol frac 
Pred S CME 
mol frac 
S CME 





















    0.95 
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